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1. Summary 
 
GABAB receptors are G-protein coupled receptors for gamma-amino butyric acid, the 
main inhibitory neurotransmitter in the brain. Functional GABAB receptors are obligate 
heterodimers composed of GABAB1 and GABAB2 subunits. The GABAB1 subunit exists in 
two isoforms, GABAB1a and GABAB1b, that can be differentiated by a pair of sushi domains 
exclusively located on the ectodomain of GABAB1a. As a consequence, two distinct 
receptor subtypes, GABAB(1a,2) and GABAB(1b,2), are present in the brain. Depending on 
their subcellular localization, GABAB receptors exert distinct regulatory effects on synaptic 
transmission. Presynaptically, GABAB receptors inhibit Ca
2+ influx by closing voltage-gated 
Ca2+-channels therefore regulating neurotransmitter release. Postsynaptically, GABAB 
receptors activate inwardly rectifying Kir3-type K+-channels leading to hyperpolarisation 
of the postsynaptic membrane. Recently, it has become clear that GABAB(1a,2) and 
GABAB(1b,2) receptors convey individual functions, which are, at least in part, related to 
their distinct subcellular distribution. 
 
The aim of this thesis was to gain further insight into the function of GABAB receptors by 
characterizing their localization at the ultrastructural level in respect to effector channels 
and subtype composition. Moreover, it was of interest to study the dynamic regulation of 
GABAB receptors in response to synaptic activity. 
 
In the first part of this thesis, the localization of GABAB receptors and Kir3-type effector 
channels was investigated in the CA1 region of the hippocampus. It could be 
demonstrated that postsynaptic GABAB receptors colocalize with the Kir3.2 subunit of K
+-
channels in dendritic spines, but not in dendritic shafts of CA1 pyramidal cells (chapter 
6.1.; Kulik et al., 2006). 
The differential distribution of GABAB1 subunit isoforms at the mossy fiber-CA3 pyramidal 
neuron synapse was investigated in the second part of this work. Due to the lack of 
isoform specific antibodies, mice selectively expressing GABAB1a or GABAB1b were used. It 
could be shown that mainly the GABAB1a subunit isoform contributes to the composition 
of presynaptic GABAB receptors whereas GABAB1b is the predominant GABAB1 subunit 
isoform on the postsynaptic side. Electrophysiological recordings were used to assess the 
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contribution of the two different GABAB1 subunit isoforms to functional pre- and 
postsynaptic receptors in response to pharmacological as well as physiological GABAB 
receptor activation. The findings illustrate that the spatial segregation of GABAB1 subunit 
isoforms at mossy fiber terminals is sufficient to produce a strictly subtype–specific 
response (chapter 6.2.; Guetg et al., 2009). 
In the third part of this work, a new mouse model containing a GABAB1-eGFP transgene, 
allowing the visualization of GABAB receptors, was generated. Crossing the GABAB1-eGFP 
transgene into the GABAB1 deficient background allowed the study of GABAB receptors 
tagged with a fluorescent protein under expression of endogenous promoter elements. 
Therefore these mice provide a useful tool to visualize the spatio-temporal distribution of 
GABAB receptors in vivo and in vitro (chapter 6.3.; Casanova et al., 2009). 
The dynamic regulation of surface GABAB receptors induced by glutamate was 
investigated in primary hippocampal neurons and the results are presented in the last 
part of this thesis. Activation of NMDA receptors resulted in a decrease of surface GABAB 
receptor levels. This decrease involved Ca2+-dependent activation of CaMKII. A CaMKII 
phosphorylation site within the cytoplasmic domain of the GABAB1 subunit was identified. 
Evidence that phosphorylation of this site is essential for the observed effect of NMDA 
receptor activation on GABAB surface receptors is presented in this thesis. In conclusion, 
it could be demonstrated that GABAB receptors are dynamically regulated and interact 
with other receptors and kinases. The results obtained, implicate that activity-dependent 
regulation of GABAB receptors is potentially involved in the modulation of synaptic 
strength (chapter 6.4.). 
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2. Abbreviations 
 
AMPA   α-amino-3-hydroxyle-5-methyl-4-isoxazole-propionate 
AMPK   5’AMP-dependent protein kinase 
APV   D-(-)-2-Amino-5-phosphonopentanoic acid 
BAC   bacterial artificial chromosome 
Ca2+/CaM   Ca2+/Calmodulin 
CaMKII   Ca2+/Calmodulin-dependent kinase II 
DIV   day in vitro 
eGFP   enhanced green fluorescent protein 
EPSC   excitatory postsynaptic current 
ER  endoplasmic reticulum 
ESI-MS/MS  electrospray-ionisation mass spectrometry 
GABA   gamma-amino butyric acide 
GABAA   gamma-amino butyric acid type A 
GABAB   gamma-amino butyric acide type B 
GABAB1
-/-   GABAB1 deficient 
GABAB2
-/-   GABAB2 deficient 
GABAC   gamma-amino butyric acide type C 
GDP   guanosine diphosphate 
GHB   gamma-hydroxybutyrate 
GPCR   G-protein coupled receptor 
GTP   guanosine-5'-triphosphate 
IPSC   inhibitory postsynaptic current 
KN-93 N-[2-[[[3-(4-Chlorophenyl)-2-propenyl]methylamino]- 
methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxy-
benzenesulphonamide 
LTD   long term depression 
LTP   long term potentiation 
mGluR   metabotropic glutamate receptor 
MF   mossy fiber 
NMDA   N-methyl-D-aspartate 
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PKA   cyclic AMP-dependent protein kinase 
PSD   postsynaptic density 
RP-HPLC   reverse-phase high-pressure liquid chromatography 
WT   wild-type 
1a-/-   GABAB1a deficient 
1b-/-   GABAB1b deficient 
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3. Preface 
 
This thesis is based on the following papers that are published or in preparation. Asterisks 
(*) indicate equal contributions by the authors. 
 
I. Compartment-dependent colocalization of Kir3.2-containing K+ channels and 
GABAB receptors in hippocampal pyramidal cells 
Kulik A, Vida I, Fukazawa Y, Guetg N, Kasugai Y, Marker CL, Rigato F, Bettler B, 
Wickman K, Frotscher M, Shigemoto R 
The Journal of Neuroscience 2006; 26:4289-97. 
 
II. The GABAB1a isoform mediates heterosynaptic depression at hippocampal 
mossy fiber synapses 
Guetg N*, Seddik R*, Vigot R, Turecek R, Gassmann M, Vogt KE, Bräuner-
Osborne H, Shigemoto R, Kretz O, Frotscher M, Kulik A, 
Bettler B 
The Journal of Neuroscience 2009; 29:1414-23 
 
III.  A mouse model for visualization of GABAB receptors 
Casanova E*, Guetg N*, Vigot R, Seddik R, Julio-Pieper M, Hyland NP, Cryan JF, 
Gassmann M, and Bettler B 
Genesis 2009; 47:595-602 
 
IV. NMDA Receptor-Dependent GABAB Receptor Internalization via CaMKII 
Phosphorylation of Serine 867 in GABAB1 
Guetg N*, Abdel Aziz S*, Holbro N, Turecek R, Rose T, Seddik R, Gassmann M, 
Moes S, Jenoe P, Oertner TG, Casanova E, and Bettler B 
submitted 
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4. Background 
 
The brain is a complex biological organ of great computational capability 
that constructs our sensory experiences, regulates our thoughts and 
emotions, and controls our actions. 
(Eric R. Kandel) 
 
 
4.1. Synapses 
 
The human brain consists of billions of neurons communicating among each other to 
acquire, coordinate and disseminate information about the body and its environment. 
Communication between nerve cells is achieved through synapses, which transfer 
information by using electrical and chemical signals. 
Electrical synapses are composed of specialized membrane channels localized in the pre- 
and postsynaptic plasma membrane, termed gap junctions. These membrane proteins 
are paired and aligned to form a pore connecting the pre- and postsynaptic cells. Through 
this relatively large pore a subset of substances including ions can simply diffuse. Action 
potential generation creates an altered ionic balance in the presynaptic side of an 
electrical synapse. As a result, ions diffuse through the pore which then changes the 
membrane potential of the associated postsynaptic cell (Sohl et al., 2005). 
The second type of synapse is the chemical synapse. Presynaptic terminals contain 
membrane bound vesicles which are filled with neurotransmitters, the chemical 
components responsible for transmitting the signal between neurons. A change in 
membrane potential caused by an incoming action potential leads to the activation of 
voltage-gated Ca2+-channels localized on the presynaptic terminal. The consequence is a 
rapid influx of Ca2+ ions. The increased presynaptic Ca2+ concentration leads to the fusion 
of the vesicles with the presynaptic membrane and the release of neurotransmitters in 
the synaptic cleft. Neurotransmitters diffuse through the synaptic cleft and bind to and 
activate receptors localized in the postsynaptic membrane. This leads to the opening of 
postsynaptic ion channels, and to changes in conductance and membrane potential of the 
postsynaptic cell (Becherer and Rettig, 2006; Di Maio, 2008). 
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The advantage of electrical synapses is the bidirectional nature of the transmission and its 
high speed. This facilitates the synchronization of signals over a population of neurons. In 
contrast, chemical synapses are slower but enable more specific and controlled way of 
transmitting signals. 
 
 
4.2. Ionotropic and metabotropic receptors 
 
Excitatory as well as inhibitory neurotransmitters act on two types of receptors; 
ionotropic and metabotropic receptors. 
Ionotropic receptors mediate rapid communication between neurons. They are generally 
assembled from multiple subunits and form channels across the plasma membrane. 
Different subunit compositions result in different receptor characteristics and therefore 
specify and enlarge the range of functions associated with each receptor. An advantage 
of ionotropic receptors is the direct coupling of the neurotransmitter to the pore-forming 
channels. Upon neurotransmitter binding, a conformational change occurs allowing the 
flow of cations or anions across the membrane. The main class of excitatory ionotropic 
receptors are the glutamate receptors, consisting of the N-methyl-D-aspartate (NMDA) 
receptors, α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors and 
kainate receptors. The main class of inhibitory ionotropic receptors are the gamma-amino 
butyric acid type A (GABAA) and glycine receptors (Barrera and Edwardson, 2008; Lodge, 
2009). 
In contrast to ionotropic receptors, metabotropic receptors cannot serve themselves as 
channels for ion flow. They are G-protein coupled receptors (GPCRs). The classical GPCR 
signaling is mediated by coupling of receptors to heterotrimeric G-proteins and the 
subsequent regulation of numerous intracellular pathways. Upon agonist binding, the G-
protein bound guanosine diphosphate (GDP) is exchanged for guanosine-5'-triphosphate 
(GTP) causing the heterotrimer dissociation into a Gα subunit and a Gβγ-dimer, both of 
which independently activate or inhibit different effectors such as adenylyl cyclase, 
phospholipases and ion channels. Hydrolysis of GTP to GDP by GTPase activity terminates 
the signal. Three classes of glutamate induced metabotropic receptors (mGluRs) exist. 
They are classified by their sequence similarity, pharmacology and intracellular signaling 
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mechanism. The metabotropic receptor for GABA is the gamma-amino butyric acide type 
B (GABAB) receptor which will be described in more detail in a following section (Bouvier, 
2001; Prinster et al., 2005; Jacoby et al., 2006; Smrcka, 2008). 
 
 
4.3. Glutamate receptors 
 
L-glutamate (referred to as glutamate), the main excitatory neurotransmitter in the 
central nervous system, was first identified by Curtis and colleagues in the late fifties 
(Curtis et al., 1959). Glutamate released from a presynaptic neuron activates ionotropic 
as well as metabotropic glutamate receptors. Based on pharmacological and structural 
criteria, the ionotropic glutamate receptors are subdivided into three major classes; 
NMDA, AMPA and kainate receptors. In addition, glutamate can also activate the three 
classes of mGluRs (Collingridge and Lester, 1989). The ionotropic glutamate receptors are 
named according to their pharmacological agonists. One glutamate receptor, studied in 
this thesis, is the NMDA receptor and is therefore described in more detail. 
Postsynaptic NMDA receptors are heterotetramers composed of NR1, NR2 (NR2A-D) and 
NR3 (A and B) subunits. Most functional NMDA receptors are formed by NR1 and NR2 
subunits in which the NR1/NR2A heteromer represent the functional unit (Furukawa et 
al., 2005; Kohr, 2006). The NMDA receptor contains an extracellular binding site for 
glutamate and glycine and is blocked in a voltage-dependent way by the presence of a 
Mg2+ ion in the channel pore. (Lynch et al., 1983; Mayer et al., 1984; Nowak et al., 1984). 
Under physiological conditions, the Mg2+ block is removed by depolarization of the 
postsynaptic membrane induced by AMPA receptor activation. AMPA receptors primarily 
function as Na+ channels, with rapid activation kinetics. The NMDA receptor is permeable 
for Na+ and K+ ions; and unlike AMPA receptors, they are also permeable to Ca2+ and are 
characterized by their slow kinetics (Lynch et al., 1983). The binding of the obligate co-
agonist glycine potentiates the channel conductance of NMDA receptors (Dingledine et 
al., 1990). However, it is still controversial if saturating levels of glycine are present under 
physiological conditions (Yang and Svensson, 2008; Li et al., 2009). The NMDA receptors 
are believed to be the main pathway for Ca2+ entry into dendritic spines during synaptic 
activity (Mainen et al., 1999; Kovalchuk et al., 2000). The Ca2+ influx following NMDA 
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receptor activation is crucial for NMDA receptor-dependent plasticity and can promote 
the activation of Ca2+/Calmodulin-dependent kinase II (CaMKII) (Malenka et al., 1989b; 
Malenka et al., 1989a; Malinow et al., 1989; Lisman et al., 2002). 
 
 
4.4. The Ca2+/Calmodulin-dependent kinase II 
 
CaMKII is one of the most abundant serine/threonine kinases in the brain and is activated 
by binding of Ca2+/Calmodulin (Ca2+/CaM) (Bennett et al., 1983; Kennedy et al., 1983). 
CaMKII is present predominantly in dendritic spines and is a component of the 
postsynaptic density (PSD). After binding of Ca2+/CaM, autophosphorylation turns the 
kinase into an active state (Miller and Kennedy, 1986; Ouyang et al., 1997). Dissociation 
of Ca2+/CaM exposes two previously hidden sites which are subsequently 
autophosphorylated preventing maximal kinase activity (Meador et al., 1993). Many 
papers have been published describing substrates and binding partners of CaMKII. CaMKII 
is involved in synaptic plasticity and memory formation. Several mouse models with 
altered CaMKII function have been generated over the years and all of them show 
impaired memory and learning functions (Elgersma et al., 2004). CaMKII has been shown 
to be a key molecule in long term potentiation (LTP), an experimental molecular model 
for memory formation. The Ca2+ influx following NMDA receptor activation promotes 
CaMKII-dependent phosphorylation of AMPA receptors and their recruitment to the PSD 
in spines (Malenka et al., 1989b; Malenka and Nicoll, 1999; Shen and Meyer, 1999). 
Today, the main focus of CaMKII research addresses the question of 
compartmentalization and translocation of CaMKII. Recent findings propose that CaMKII 
activity is restricted to single spines and therefore influences synaptic plasticity with a 
high degree of specificity (Lee et al., 2009). 
 
 
4.5. GABA receptors 
 
Gamma aminobutyric acid (GABA), first identified by Roberts and Frankel, is the main 
inhibitory neurotransmitter in the central nervous system, (Roberts and Frankel 1950). 
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Activation of GABA receptors generally results in hyperpolarisation of the membrane. 
Two classes of GABA receptors, differing in pharmacology and structure, the ionotropic 
GABAA and metabotropic GABAB receptors, have been identified in the central nervous 
system. In addition, a third class, the GABAC activated receptors, has been described and 
is mainly found in the retina (Chebib, 2004). However some controversy remains whether 
these receptors constitute an independent class of receptors or if they are a subtype of 
GABAA receptors. 
Postsynaptic GABAA receptors clamp the membrane at negative potentials by increasing 
chloride conductance (Payne et al., 2003). GABAA receptors are heteropentamers 
composed of multiple subunits. Until now, sixteen different subunits (α1-6, β1-3, γ1-3, δ, ε, 
π, θ) have been identified and provide structural heterogeneity. Most GABAA receptors 
consist only of α-, β- and γ-subunits. The subunit composition determines the physiology 
and partially the localization of the receptor (Mohler et al., 1996). GABAA receptors 
contain a benzodiazepine and barbiturate binding site making them an attractive drug 
target for treatment of numerous neurological disorders such as anxiety and epilepsy 
(Foster and Kemp, 2006). Benzodiazepine binding increases the frequency of channel 
opening whereas barbiturates prolong the duration of chloride channel open state. The 
fast inhibitory postsynaptic currents (IPSCs) mediated by the ionotropic GABAA receptors 
can be distinguished from the slow IPSCs generated by metabotropic GABAB receptors. 
This receptor type is described in more detail in the following section. 
 
 
4.6. The GABAB receptor 
 
History 
Twenty years after the identification of GABA in the brain, the first specific GABAA 
antagonist, bicuculline, was described (Curtis et al., 1971). However, upon bicuculline 
application, some GABAergic effects remained, especially in the cerebral cortex. This was 
the first indication for the existence of multiple GABA receptor types. During the same 
time, the pharmaceutical industry brought the antispastic drug Lioresal (racemic 
baclofen) on the market. It was assumed that baclofen acts on non-classical, bicuculline-
insensitive GABA receptors. Nevertheless, it took 10 years before GABAB receptors were 
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first described (Bowery et al., 1979; Bowery et al., 1981; Hill and Bowery, 1981). First 
structural evidence came in 1984 with the finding that application of guanyl nucleotides 
reduces agonist affinity of GABAB receptors (Hill et al., 1984). This was the proof that the 
GABAB receptor is a G-protein coupled receptor. (Kerr and Ong, 1995) 
 
Structure 
Among G-protein coupled receptors, GABAB receptors are unique in that they require two 
distinct subunits, GABAB1 and GABAB2, to be functional (Jones et al., 1998; Kaupmann et 
al., 1998b; White et al., 1998; Kuner et al., 1999; Martin et al., 1999; Ng et al., 1999). Both 
subunits are seven-transmembrane domain proteins containing a long N-terminal domain 
and sharing a high degree of homology. However, within the GABAB heteromer the 
individual subunits exert unique functions. The GABAB1 subunit binds GABA whereas the 
GABAB2 subunit is responsible for G-protein coupling (Malitschek et al., 1999; Galvez et 
al., 2000). Subsequent studies revealed that the GABAB1 subunit cannot translocate to the 
cell surface in the absence of the GABAB2 subunit and remains in the endoplasmic 
reticulum (ER) (Couve et al., 1998). The GABAB1 C-terminus contains a retention motif, 
RSRR, which can be masked by the GABAB2 subunit upon assembly in the ER (Margeta-
Mitrovic et al., 2000; Pagano et al., 2001; Gassmann et al., 2005). As a consequence, the 
ER retention signal represents an important quality control mechanism that only allows 
correctly formed GABAB heterodimers to integrate into the plasma membrane. Mice 
lacking the GABAB1 or GABAB2 protein do not show any remaining physiological GABAB 
responses (Schuler et al., 2001; Gassmann et al., 2004). These data ultimately 
demonstrate that both receptor subunits, GABAB1 and GABAB2, are required for the 
formation of functional GABAB receptors. 
Molecular diversity in the GABAB system is based on the subunit isoforms GABAB1a and 
GABAB1b, which are encoded by the same gene but independently regulated at the 
transcriptional level (Steiger et al., 2004). The only structural difference between GABAB1a 
and GABAB1b are the two N-terminal sushi domains unique to GABAB1a (Blein et al., 2004). 
No pharmacological difference in agonist binding has been described for the subunit 
isoforms in vitro in heterologous cells (Kaupmann et al., 1997). The differential 
distribution and the subsequent differential coupling to effector channels are discussed in 
more detail in the following chapters. 
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Figure 4.1. Structure and physiological role of GABAB receptors. GABAB receptors form 
obligate heterodimers composed of GABAB1 and GABAB2 subunits. The GABAB1 subunit 
contains the GABA binding site whereas the GABAB2 subunit couples to the G-protein. 
Two isoforms, GABAB1a and GABAB1b, exist, differing in the two sushi domains at the N-
terminus. Upon activation of GABAB receptors and the subsequent dissociation of the G-
protein, the Gi/oα subunit inhibits adenylyl cylclase, whereas Gβγ-dimer translocates and 
binds to effector channels. Presynaptically, GABAB receptor activation results in 
inhibition of voltage gated Ca2+-channels and therefore in the inhibition of 
neurotransmitter release. Postsynaptically, the coupling of the Gβγ-dimer to Kir3-type 
K+-channels results in accelerated K+ efflux and therefore in inhibition of the 
postsynaptic cell. 
 
 
Physiological function 
GABAB receptors are metabotropic receptors and as such their physiological effects are 
mediated through G-protein activation. The GABAB receptor predominantly couples to 
Giα- and Goα-type G-proteins (Campbell et al., 1993; Greif et al., 2000). After activation of 
the GABAB receptor, the coupled G-protein dissociates into the Gα subunit and the Gβγ-
dimer modulating signaling cascades and effector channels. 
Presynaptically, GABAB receptors control the release of GABA (autoreceptors) and other 
neurotransmitters (heteroreceptors), which is primarily mediated by the Gβγ-dimer 
(Bowery et al., 2002). Coupling of the Gβγ-dimer to the voltage-gated P/Q- (Cav2.1) and 
N-type (Cav2.2) Ca
2+-channels decreases their conductance, thereby inhibiting 
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neurotransmitter release (Mintz and Bean, 1993; Santos et al., 1995; Herlitze et al., 1996; 
Ikeda, 1996; Lambert and Wilson, 1996; Poncer et al., 1997). In addition, the Gi/oα subunit 
reduces intracellular cAMP levels through inhibition of adenylyl cyclase. This restricts 
vesicle recruitment and priming (Xu and Wojcik, 1986; Knight and Bowery, 1996; 
Kaupmann et al., 1997; Sakaba and Neher, 2003). 
Postsynaptically, the Gβγ-dimer couples to inwardly rectifying Kir3-type K+-channels 
(Luscher et al., 1997; Kaupmann et al., 1998a). The activation of K+-channels results in a K+ 
efflux and therefore in cell hyperpolarization. GABAB receptors induce a slow inhibitory 
postsynaptic current (slow IPSC) which is distinct from the fast IPSC mediated by GABAA 
receptors (Otis et al., 1993). 
In electrophysiological experiments, presynaptic GABAB heteroreceptor and autoreceptor 
activity is revealed from the inhibition of excitatory postsynaptic currents (EPSCs) and 
IPSCs, respectively. Postsynaptic GABAB receptor activity is detected directly by recording 
Kir3-type K+-currents. 
 
Localization 
In early postnatal development, GABAB1 and GABAB2 subunits are observed mainly in 
neurons and to a lower level in glial cells (Lopez-Bendito et al., 2004; Lujan and 
Shigemoto, 2006). In the adult, GABAB receptors are expressed in the entire brain (Benke 
et al., 1999; Bischoff et al., 1999), and pre- and postsynaptic localization have been 
described for various brain regions including cerebellum and ventrobasal thalamus (Kulik 
et al., 2002), as well as hippocampus (Kulik et al., 2003). In the hippocampus, the GABAB 
receptor was found on GABAergic and glutamatergic terminals mainly extrasynaptically 
and only rarely at the presynaptic membrane specialization. Postsynaptically, the GABAB 
receptors were mainly found in the perisynaptic and extrasynaptic region of the spines of 
CA1 pyramidal cells. As a consequence most GABAB receptors are located distant from 
release sites and probably require pooling of synaptically released GABA to be activated. 
Significant advances in our understanding of GABAB receptor heterogeneity, particularly 
in respect to receptor localization and function, came with the generation of GABAB1a and 
GABAB1b deficient mice (from here on referred as 1a
-/- and 1b-/- respectively) (Vigot et al., 
2006). It was expected that GABAB1a and GABAB1b subunit isoforms have different 
physiological roles. However, the lack of isoform-specific pharmacological compounds 
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and antibodies made this issue hard to address. Therefore, an alternative appealing 
approach was the generation of mice selectively expressing GABAB1a or GABAB1b subunit 
isoforms. By using these mutant mice, several groups studied the localization and 
physiological function of the two subunit isoforms in different brain regions (Perez-Garci 
et al., 2006; Shaban et al., 2006; Vigot et al., 2006; Ulrich et al., 2007). 
Quantification of immunohistochemical experiments using electron microscopy revealed 
that, in the CA1 region of the hippocampus, GABAB1a was predominantly localized 
presynaptically on glutamatergic synapses whereas GABAB1b was more abundant 
postsynaptically. This distribution was confirmed with electrophysiological experiments 
showing that the inhibition of EPSCs was dramatically reduced in 1a-/- mice compared to 
wild-type (WT) mice. This indicates that GABAB(1a,2) is the main receptor contributing to 
presynaptic receptor function at CA3-CA1 synapses. Interestingly, no differences in 
inhibition of IPSCs were observed for 1a-/- and 1b-/- compared to WT mice indicating equal 
contribution of GABAB1a and GABAB1b subunit isoforms on presynaptic GABAergic 
terminals. Postsynaptically, 1a-/- mice show K+-currents similar to WT mice, whereas a 
50% reduction was reported in 1b-/- mice. This indicates that postsynaptic GABAB 
responses are predominantly mediated by the GABAB1b isoform (Vigot et al., 2006). In 
layer 5 neocortical pyramidal neurons inhibition of dendritic Ca2+ spikes was exclusively 
mediated by GABAB(1b,2) receptors whereas the presynaptic inhibition of GABA release 
was mediated through GABAB(1a,2) receptors (Perez-Garci et al., 2006). Studying the role of 
presynaptic GABAB receptors during NMDA-independent presynaptic LTP in the lateral 
amygdala revealed that GABAB1a, but not GABAB1b, is the main heteroreceptor-forming 
subunit isoform at cortical afferents (Shaban et al., 2006). Similar functional segregation 
of GABAB(1a,2) and GABAB(1b,2) receptors was also observed in the thalamus (Ulrich et al., 
2007). 
In conclusion, these studies revealed that GABAB1a and GABAB1b differentially influence 
synaptic functions, primarily as a result of their distinct distribution. However, to clearly 
establish a regulatory significance for GABAB receptor subtypes, it has to be 
demonstrated that they do not only generate differential effects in response to 
pharmacological but also in response to physiological activation. 
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Regulation and trafficking 
Regulation and trafficking of GABAB receptors are controversial topics in the field of 
GABAB research. As described above, GABAB receptors are assembled in the ER and it was 
assumed that they are transported as functional heterodimers. However, a recent 
publication proposes that GABAB1 and GABAB2 subunits are independently transported in 
dendritic intracellular compartments and assemble in the dendritic ER prior to insertion 
into the plasma membrane (Ramirez et al., 2009). 
The presence of receptors at the cell surface determines their availability to 
neurotransmitters and consequently their activity. In recent years, a number of 
publications have discussed agonist-induced internalization, degradation and recycling of 
GABAB receptors. GPCRs are known to desensitize as a result of agonist-induced 
internalization. However, it is generally believed that GABAB receptors are stably 
expressed at the cell surface despite agonist-induced GABAB receptor desensitization 
(Sickmann and Alzheimer, 2003; Cruz et al., 2004; Fairfax et al., 2004). Recently, it 
became clear that surface receptors undergo constitutive endocytosis and recycling in 
heterologous and in neuronal systems (Grampp et al., 2008; Vargas et al., 2008). 
Importantly, it was reported that glutamate regulates surface availability of GABAB 
receptors in cortical neurons by promoting the degradation of endocytosed receptors 
(Vargas et al., 2008). 
Similar to other GPCRs, the stability of GABAB receptors at the membrane can be 
modulated by phosphorylation. Phosphorylation of serine 892 on the GABAB2 subunit 
(GABAB2S982) through cyclic AMP-dependent protein kinase (PKA) increases GABAB 
surface stability and as a consequence reduces the desensitization of postsynaptic GABAB 
receptor responses (Couve et al., 2002). Similarly, phosphorylation of serine 783 on the 
GABAB2 subunit (GABAB2S783) by 5’AMP-dependent protein kinase (AMPK) is reported to 
stabilize postsynaptic cell surface GABAB receptors (Kuramoto et al., 2007). In addition, in 
vitro kinase assays, using GST-fusion proteins, identified serine 917 (GABAB1S917) and 
serine 923 (GABAB1S923) within the C-terminus of the GABAB1 subunits as AMPK 
phosphorylation sites. However, the physiological relevance for these phosphorylation 
sites has not been established yet (Kuramoto et al., 2007). 
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GABAB receptors and neurological disorders 
Neurological disorders such as bipolar disorders, anxiety, epilepsy and depression often 
result from an imbalance between excitation and inhibition. Therefore, ionotropic and 
metabotropic receptors are interesting therapeutic targets. A relatively wide range of 
drugs targeting GABAA are on the market. In contrast, only two GABAB receptor agonists 
are marketed. Gamma-hydroxybutyrate (GHB) (traded as XyremTM) is used in narcolepsy 
treatment. Baclofen (traded as LioresalTM) is a muscle relaxant used in the treatment of 
spasticity. Unfortunately, baclofen treatment leads to adverse reactions such as 
drowsiness, nausea, muscle weakness, hallucinations and mental confusion. Only one 
additional compound is currently in phase II clinical studies; a GABAB antagonist for 
potential for the treatment of Alzheimer’s disease. (Bowery, 2006; Foster and Kemp, 
2006) 
 
Future perspectives 
Despite the increasing knowledge gained since 1981 when Bowery et al. first described 
the GABAB receptor, many questions remain unanswered. Recombinant GABAB receptors 
do not fully reproduce the characteristic responses of native GABAB receptors. It is 
therefore believed that the interaction of native GABAB receptors with so far unknown 
proteins is crucial for their physiological function. One important field in GABAB research 
in the near future will therefore be the identification of interacting proteins and their 
influence on GABAB receptor regulation, localization, stabilization or desensitization. The 
sushi domains may represent a target for identifying interacting proteins and the 
subsequent description of functional properties. 
Studies have shown that GABAB receptors are not regulated in a way characteristic for 
classical GPCRs. Furthermore, not much is known about the modulation of GABAB 
receptors in response to synaptic activity. Therefore, it is necessary to further investigate 
the regulation of GABAB receptors in response to GABA and other neurotransmitters. 
Studying the regulatory mechanism of GABAB receptors involves the discovery and 
description of new phosphorylation sites on both subunits, GABAB1 and GABAB2. 
Furthermore, the functional interaction between GABAB receptors and other inhibitory as 
well as excitatory neurotransmitter receptors at single synapses is important to be 
understood. 
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Drug development represents the most important topic to be developed. Enormous work 
has been done to describe the structure, localization and function of the GABAB receptor. 
However, only two drugs have been marketed thus far and adverse reactions are known 
for baclofen treatment. It should be the final goal of GABAB receptor research to develop 
useful drugs based on the knowledge obtained from basic research. 
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6.1. Compartment-dependent colocalization of Kir3.2-containing K+ channels and 
GABAB receptors in hippocampal pyramidal cells 
 
Kulik A, Vida I, Fukazawa Y, Guetg N, Kasugai Y, Marker CL, Rigato F, Bettler B, 
Wickman K, Frotscher M, Shigemoto R 
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The inwardly rectifying Kir3-type K+-channels are the postsynaptic G-protein activated 
effector channels of GABAB receptors (Luscher et al., 1997). The Kir3-type channels are 
comprised of four subunits: Kir3.1, Kir3.2, Kir3.3 and Kir3.4 (Dascal, 1997). Kir3.1 and 
Kir3.2 are the prevalent subunits in the brain. This study investigates the spatial 
distribution and correlation of GABAB receptors and Kir3.2 in the rat hippocampus by 
using preembedding electron microscopy and SDS-digested freeze-fracture replica 
immunolabeling. 
Within this work, it was demonstrated that immunoreactivities for GABAB1 and Kir3.2 are 
similarly distributed in the hippocampus. In the CA1 area of the rat hippocampus, Kir3.2-
channels were enriched peri- and extrasynaptically and were observed only rarely in the 
synaptic membrane specialization. Quantitative analysis revealed that at asymmetrical 
synapses (putative glutamatergic synapses) both GABAB1 and Kir3.2 were enriched 
perisynaptically and that their distribution was overlapping. In contrast, at symmetrical 
synapses (putative GABAergic synapses) Kir3.2 and GABAB1 immunoparticles were 
distributed equally over the extrasynaptic space. 
Furthermore, the spatial relationship between Kir3.2 and GABAB1 immunoreactivity was 
investigated. Interestingly, a different relative distance between Kir3.2 and GABAB1 was 
observed in dendritic spines and dendritic shafts of CA1 pyramidal neurons. In 70% of the 
dendritic spines containing Kir3.2 and GABAB1, the distance between immunogold 
particles representing GABAB1 and Kir3.2 was less than 50nm. In contrast, the mean 
distance between GABAB1 and Kir3.2 immunogold particles in the dendritic shaft was 
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significantly increased. A similar distribution was observed in dendritic spines and shafts 
of CA3 pyramidal neurons. 
These data indicate that at least in the dendritic spines GABAB receptors and K
+-channels 
are clustered allowing efficient Gβγ-mediated effector coupling. Furthermore, it can be 
proposed that K+-channels, localized in the dendritic shaft of pyramidal cells, may be 
predominantly activated by other GPCRs than GABAB. It is possible that this differential 
distribution of Kir3.2–GABAB1 clusters provides an effective tool to control the 
postsynaptic inhibition of the neurons both temporally and spatially. 
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Compartment-Dependent Colocalization of Kir3.2-
Containing K Channels and GABAB Receptors in
Hippocampal Pyramidal Cells
A´kos Kulik,1,2 Imre Vida,1 Yugo Fukazawa,2,5Nicole Guetg,1,3 Yu Kasugai,2 Cheryl L. Marker,4 Franck Rigato,1
Bernhard Bettler,3 KevinWickman,4Michael Frotscher,1 and Ryuichi Shigemoto2,5,6
1Institute of Anatomy and Cell Biology, Department of Neuroanatomy, University of Freiburg, 79104 Freiburg, Germany, 2Division of Cerebral Structure,
National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan, 3Pharmazentrum, Department of Clinical–Biological Sciences, University
of Basel, 4056 Basel, Switzerland, 4Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, 5Department of Physiological
Sciences, The Graduate University of Advanced Studies (Sokendai), Myodaiji, Okazaki 444-8787, Japan, and 6SORST Japan Science and Technology
Corporation, Kawaguchi 332-0012, Japan
G-protein-coupled inwardly rectifying K channels (Kir3 channels) coupled to metabotropic GABAB receptors are essential for the
control of neuronal excitation. To determine the distribution of Kir3 channels and their spatial relationship to GABAB receptors on
hippocampal pyramidal cells, we used a high-resolution immunocytochemical approach. Immunoreactivity for the Kir3.2 subunit was
most abundant postsynaptically and localized to the extrasynaptic plasma membrane of dendritic shafts and spines of principal cells.
Quantitative analysis of immunogold particles for Kir3.2 revealed an enrichment of the protein around putative glutamatergic synapses
on dendritic spines, similar to that of GABAB1. Consistent with this observation, a high degree of coclustering of Kir3.2 and GABAB1 was
revealed around excitatory synapses by the highly sensitive SDS-digested freeze–fracture replica immunolabeling. In contrast, in den-
dritic shafts receptors and channels were found to be mainly segregated. These results suggest that Kir3.2-containing K channels on
dendritic spines preferentially mediate the effect of GABA, whereas channels on dendritic shafts are likely to be activated by other
neurotransmitters aswell. Thus, Kir3 channels, localized to different subcellular compartments of hippocampal principal cells, appear to
be differentially involved in synaptic integration in pyramidal cell dendrites.
Key words: GABAB1 ; Kir3; G-protein-coupled receptors; electron microscopy; immunocytochemistry; spillover
Introduction
Inwardly rectifying potassium channels play a crucial role in the
control of neuronal excitation by mediating slow inhibitory syn-
aptic responses and contributing to the restingmembrane poten-
tial (Hille, 1992; Chen and Johnston, 2005). A subfamily of in-
wardly rectifying channels (Kir3) is directly coupled to
G-proteins andmediates the effect ofmetabotropic receptors in a
membrane-delimited manner (Wickman et al., 1994; Huang et
al., 1995; Wickman and Clapham, 1995; Schreibmayer et al.,
1996; Dascal, 1997; Yamada et al., 1998; Stanfield et al., 2002;
Bichet et al., 2003). Kir3 channels serve as a common effector for
various neurotransmitters including the major inhibitory trans-
mitter GABA acting on type B receptors (GABABRs) (Andrade et
al., 1986; Mihara et al., 1987; North et al., 1987; Trussell and
Jackson, 1987; Lu¨scher et al., 1997; Sharon et al., 1997; Kaup-
mann et al., 1998; Torrecilla et al., 2002; Chen and Johnston,
2005; Koyrakh et al., 2005; Marker et al., 2005).
The mammalian Kir3 channel subfamily comprises four sub-
units designated Kir3.1, Kir3.2, Kir3.3, andKir3.4 (Dascal, 1997).
The functional channels exist as homotetrameric or heterotet-
rameric complexes (Inanobe et al., 1995; Kofuji et al., 1995;
Krapivinsky et al., 1995; Slesinger et al., 1996; Spauschus et al.,
1996;Wischmeyer et al., 1997). In the CNS, channels are thought
to bemainly composed of the Kir3.1 andKir3.2 subunits (Duprat
et al., 1995; Lesage et al., 1995; Leaney, 2003). Recent evidence
further suggests that the Kir3.2 subunit is an essential part of the
functional channel, determining its assembly and surface local-
ization (Inanobe et al., 1999; Ma et al., 2002). Indeed, lack of
Kir3.2 leads to reduced Kir3.1 expression (Liao et al., 1996; Si-
gnorini et al., 1997) and to loss of slow inhibitory postsynaptic
responses in hippocampal pyramidal cells (Lu¨scher et al., 1997).
Neurons in the hippocampal formation express high levels of
Kir3 subunit transcripts (Dixon et al., 1995; Kobayashi et al.,
1995; Karschin et al., 1996; Liao et al., 1996). Although a large
body of electrophysiological and pharmacological data are avail-
able on the function of these channels (Ga¨hwiler and Brown,
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1985; Andrade et al., 1986; Andrade and Nicoll, 1987; Nicoll,
1988; Sodickson and Bean, 1996; Lu¨scher et al., 1997; Takigawa
and Alzheimer, 2002, 2003; Leaney, 2003; Chen and Johnston,
2005), the localization of Kir3 in various subcellular compart-
ments of principal cell remains mostly unknown. Previous im-
munohistochemical studies showed high levels of Kir3 channels
in the dendrites of pyramidal cells (Ponce et al., 1996; Drake et al.,
1997), suggesting a subcellular distribution similar to that of
GABAB receptors (Kulik et al., 2003). To investigate the spatial
relationship of the channel and receptor, we studied the subcel-
lular localization of the Kir3.2 subunit and determined the
compartment-dependent colocalization ofKir3.2 andGABAB1 in
pyramidal cells by using high-resolution immunocytochemical
techniques. Interestingly, we found that Kir3.2 and GABAB1 are
mostly segregated on dendritic shafts, contacted by inhibitory
GABAergic boutons, whereas the two proteins are highly colocal-
ized on dendritic spines adjacent to the excitatory synapses.
Materials andMethods
Antibodies and controls
Antibodies. An affinity-purified polyclonal antibody specific for the
C-terminal domain of the Kir3.2 subunit (Lesage et al., 1994; Isomoto et
al., 1996) was purchased from Alomone Labs (Jerusalem, Israel). This
antibody recognizes the Kir3.2a and Kir3.2c splicing isoforms. It addi-
tionally recognizes the Kir3.2d isoform, which is predominantly ex-
pressed in testis (Inanobe et al., 1999). To localize GABAB receptors
composed of GABAB1 and GABAB2 subunits (Kaupmann et al., 1998),
two affinity-purified polyclonal antibodies recognizing both a and b
splice variants of theGABAB1 subunitwere used. The first antibody (B17)
was raised in rabbits, and its characteristics and specificity have been
described previously (Kulik et al., 2002, 2003). The second antibody
(B62) was raised in guinea pigs against a GST fusion protein containing
amino acid residues 857–960 of the GABAB1 protein (Kaupmann et al.,
1997). Its specificity was confirmed by immunoblot analysis: it gave rise
to two immunoreactive bands withmolecularmasses of 130 and 100 kDa
corresponding to GABAB1a and GABAB1b proteins (supplemental Fig.
1A, available at www.jneurosci.org as supplemental material). The B62
antibody yielded an immunoreactive pattern in the hippocampus (sup-
plemental Fig. 1B, available at www.jneurosci.org as supplemental ma-
terial) similar to that obtained with the well characterized B17 antibody.
To identify the postsynaptic density of excitatory synapses, amonoclonal
anti-postsynaptic density-95 (PSD-95) antibody was also used (Upstate
Biotechnology, Lake Placid,NY). Todetermine the spatial relationship of
GABAB receptors and the K
–Cl cotransporter 2 (KCC2) an antibody
against the cotransporter (Upstate Biotechnology) was used.
Controls. The specificity of the immunolabeling for Kir3.2 and
GABAB1 in these experiments was controlled by (1) staining of sections
obtained from either Kir3.2- (Torrecilla et al., 2002) or GABAB1-
deficient mice (Schuler et al., 2001), and (2) in case of double- and
triple-labeling experiments, omitting one of the primary antibodies. No
immunolabeling was detected on sections and replicas derived from
Kir3.2- or GABAB1-deficient mice (supplemental Fig. 1C, available at
www.jneurosci.org as supplemental material) stained with the respective
primary antibodies in preembedding and replica experiments, further
confirming specificity of the antibodies. When one of the primary anti-
bodies was omitted, but secondary antibodies were included, no immu-
nolabeling was detected for the respective protein excluding the possibil-
ity of cross-reactivity of the primary and secondary antibodies.
Immunoblot analysis
Immunoblot analysis was performed as described previously (Shigemoto
et al., 1997). The crude membrane preparations from adult rat forebrain
were separated by 7.5% SDS-PAGE and transferred onto polyvinylidene
difluoride (Bio-Rad, Hercules, CA) membrane. The membrane was
blocked with Block-Ace (Dainippon Pharmaceutical, Suita, Japan) and
then reacted with the affinity-purified GABAB1 (B62) antibody (0.5 g/
ml). An alkaline phosphatase-labeled secondary antibody (1:5000;
Chemicon, Temecula, CA) was used to visualize protein bands.
Immunocytochemistry
A total of 19 adult male Wistar rats (Charles River, Freiburg, Germany),
7 adult wild-type mice, 5 Kir3.2-deficient mice, and 6 GABAB1-deficient
mice were used in the present study. Care and handling of the animals
before andduring the experiments followedEuropeanUnion regulations
and was approved by the animal care and use committees of the authors’
institutions.
Preembedding immunocytochemistry
Immunohistochemical labeling for light and electron microscopy was
performed as described previously (Kulik et al., 2002). For light micros-
copy, animals (n 5 rats; n 3 wild-type mice; n 2 Kir3.2-deficient
mice; n  3 GABAB1-deficient mice) were deeply anesthetized with
Narkodorm-n (pentobarbital; 180 mg/kg, i.p.) (Alvetra, Neumu¨nster,
Germany) and perfused transcardially with 4% paraformaldehyde
(Merck, Darmstadt, Germany), 15% saturated picric acid, and 0.05%
glutaraldehyde (Polyscience, Warrington, PA) made up in 0.1 M phos-
phate buffer (PB). Tissue blocks were cryoprotected and freeze-thawed,
and sections were cut (40 m). Sections were incubated with 0.6 g/ml
primary antibody for Kir3.2 in 25 mM PBS containing 3% normal goat
serum (NGS) (Vector Laboratories, Burlingame, CA) and 0.1% Triton
X-100. After washes in PBS, the sections were incubated with biotinyl-
ated goat anti-rabbit IgG antibody (1:100; Vector Laboratories), then
reacted with avidin–biotin peroxidase complex (ABC kit; 1:100; Vector
Laboratories), and finally incubatedwith 0.025%3,3-diaminobenzidine
tetrahydrochloride (Sigma, St. Louis, MO) and 0.003% hydrogen perox-
ide. For electron microscopy, animals (n 8 rats; n 2 wild-type mice;
n  1 Kir3.2-deficient mouse; n  1 GABAB1-deficient mouse) were
perfused with the same fixative as described for light microscopy. Sec-
tions (50 m) were incubated in a blocking solution followed by the
primary antibodies (2.0–3.0g/ml) diluted inTris-buffered saline (TBS)
containing 3%NGS. After washing, the sections were incubated with 1.4
nm gold-coupled goat anti-rabbit or goat anti-guinea pig secondary an-
tibodies (Fab fragment; 1:100; Nanogold; Nanoprobes, Stony Brook,
NY), and then reacted with HQ Silver kit (Nanoprobes). After treatment
withOsO4, the sectionswere stainedwith uranyl acetate, dehydrated, and
flat-embedded in epoxy resin (Durcupan; ACM; Fluka; Sigma).
Three-dimensional reconstruction and quantification of Kir3.2
and GABAB1 immunoreactivity
The three-dimensional (3D) reconstruction of CA1 pyramidal cell den-
dritic spines and shafts immunoreactive for either the Kir3.2 or GABAB1
subunits was performed from serial ultrathin sections obtained from
preembeddingmaterial as described previously (Kulik et al., 2002). Sam-
ples were taken from the very surface (3 m) of blocks containing
strata oriens, radiatum, or lacunosum-moleculare of CA1. For each im-
munoparticle (located within 25 nm from the membrane), the distances
to the closest edge of asymmetrical and symmetrical synapses were mea-
sured along the surface of the 3D reconstructed profiles.
SDS-digested freeze–fracture replica immunolabeling
Animals (n 6 rats; n 2 wild-type mice; n 2 Kir3.2-deficient mice;
n  2 GABAB1-deficient mice) were deeply anesthetized with sodium
pentobarbital (50 mg/kg, i.p), and the hearts were surgically exposed for
perfusion fixation. First, the vascular systemwas flushed by circulating 25
mM PBS for 1 min. This was followed by transcardial perfusion with a
fixative containing 2% paraformaldehyde and 15% saturated picric acid
made up in 0.1 M PB. Sagittal sections from the CA1 or the CA3 area were
cut on a microslicer at a thickness of 90 m. The slices were cryopro-
tected in a solution containing 30% glycerol made up in 0.1 M PB over-
night at 4°C, and then were frozen by a high-pressure freezing machine
(HPM 101; BAL-TEC, Balzers, Lichtenstein). Frozen samples were in-
serted into a double replica table and then fractured into two pieces at
115°C. Fractured faces were replicated by deposition of carbon (2–3
nm thickness), platinum (2 nm), and carbon (20 nm) in a freeze–fracture
replica machine (BAF 060; BAL-TEC). They were digested in a solution
containing 2.5% SDS and 20% sucrosemade up in 15mMTris buffer, pH
8.3, at 105°C for 15min followed by their incubation in the same solution
overnight at room temperature. The replicas were washed in 25 mM TBS
containing 0.05% bovine serum albumin (BSA) (Nacalai Tesque, Kyoto,
4290 • J. Neurosci., April 19, 2006 • 26(16):4289–4297 Kulik et al. • Colocalization of Kir3 Channels and GABABRs
Japan) and incubated in a blocking solution containing 5%BSA in 25mM
TBS for 1 h. Subsequently, the replicas were incubated in the primary
antibody for Kir3.2 or, in double- and triple-immunolabeling experi-
ments, with mixtures of primary antibodies (20–25 g/ml) for Kir3.2
and GABAB1 or Kir3.2, GABAB1, and PSD-95 diluted in TBS containing
5%BSA overnight at room temperature. In control experiments, replicas
were incubated in a mixture of primary antibodies for KCC2, GABAB1,
and PSD-95 diluted in the same solution as described above. After several
washes, the replicas were reacted with a mixture of gold-coupled goat
anti-rabbit (for Kir3.2 or KCC2), goat anti-guinea pig (for GABAB1), and
goat anti-mouse (for PSD-95) secondary antibodies (1:30; BioCell Re-
search Laboratories, Cardiff, UK) made up in 25 mM TBS containing 5%
BSA overnight at room temperature. They were then washed and picked
upon100-mesh grids. For quantitative analysis, sampleswere taken from
layers of CA1 and CA3 double-immunolabeled for the Kir3.2 and
GABAB1 subunits. Clusters of immunoparticles for Kir3.2 and GABAB1
were determined by outlining the areas covered by immunogold particles
(three particles or more within a distance of 50 nm) on dendritic shafts
and on dendritic spines of pyramidal cells. Distances between the center
of clusters of Kir3.2 and the closest clusters of GABAB1 were measured
along the surface of the profiles. The relative frequency for the cluster
pairs was determined by binning the data set at 50 nm. Values are ex-
pressed as mean SEM, and for statistical comparison the nonparamet-
ric double-sided nonpaired Wilcoxon–Mann–Whitney test was used.
Results
Kir3.2 immunoreactivity in dendritic
layers of the hippocampus
The use of the Kir3.2 affinity-purified an-
tibody revealed a specific pattern of im-
munostaining in the rat (Fig. 1A) and
wild-type mouse hippocampus (Fig. 1B).
The immunoreactivity for the protein was
widely distributed in the hippocampus
with moderate to strong staining in den-
dritic layers. In CA1, the immunolabeling
for Kir3.2 was homogeneously strong in
the stratum lacunosum-moleculare,
whereas the strata radiatum and oriens
showed an uneven immunostaining with
moderate intensity in the proximal half
and high intensity in the distal half of these
layers. In CA3, the immunoreactivity was
strongest in strata oriens, radiatum, and
lacunosum-moleculare, whereas in the
stratum lucidum it was moderate. In the
dentate gyrus, strong immunostaining for
the subunit was detected in the hilus and
moderate in the molecular layer. In the
pyramidal and granule cell layers, weak la-
beling was observed. No immunoreactiv-
ity for Kir3.2 was detected in the white
matter. In sections obtained from Kir3.2-
deficient mice, the specific immunolabeling
pattern was completely abolished (Fig. 1C).
Kir3.2 is preferentially localized to
extrasynaptic membrane of dendrites
To determine the subcellular localization
of Kir3.2 responsible for the immuno-
staining in dendritic layers, we used
preembedding immunogold labeling. For
electron-microscopic investigation, tissue
blocks were taken from the CA1 area. Im-
munoreactivity for the Kir3.2 subunit was
primarily found in postsynaptic elements,
namely, on dendritic shafts and spines of putative pyramidal cells
(Fig. 2). Clusters of immunogold particles were localized to the
extrasynaptic plasma membrane of dendritic shafts (Fig.
2A,B,F,G,I) establishing symmetrical (putative GABAergic)
synapses with presynaptic boutons (Fig. 2B,G). Strong immuno-
labeling was also found on the extrasynaptic membrane of den-
dritic spines (Fig. 2A,C–F,H, I). Immunoparticles also appeared
occasionally at the edge (Fig. 2D,F) and over the postsynaptic
membrane specialization of asymmetrical, putative glutamater-
gic synapses on dendritic spines (Fig. 2C). This predominantly
extrasynaptic localization of the channel is in good agreement
with the finding of Nehring et al. (2000), who showed that the
Kir3.2 subunit is unable to form a complex with PSD-95 at
postsynaptic sites. In addition to pyramidal cells, immunoreac-
tivity for Kir3.2 was also seen on the extrasynaptic plasma mem-
brane of putative interneuron dendrites (Fig. 2 I), identified by
the lack of dendritic spines and the presence of asymmetrical
synapses. In contrast to the strong dendritic labeling, very little
immunolabeling was seen in somata of pyramidal cells under our
experimental conditions. Presynaptically, weak immunoreactiv-
ity for Kir3.2 was occasionally detected in axon terminals making
Figure1. Distributionof immunoreactivity for theKir3.2 subunit in thehippocampus.A,B, The immunostainingwasmoderate
to strong in dendritic layers of the CA area and dentate gyrus in the rat (A) and wild-type (WT) mouse (B). In the CA1, the
immunolabeling for the protein was strong and homogeneous in the stratum lacunosum-moleculare, whereas the strata oriens
and radiatum showed uneven immunostaining with moderate intensity of immunoreactivity in the proximal half and high
intensity in the distal half of these layers. In CA3, the immunoreactivity for Kir3.2 was strong in the strata oriens, radiatum, and
lacunosum-moleculare. In the dentate gyrus, strong immunostaining was detected in the hilus and moderate in the molecular
layer. C, No immunoreactivity for Kir3.2 was found in the hippocampus of the Kir3.2-deficient (KO) mice. Scale bars, 200m. o,
Stratum oriens; p, stratum pyramidale; r, stratum radiatum; l-m, stratum lacunosum-moleculare; m, stratum moleculare; g,
stratum granulosum; h, hilus.
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asymmetrical synapses with dendritic
spines in strata oriens and radiatum (Fig.
2C,E). Immunoparticles were localized ei-
ther to the extrasynaptic plasma mem-
brane (Fig. 2C) or to the presynaptic
membrane specialization of boutons (Fig.
2E). The specificity of the labeling in
preembedding material was confirmed by
the absence of labeling in Kir3.2-deficient
animals.
Enrichment of Kir3.2 around excitatory
synapses on dendritic spines
The pattern of the subcellular distribution
of Kir3.2, particularly the strong labeling
on dendritic spines of hippocampal pyra-
midal cells, is very similar to that of
GABAB receptors (Kulik et al., 2003). To
compare the distribution of the Kir3.2 and
GABAB1 on dendrites of pyramidal cells in
relation to putative GABAergic and gluta-
matergic synapses, three-dimensional
(3D) reconstructions were made from se-
rial ultrathin sections and the distances of
the immunoparticles from the edge of
symmetrical and asymmetrical synaptic
specializations were measured. This ap-
proach revealed that, on dendritic shafts,
the channel and the receptor showed no
association to symmetrical, putative
GABAergic synapses (Fig. 3A) (209 parti-
cles on eight dendrites for Kir3.2 and 241
particles on seven dendrites for GABAB1).
In contrast, on dendritic spines, both
Kir3.2 andGABAB1 were found to be pref-
erentially localized around asymmetrical
synapses. The distribution for Kir3.2
showed a peak between 0 and 240 nm
from the synapses (Fig. 3B) (313 particles on 66 spines). Simi-
larly, for GABAB1 the peak of the distribution was located be-
tween 60 and 240 nm (Fig. 3B) (325 particles on 49 spines),
consistent with previous data obtained from CA1 and CA3 areas
(Kulik et al., 2003). For both proteins60% of the immunopar-
ticles were located within a distance of 240 nm from the edge of
asymmetrical synapses indicating an enrichment of the mole-
cules in the vicinity of putative glutamatergic synapses on den-
dritic spines.
Preferential colocalization of Kir3.2 and GABAB1 on dendritic
spines of CA1 pyramidal cells
Todirectly investigate the colocalization ofKir3.2 andGABAB1 in
subcellular compartments of CA1 pyramidal cells, we performed
double- and triple-labeling immunocytochemistry by using the
highly sensitive SDS-digested freeze–fracture replica immunola-
beling technique (Hagiwara et al., 2005; Tanaka et al., 2005).
Consistent with the results of preembedding experiments, strong
immunolabeling for Kir3.2 was found postsynaptically. Clusters
of immunoparticles were observed on the protoplasmic face of
the membrane of dendritic shafts and spines of putative pyrami-
dal cells (Fig. 4A). Double immunolabeling for Kir3.2 and
GABAB1 further revealed that, on dendritic shafts, the channels
and receptors were mainly segregated (Fig. 4B), whereas on den-
dritic spines, a high degree of coclustering of the immunogold
particles for the two proteins was observed (Fig. 4C). To quantify
the spatial relationship of the channel and receptor subunits, the
distances between clusters of Kir3.2 and the closest clusters of
GABAB1 were measured on dendritic shafts and spines (Fig. 4D).
This analysis revealed that, on dendritic shafts, only 84 of 302
clusters (28%) were within 100 nm, whereas on dendritic spines
86 of 90 clusters (96%) were within this distance (Fig. 4D). The
location of the Kir3.2–GABAB1 complexes relative to excitatory
synaptic sites, demarcated by the presence of PSD-95, an essential
component of the excitatory postsynaptic specialization, was in-
vestigated in triple-immunolabeling experiments. The Kir3.2–
GABAB1 coclusters were found on the extrasynaptic membrane
close to the location of PSD-95 immunoreactivity on dendritic
spines (Fig. 4E,F). Weak Kir3.2 and GABAB1 immunolabeling
was found in putative excitatory terminals, but no coclustering of
the proteins was observed. Thus, our results demonstrate that, on
dendritic shafts, where mostly GABAergic synapses are located,
the Kir3.2-containing inwardly rectifying K channels and
GABAB receptors are mainly segregated, whereas on dendritic
spines, adjacent to glutamatergic synapses, the two proteins show
a close association.
To assess the functional relevance of the observed association,
we investigated the spatial relationship of molecules on dendritic
spines that are functionally unrelated to GABAB receptors. To
this end, we have performed immunogold labeling for KCC2,
Figure 2. Preferential postsynaptic localization of Kir3.2 in dendritic layers of the CA1 area. Electronmicrographs show immu-
noreactivity for the Kir3.2 subunit in the strata oriens (A, C), radiatum (B, D, E), and lacunosum-moleculare (F–I ) as detected by
the preembedding immunogoldmethod.A,B, F,G, I, Clusters of immunogold particleswere seen along the extrasynaptic plasma
membrane (arrows) of dendritic shafts (Den) of pyramidal cells contacted by terminals (T) of presumed GABAergic cells. Labeling
was occasionally found at the edge of symmetrical synaptic specializations (arrowheads in B, G). A, C–F, H, I, Immunoparticles
were abundant on the extrasynaptic plasma membrane (arrows) of dendritic spines of pyramidal cells (s). They also appeared
occasionally over the postsynaptic specialization (double arrowhead in C) at synapses between axon terminals (T) of putative
pyramidal cells and dendritic spines and at the edge of asymmetrical synapses (arrowheads in D, F ). C, E, Presynaptically,
immunogold particles (double arrows) were localized to the extrasynaptic plasma membrane and to the presynaptic membrane
specialization of axon terminals (T) establishing asymmetrical synapses. I, Immunolabeling was also visible in dendritic shafts of
presumed interneurons (Den1) establishingasymmetrical synapseswithpresynaptic boutons (T1, T2). Note that thedendritic spine
(s), contacted by an axon terminal (T3), and the dendritic shaft (Den2) of a pyramidal cell are also labeled. Scale bars, 0.2m.
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GABAB1, and PSD-95. This experiment revealed that, although
immunoreactivity for KCC2 is abundantly localized to the den-
dritic spines (Gulya´s et al., 2001), the cotransporter and the re-
ceptor were found to be mainly segregated (Fig. 4G) in this
compartment.
Colocalization of Kir3.2 and GABAB1 on CA3 pyramidal cells
Finally, we investigated the distribution and colocalization of
Kir3.2 and GABAB1 in the CA3 region. Samples were taken from
the stratum oriens and processed for Kir3.2, GABAB1, and
PSD-95 immunolabeling using the replica technique. Similarly to
the CA1 area, clusters of immunogold particles for Kir3.2 were
found on dendritic shafts (Fig. 5A) and spines (Fig. 5B). The
meannumber of particles per cluster on the dendritic shafts of the
CA3 area was, however, higher (6.4  0.2 particles/cluster; 162
clusters) comparedwith the CA1 area (4.2 0.2 particles/cluster;
93 clusters; p 0.01) in a good agreement with the difference in
the staining intensity observed at the light-microscopic level (Fig.
1A). Despite this difference in cluster size, the colocalization pat-
tern of Kir3.2 andGABAB1was similar to that of theCA1 area.On
dendritic shafts, the channel and receptor weremainly segregated
(Fig. 5A), whereas on dendritic spines, the proteins showed a high
level of colocalization (Fig. 5B).
Discussion
The present study describes the subcellular localization of the
Kir3.2 subunit of the G-protein-coupled inwardly rectifying K
channel and its spatial relationship to GABAB receptor in the
adult rat hippocampus. Kir3 channel proteins were primarily
found postsynaptically and localized to dendritic shafts and den-
dritic spines of pyramidal cells. Double immunolabeling for
Kir3.2 and GABAB1 using the replica technique revealed that, on
dendritic shafts, the two proteins were mostly segregated,
whereas on dendritic spines, around putative glutamatergic syn-
apses, a high degree of coclustering of the ion channel and recep-
tor subunits was observed. Immunolabeling for KCC2, a protein
with no known functional association with GABAB receptors,
showed that the transporter and the receptor were mainly segre-
gated on dendritic spines. Thus, the observed close spatial rela-
tionship of Kir3.2 and GABAB1 likely reflects their functional
interaction in this subcellular compartment.
Kir3.2 is preferentially localized to dendritic shafts and spines
in hippocampal pyramidal cells
The Kir3.2 is the most abundant subunit of the Kir3 channel in
the hippocampus as shown by previous in situ hybridization
(Kobayashi et al., 1995; Karschin et al., 1996; Liao et al., 1996) and
immunocytochemical studies (Liao et al., 1996; Signorini et al.,
1997; Inanobe et al., 1999; Koyrakh et al., 2005). It has been
further suggested that this subunit plays an essential role in the
assembly and surface localization of functional channels
(Inanobe et al., 1999; Ma et al., 2002). Accordingly, our results,
obtained by using an antibody recognizing the Kir3.2a and
Kir3.2c isoforms, but not the ubiquitously expressed Kir3.2b
splice variant (Isomoto et al., 1996), show that the Kir3.2 protein
was widely distributed in the hippocampus and the immunola-
beling was particularly strong in dendritic layers.
At the ultrastructural level, themajority of the Kir3.2 subunits
were observed on the extrasynapticmembrane of dendritic shafts
and spines and was hardly detectable on somata of pyramidal
cells. These immunocytochemical data thus underlie the domi-
nant postsynaptic role ofKir3 channels observed in previous elec-
trophysiological studies (Andrade et al., 1986; Lu¨scher et al.,
1997; Kurachi and Ishii, 2003). Furthermore, the dendritic local-
ization of the subunit corresponds well to the fact that Kir3-
mediated currents are significantly larger in dendrites than in
somata of hippocampal neurons (Newberry and Nicoll, 1985;
Inanobe et al., 1999; Takigawa and Alzheimer, 1999; Chen and
Johnston, 2005). This preferential dendritic localization offers an
optimal position, on the one hand, for the modulation of the
channels by various G-protein-coupled receptors residing in the
dendritic compartments (Dournaud et al., 1996; Kia et al., 1996;
Lujan et al., 1997, Shigemoto et al., 1997; Kulik et al., 2003). On
the other hand, dendritic channels can be efficiently involved in
the integration of synaptic inputs. Kir3 channels were shown to
contribute to the restingmembrane potential on dendrites (Chen
and Johnston, 2005) and can therebymodulate the amplification
of synaptic potentials by voltage-gated channels (Johnston et al.,
Figure 3. Distribution of immunoparticles for the Kir3.2 and GABAB1 subunits relative to
symmetrical and asymmetrical synapses on dendrites of CA1 pyramidal cells as assessed by
preembedding immunogold labeling. A, Histogram showing the spatial distribution of immu-
noparticles for Kir3.2 (open bars; n 209) and GABAB1 (filled bars; n 241) around symmet-
rical synapses on dendritic shafts. Distances of immunogold particles were measured from the
closest edge of the synapses along the surface of dendritic shafts reconstructed from serial
ultrathin sections. Valueswere allocated to60-nm-widebins andexpressedas relative frequen-
cies.B, Histogram showing the spatial distribution of immunoparticles for Kir3.2 (n 313) and
GABAB1 (n 325) around asymmetrical synapses on dendritic spines. These data show that
there is no association of Kir3.2 and GABAB1 to symmetrical, putative GABAergic synapses on
dendritic shafts, but there is an enrichment of both proteins in the vicinity of asymmetrical,
putative glutamatergic synapses on dendritic spines.
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1996). Kir3 channels associated with glu-
tamatergic synapses can counteract exci-
tatory postsynaptic responses by hyperpo-
larization and by shunting the excitatory
synaptic currents (Takigawa and Alzhei-
mer, 2003). Furthermore, after activation
by GABAB receptors, these channels can
also act as a brake on NMDA receptor re-
sponses by favoring their Mg2 block and
resulting in reduced synaptic plasticity
(Otmakhova and Lisman, 2004). Con-
versely, activation of NMDA receptors re-
sults in the potentiation of the GABAB-
and Kir3-mediated slow inhibitory synap-
tic response (Huang et al., 2005) that par-
allels with the long-term potentiation of
excitatory transmission.
In addition to the strong postsynaptic
labeling, a low but consistent presynaptic
immunoreactivity for Kir3.2 was detected.
Similar results were obtained for three
subunits, Kir3.1, Kir3.2, and Kir3.3, in
various brain regions in previous immu-
nocytochemical studies (Liao et al., 1996;
Morishige et al., 1996; Ponce et al., 1996;
Drake et al., 1997; Grosse et al., 2003). Al-
though the function of the presynaptic
Kir3 channels remains unknown (Lu¨scher
et al., 1997), their proximity to the axonal
active zones strongly suggests an involve-
ment in the regulation of neurotransmit-
ter release.
Predominant colocalization of Kir3.2
with GABAB1 on dendritic spines of
pyramidal cells
The coupling between Kir3 channels and
receptors is mediated by G-proteins in a
membrane-delimited manner (Pfaffinger
et al., 1985; Dascal, 1997; Yamada et al.,
1998). Theoretical considerations suggest
that the distance between receptor and ef-
fector should be small (e.g., 500 nm)
(Karschin, 1999) to enable their interac-
tion. Moreover, it was hypothesized that
preformed receptor–ion channel com-
plexes could exist ensuring reliable and ef-
ficient coupling. The rapid activation of
Kir3 channels by GABAB receptors in re-
sponse to synaptically released GABA
would support this latter hypothesis (Otis
et al., 1993). To address the spatial rela-
tionship of Kir3.2 and the GABAB recep-
tors, we used the highly sensitive SDS-digested freeze–fracture
replica immunolabeling method, which provides a means for
visualizing the distribution of molecules over the surface of the
plasma membrane (Hagiwara et al., 2005). The results of this
approach revealed that, on dendritic shafts of the pyramidal cells,
contacted by GABAergic boutons, ion channels and receptors
were mainly segregated, whereas on dendritic spines, contacted
by excitatory terminals, a high degree of coclustering of the pro-
teins was detected.
The observed distribution of the ion channels and GABAB
receptors on dendritic shafts raises the question how segregated
channels are activated. First, the Kir3.2-containing channels may
cocluster with and couple to other G-protein-coupled receptors
(e.g., adenosine A1, 5-HT1A, D2) (Andrade et al., 1986; Nicoll,
1988; Liao et al., 1996; Ehrengruber et al., 1997; Lu¨scher et al.,
1997; Takigawa and Alzheimer, 1999). This possibility is sup-
ported by the results of electrophysiological experiments in
which theGABAB receptor agonist baclofen evokedKir3 currents
only in a subset of isolated patches of pyramidal cell dendrites,
whereas agonists of other metabotropic receptors could elicit
Figure 4. Colocalization of Kir3.2 and GABAB1 on dendritic spines of CA1 pyramidal cells. Localization of the Kir3.2 subunit and
its colocalization with the GABAB1 subunit is demonstrated by the SDS-digested freeze–fracture replica labeling technique. A,
Immunoparticles for Kir3.2 were found on dendritic spines (s) of principal cells. B, Double immunogold labeling for Kir3.2 (5 nm
particles; arrows) and GABAB1 (10 nm; double arrows) revealed that the two proteins weremainly segregated on dendritic shafts
of pyramidal cells (Den). C, Double labeling for Kir3.2 (15 nm) and GABAB1 (10 nm) showed that the two proteins coclustered on
dendritic spines of pyramidal cells (s). D, Histogram showing the spatial relationship between clusters of Kir3.2 and GABAB1 on
dendritic shafts (n 302 clusters; open bars) and on dendritic spines (n 90 clusters; filled bars). Distances were measured
between the center of Kir3.2 clusters and the closest GABAB1 cluster. Values were allocated to 50-nm-wide bins and expressed as
relative frequencies. E, F, Triple immunolabeling for Kir3.2 (5 nm), GABAB1 (10 nm), and PSD-95 (15 nm) demonstrated the
coclustering of the Kir3.2 (arrows) and GABAB1 (double arrows) subunits around the site of the location of the PSD-95, indicating
a close localization of Kir3.2-GABAB1 to glutamatergic synapses on dendritic spines of pyramidal cell.G, The spatial relationship of
GABAB (double arrows) receptors and the functionally unrelated KCC2 (arrows) was also investigated on dendritic spines. Two
proteins were found to be preferentially segregated in this subcellular compartment. Scale bars, 0.2m.
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currents in nonresponsive ones (Takigawa and Alzheimer, 1999;
Chen and Johnston, 2005). Second, these channels may also be
activated by GABAB receptors. Despite the segregation of Kir3.2
and GABAB1, the mean distance between molecules may be suf-
ficient for functional interaction (Karschin, 1999), although, in
this scenario, the coupling is expected to be less efficient and less
reliable. Finally, constitutively active dendritic Kir3 channels
have been observed in CA1 pyramidal cells (Chen and Johnston,
2005). Although the identity and the subunit composition of
these ion channels are unclear, they may correspond to a segre-
gated channel population.
It was proposed that GABAB receptor localization to dendritic
spines is important for the modulation of metabotropic gluta-
mate receptors (Hirono et al., 2001; Tabata et al., 2004). How-
ever, the intimate spatial relationship of GABAB receptors and
Kir3 channels on dendritic spines around excitatory synapses,
observed in this study, is suggestive of a functional coupling of the
two proteins and may reflect the existence of preformed com-
plexes. This scenario is further supported by the observation that
the functionally unrelatedKCC2 andGABAB1weremainly found
to be segregated in this subcellular compartment. In turn, the
high level of colocalization of Kir3.2 and GABAB1 indicates that
the ion channels strategically located to interact with individual
glutamatergic synapses are primarily under the control of the
inhibitory transmitter GABA spilling over from GABAergic syn-
apses (Isaacson et al., 1993; Kulik et al., 2003; Cryan and Kaup-
mann, 2005).
In summary, the present study shows that the Kir3.2-
containing K channels are preferentially located on the extra-
synaptic membrane of hippocampal pyramidal cells and can be
divided into twomajor populations with different roles in synap-
tic integration. Kir3 channels on dendritic shafts can mediate the
effect of various transmitter systems including subcortical pro-
jections that show behavior state-dependent activity (Pace-
Schott and Hobson, 2002). In contrast, Kir3 channels on den-
dritic spines appear to preferentially mediate the effect of GABA
released from local feedback and feedforward inhibitory circuits
via GABAB receptors. Thus, this channel population can provide
a spatially and temporally well defined control to excitatory
transmission by the GABAergic system.
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6.2. The GABAB1a isoform mediates heterosynaptic depression at hippocampal 
mossy fiber synapses 
 
Guetg N*, Seddik R*, Vigot R, Turecek R, Gassmann M, Vogt KE, Bräuner-
Osborne H, Shigemoto R, Kretz O, Frotscher M, Kulik A, 
Bettler B 
 
  The Journal of Neuroscience 2009; 29:1414-23 
  *Authors contributed equally to this work. 
 
 
GABAB receptors are composed of GABAB1a and GABAB1b subunit isoforms forming 
functional receptors together with the GABAB2 subunit. In this publication, the differential 
subcellular localization of GABAB receptor subtypes in the CA3 region of the hippocampus 
was investigated. It was of particular interest to understand to what extend GABAB(1a,2) 
and GABAB(1b,2) receptors inhibit glutamate release in response to physiological activation. 
Because of the lack of isoform specific antibodies, mice deficient for either GABAB1a (1a
-/- 
mice) or GABAB1b (1b
-/- mice) were used. Using preembedding electron microscopy, it was 
first demonstrated that the GABAB receptor is present pre- and postsynaptically at mossy 
fiber (MF)–CA3 pyramidal neuron synapses. While GABAB(1a,2) is the predominant receptor 
localized on glutamatergic MF terminals, GABAB(1b,2) is more abundant in spines and 
dendritic shafts of pyramidal neurons. This is in agreement with findings at other 
glutamatergic synapses (Vigot et al., 2006; Ulrich et al., 2007). Furthermore, the 
subsynaptic distribution of GABAB1 isoforms at the MF-CA3 pyramidal neuron synapse 
was studied. In 1a-/- mice, significantly lower levels of immunogold particles were found 
to be localized over the presynaptic membrane specialization compared to wild-type 
(WT) mice. Postsynaptically, an accumulation of immunoparticles in vicinity of the 
postsynaptic density was observed. However, no difference in the spatial distribution 
between WT, 1a-/- and 1b-/- mice was found. 
Using electrophysiological whole-cell patch-clamp recordings, the contribution of GABAB1a 
and GABAB1b to functional pre- and postsynaptic GABAB receptors at the MF-CA3 
pyramidal neuron synapse was assessed. In a first series of experiments GABAB receptors 
Publications: Guetg et al., JNeurosci 2009  39 
were activated pharmacologically with saturating concentrations of baclofen. In 1a-/- 
mice, the inhibition of EPSCs mediated by presynaptic GABAB(1b,2) receptors was reduced 
by 50% compared to WT mice. In contrast, presynaptic GABAB receptors were fully 
functional in 1b-/- mice. Postsynaptically, pharmacological activation of GABAB receptors 
elicited similar outward K+-currents in 1a-/- and 1b-/- mice. These currents were reduced 
compared to WT mice. Surprisingly, the pharmacological activation of pre- as well as 
postsynaptic GABAB receptors at MF-CA3 pyramidal neuron synapses did not however 
entirely reproduce the spatial segregation observed in the ultrastructural analysis. 
The physiological activation of GABAB receptors at the MF-CA3 pyramidal neuron synapse 
was studied next. For this purpose, heterosynaptic depression in WT, 1a-/- and 1b-/- mice 
was examined. The results obtained indicate, that only GABAB(1a,2) receptors are 
responsible for presynaptic inhibition of glutamate release in response to endogenously 
released GABA from neighboring interneurons. The spatial segregation of GABAB1 subunit 
isoforms at mossy fiber terminals is therefore sufficient to produce a strictly subtype–
specific response. In addition, postsynaptic GABAB receptor activation by endogenously 
released GABA was investigated. Late IPSC were only detectable in WT mice but not in 1a-
/- and 1b-/- mice respectively. This implies that both GABAB(1a,2) and GABAB(1b,2) contribute 
to postsynaptic responses under physiological conditions. 
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The GABAB1a IsoformMediates Heterosynaptic Depression
at Hippocampal Mossy Fiber Synapses
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Structure, National Institute for Physiological Sciences, and 6Department of Physiological Sciences, The Graduate University of Advanced Studies
(Sokendai), Myodaiji, Okazaki 444-8787, Japan, and 7Solution Oriented Research for Science and Technology, Japan Science and Technology Corporation,
Kawaguchi 332-0012, Japan
GABAB receptor subtypes are based on the subunit isoforms GABAB1a and GABAB1b , which associate with GABAB2 subunits to form
pharmacologically indistinguishable GABAB(1a,2) and GABAB(1b,2) receptors. Studies with mice selectively expressing GABAB1a or
GABAB1b subunits revealed that GABAB(1a,2) receptors are more abundant than GABAB(1b,2) receptors at glutamatergic terminals. Ac-
cordingly, it was found that GABAB(1a,2) receptors are more efficient than GABAB(1b,2) receptors in inhibiting glutamate release when
maximally activated by exogenous application of the agonist baclofen. Here, we used a combination of genetic, ultrastructural and
electrophysiological approaches to analyze towhat extent GABAB(1a,2) andGABAB(1b,2) receptors inhibit glutamate release in response to
physiological activation. We first show that at hippocampal mossy fiber (MF)-CA3 pyramidal neuron synapses more GABAB1a than
GABAB1b protein is present at presynaptic sites, consistent with the findings at other glutamatergic synapses. In the presence of baclofen
at concentrations1M,bothGABAB(1a,2) andGABAB(1b,2) receptors contribute topresynaptic inhibitionof glutamate release.However,
at lower concentrations of baclofen, selectively GABAB(1a,2) receptors contribute to presynaptic inhibition. Remarkably, exclusively
GABAB(1a,2) receptors inhibit glutamate release in response to synaptically released GABA. Specifically, we demonstrate that selectively
GABAB(1a,2) receptors mediate heterosynaptic depression of MF transmission, a physiological phenomenon involving transsynaptic
inhibition of glutamate release via presynaptic GABAB receptors. Our data demonstrate that the difference in GABAB1a and GABAB1b
protein levels atMF terminals is sufficient to produce a strictly GABAB1a-specific effect under physiological conditions. This consolidates
that the differential subcellular localization of the GABAB1a and GABAB1b proteins is of regulatory relevance.
Key words: GABA(B); GABA-B; metabotropic; hippocampus; presynaptic inhibition; heteroreceptor
Introduction
GABAB receptors are the G-protein coupled receptors for
-aminobutyric acid (GABA), the main inhibitory neurotrans-
mitter in the CNS. They have been implicated in a variety of
disorders, including cognitive impairments, anxiety, depression
and epilepsy (Calver et al., 2002; Bettler et al., 2004). Presynaptic
GABAB receptors inhibit neurotransmitter release via the inhibi-
tion of Ca2 channels and second-messenger-mediated effects
downstream of Ca2 entry (Scanziani et al., 1992; Jarolimek and
Misgeld, 1997; Yamada et al., 1999; Sakaba and Neher, 2003).
They are commonly divided into autoreceptors and heterorecep-
tors depending on whether they control the release of GABA or
other neurotransmitters, respectively. Postsynaptic GABAB re-
ceptors activate Kir3-type K channels, which induces slow in-
hibitory potentials and mediates shunting inhibition (Lu¨scher et
al., 1997). The physiological functions of GABAB receptors have
been mostly inferred from electrophysiological experiments in
which the receptors were pharmacologically activated by exoge-
nous application of the agonist baclofen. Physiological activation
of GABAB receptors usually requires strong stimulus intensities,
suggesting that pooling of synaptically released GABA is required
to activate them (Isaacson et al., 1993; Scanziani, 2000). This
agrees with ultrastructural data demonstrating that most GABAB
receptors are located distant from release sites (Lo´pez-Bendito et
al., 2004; Lacey et al., 2005; Kulik et al., 2006). A tonic activation
of GABAB receptors through ambient GABA was also observed,
which may partly explain their predominantly extrasynaptic lo-
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calization as well (Lei and McBain, 2003; Price et al., 2005; Liu et
al., 2006).
GABAB receptors are heteromers composed of GABAB1 and
GABAB2 subunits (Calver et al., 2002; Bettler et al., 2004). The
onlymolecular distinction in theGABAB receptor system is based
on the subunit isoforms GABAB1a and GABAB1b, which differ in
their ectodomains by a pair of “sushi domains” that are unique to
GABAB1a (Hawrot et al., 1998). Heteromeric GABAB(1a,2) and
GABAB(1b,2) receptors do not exhibit pharmacological differ-
ences and couple to the same effector systems in transfected cells.
To address the reason for the existence of two receptor subtypes
we generated GABAB1a
/ (1a/) and GABAB1b
/ (1b/)
mice, which express either one or the other GABAB1 subunit
isoform. Pharmacological studies with these mice suggest that
GABAB1a and GABAB1b differentially influence synaptic func-
tions, primarily as a result of their distinct distributions to axonal
and dendritic compartments (Ulrich and Bettler, 2007). In prin-
ciple, since GABAB1a and GABAB1b subunits are independently
regulated at the transcriptional level (Steiger et al., 2004), this
allows for dynamically adjustable GABAB signaling at axonal and
dendritic effectors. However, to clearly establish a regulatory sig-
nificance for GABAB receptor subtypes, it needs to be demon-
strated that they not only yield differential effects in response to
pharmacological activation, but also in response to physiological
activation (Huang, 2006). A physiological phenomenon pro-
posed to rely on the endogenous activation of GABAB heterore-
ceptors is heterosynaptic depression (Isaacson et al., 1993; Vogt
and Nicoll, 1999; Chandler et al., 2003). Here, we studied het-
erosynaptic depression atMF-CA3pyramidal neuron synapses to
address to what extent the two GABAB receptor subtypes inhibit
glutamate release in response to activation by synaptically re-
leased GABA.
Materials andMethods
Mutant mouse strains. The generation of 1a/ and 1b/ mice was
described previously (Vigot et al., 2006). For control experiments we
additionally used GABAB1-deficient (1
/) mice that completely lack
GABAB1 protein (Schuler et al., 2001). Homozygous mutant mice and
wild-type (WT) littermatemice were obtained by breeding heterozygous
mice on a pure inbred BALB/c genetic background. All animal experi-
ments were subjected to institutional review and approved by the veter-
inary office of Basel-Stadt.
Pre-embedding immunocytochemistry and quantitative analysis. Pre-
embedding GABAB1 immunogold labeling and electron microscopy was
done as described, using affinity-purified guinea pig polyclonal anti-
serum B62 raised against the C-terminal 103 amino acid residues of
GABAB1a and GABAB1b (Kulik et al., 2006). Light microscopy confirmed
that the B62 antiserum immunostains WT, 1a/, and 1b/ hip-
pocampal sections, but not 1/ sections (data not shown). Pre-
embedding electronmicroscopy showed a reduction of the immunogold
particle density by 86% in 1/ hippocampal sections compared with
WT sections, which agrees well with earlier control experiments where
the reduction of immunogold particles in 1/ sections was 88% (Vigot
et al., 2006). Immunogold particles that nonspecifically labeled 1/
sections were approximately equally distributed over presynaptic and
postsynaptic membranes, as described (Vigot et al., 2006). Pre-
embedding electron microscopy of WT, 1a/, and 1b/ mice (8–12
weeks old, n 3 per genotype) included the analysis of 10 different MF
boutons per mouse. MF boutons were identified by their large size (3–6
m in diameter), the dense packing with synaptic vesicles and their
contacts with at least 2 spines. For each MF bouton we examined at least
4 consecutive sections. Only immunogold particles at the plasma mem-
brane (closer than 20 nm) of morphologically identifiable largeMF bou-
tons and their postsynaptic structures were analyzed. The postsynaptic
distribution of GABAB1 protein relative to asymmetrical, putative gluta-
matergic synapses was determined by measuring the distance between
each immunogold particle and the edge of the nearest synapse along the
surface of spines. Immunogold particles were allocated to 60 nm wide
bins, followed by calculating the relative abundance in each bin. The
experimenter was blind to the genotype of the mice.
Immunoblot quantification. The ratio of GABAB1a to GABAB1b protein
in the CA3 region of the hippocampus was determined by immunoblot
analysis using rabbit polyclonal GABAB1 antiserum Ab174.1 raised
against the C-terminal domain of GABAB1a and GABAB1b (Vigot et al.,
2006). Scanned immunoblots were quantified using Scion Image soft-
ware (Scion).
Slice preparation and electrophysiology. Hippocampal slices were pre-
pared from 21- to 35-d-old mice using standard procedures (Vigot et al.,
2006). Parasagittal slices (300 m thick) were cut in ice-cold artificial
CSF (ACSF) containing (in mM) 124 NaCl, 2.7 KCl, 1.3 MgCl2, 2 CaCl2,
1.24 NaH2PO4, 26 NaHCO3, 18 glucose, 2.25 ascorbate, pH 7.3, equili-
brated with 95% O2/5% CO2. Slices were kept in oxygenated ACSF at
35°C for at least 45 min before recording. Visualized whole-cell patch-
clamp recording was used to investigate presynaptic and postsynaptic
GABAB receptor functions. Holding currents and excitatory synaptic
responses were recorded at 3032°C from the somata of CA3 pyramidal
neurons visualized using an infrared-sensitive camera (Till Photonics)
and differential interference contrast optics (BX51WI; Olympus). Drugs
were applied by superfusion into the recording chamber.
EPSCs were recorded with electrodes (5 M) filled with a solution
containing (inmM): 140 Cs-gluconate, 10HEPES, 10 phosphocreatine, 5
QX-314, 4 Mg-ATP, 0.3 Na-GTP, at pH 7.25 with CsOH, 285 mOsm.
EPSCs were elicited by voltage pulses (100 s, 2–5 V stimuli) delivered
through a bipolar Pt-Ir electrode (25 m in diameter) placed in the
stratum lucidum. MF EPSCs were identified by the presence of a
frequency-dependent short-term facilitation. EPSCs were measured at
70 mV in the presence of 100 M picrotoxin. Presynaptic GABAB and
adenosine receptors were activated by bath application of baclofen (50
M) and adenosine (100M), respectively. GABAB receptors were inhib-
ited by application of the antagonist CGP54626A (1M). For the presyn-
aptic dose–response experiments, baclofen at different concentrations
(0.1, 1 and 50 M) was bath applied for 5 min at 10 min intervals.
To record postsynaptic Kir3-type K currents, patch pipettes were
filled with a solution containing (in mM): 140 K-gluconate, 5 HEPES, 2
MgCl2, 1.1 EGTA, 2 Na2-ATP, 5 phosphocreatine, 0.6 Tris-GTP, at pH
7.25 with KOH, 285 mOsm. Kir3-type K currents induced by baclofen
(100M) or adenosine (100M) were elicited at50mV in the presence
of tetrodotoxin (TTX, 1 M). For concentration-response experiments
we applied baclofen solutions (0.3 – 100 M) for 30 s using the fast
gravitation driven application systemWAS-02 (Dittert et al., 2006). The
inner diameter of the application tubewas 300m.The distance between
the mouth of the tube and the soma of the neuron was 400 m.
GABAA- andGABAB-mediated IPSCs (early and late IPSCs, respectively)
were recorded with a solution containing (in mM) 124 K-gluconate, 16
KCl, 5HEPES, 2MgCl2, 1.1 EGTA, 2MgATP, 3Na3GTP, pH 7.25. IPSCs
were elicited at 60 mV by 100 s pulses (3 stimuli at 100 Hz) in the
presence of kynurenic acid (2 mM), DNQX (10 M), naloxone (10 M)
and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 1 M) to block gluta-
mate, opioid and A1 adenosine receptors.
GABAB-mediated heterosynaptic depression atMF synapses was stud-
ied by recording field EPSPs (fEPSPs) in the stratum lucidum (Vogt and
Nicoll, 1999; Chandler et al., 2003). The occurrence of heterosynaptic
depression is not critically dependent on the temperature, as no signifi-
cant differences were previously observed between experiments at room
temperature and at 34°–36°C (Vogt and Nicoll, 1999). We therefore
recorded fEPSPs at room temperature, using low resistance glass pipettes
filled with ACSF. Stimulating electrodes filled with ACSF were posi-
tioned into the dentate gyrus, andMF responses elicited by 100s pulses.
MF-evoked fEPSPs were identified through their characteristic short-
term plasticity and their sensitivity to the group II mGluR agonist
(2S,2R,3R)-2-(2,3-dicarboxycyclopropyl)-glycine (DCG-IV, 2 M)
(Kamiya et al., 1996). Heterosynaptic depression was measured in the
presence of naloxone (10 M) and DPCPX (1 M) to avoid interference
frompresynaptic opioid andA1 adenosine receptors, respectively (Weis-
skopf et al., 1993; Manzoni et al., 1994; Cunha, 2008). Under these con-
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ditions heterosynaptic depression was significantly reduced by the
GABAB antagonist CGP54626A (2M).Datawere acquiredwith anAxo-
patch 200B (Molecular Devices), filtered at 2 kHz and digitized at 10 kHz
using a Digidata 1322A Interface (Molecular Devices) driven by pClamp
9.2 software (Molecular Devices). Whole-cell currents and field poten-
tials were analyzed using Clampfit 9.2 software (Molecular Devices).
Baclofen and CGP54626A were from Novartis Pharma. Naloxone,
DNQX, DPCPX, and DCG-IV were from Tocris Cookson, TTX from
Latoxan. All other reagents were from Sigma-Aldrich. Most recordings
were made and analyzed in blind. All values are means SEM.
Results
Presynaptic versus postsynaptic distribution of GABAB1
isoforms at MF-CA3 pyramidal neuron synapses
Before addressing the contribution of GABAB receptor subtypes
to presynaptic inhibition at MF terminals, we determined the
GABAB1a and GABAB1b distribution at presynaptic and postsyn-
aptic sites. We performed pre-embedding immunogold electron
microscopy in the hippocampal CA3 stratum lucidum of WT,
1a/, and 1b/mice, using a pan GABAB1 antibody recogniz-
ingGABAB1a andGABAB1b.MF-CA3pyramidal neuron synapses
within large MF boutons were identified at the ultrastructural
level as asymmetrical synapses at the spines of pyramidal neu-
rons. InWTmiceGABAB1 proteinwas present at presynaptic and
postsynaptic elements of MF-CA3 pyramidal neuron synapses
(Fig. 1A–C). 19.3 10.7% of all counted immunogold particles
were localized at synaptic and extrasynaptic sites of MF boutons,
while the remaining 80.7  10.7% were associated with spines
and proximal dendritic shafts of pyramidal neurons (Fig. 1 J). A
similar distribution was reported for the MF-CA3 pyramidal
neuron synapse in rat brain (Kulik et al., 2003). In 1a/ mice,
92.7 2.1%of all immunogold particles were observed on spines
and dendritic shafts of pyramidal neurons, indicating that
GABAB1b protein mainly localizes to postsynaptic elements (Fig.
1D–F, J). In contrast, in 1b/ mice 55.3  4.6% of all immu-
nogold particles were associated with the presynaptic membrane
of MF boutons, demonstrating that GABAB1a protein is slightly
more abundant at presynaptic elements (Fig. 1G–J). Strikingly,
the ratios of pre- to postsynaptic immunogold particles in the
different genotypes were similar at MF-CA3 pyramidal neuron
synapses (ratios for WT: 0.24, 1a/: 0.08, 1b/: 1.24) and
CA3-CA1 synapses (ratios for WT: 0.31, 1a/: 0.17, 1b/:
1.61; (Vigot et al., 2006)). Quantification from immunoblots in-
dicates an overall GABAB1a to GABAB1b protein ratio of 0.60 
0.04 (n 4mice, p 0.01, one sample Student’s t test) in theCA3
region of the hippocampus (data not shown). Considering this
ratio and the synaptic distribution of immunogold particles, we
approximately estimate that the GABAB1a to GABAB1b protein
ratio at presynaptic and postsynaptic sites is 4.5:1 and 1:3.5, re-
spectively. Importantly, we did not observe any MF boutons and
associated postsynaptic spines without specific immunogold par-
ticle labeling, suggesting thatmost, if not all,MF synapses express
GABAB receptors.
Subsynaptic distribution of GABAB1 isoforms in presynaptic
and postsynaptic elements of MF-CA3 pyramidal neuron
synapses
We next studied the distribution of GABAB1 protein relative to
synaptic specializations at MF-CA3 pyramidal neuron synapses.
We first determined the percentage ofGABAB1 immunogold par-
ticles in MF boutons that are present at presynaptic membranes
opposite to postsynaptic densities (PSDs). In WT and 1b/
mice 22% of all presynaptic GABAB1 immunogold particles were
localized opposite to PSDs and 78% at extrasynaptic membranes
(Fig. 2A). In 1a/mice 11% of all immunogold particles in MF
boutons were found opposite to PSDs, demonstrating that the
GABAB1b protein distribution is significantly shifted toward ex-
trasynaptic sites. Considering an overall GABAB1a to GABAB1b
protein ratio of 0.60 (see above), we approximately estimate a
GABAB1a to GABAB1b protein ratio of 9:1 in the active zones of
MF boutons. We additionally analyzed the distribution of
GABAB1 protein in dendritic spines of CA3 pyramidal neurons.
Independent of the genotype we rarely observed immunogold
particles in the PSD, likely because the pre-embedding technique
limits penetration of immunoreagents into the PSD (Kulik et al.,
2002, 2003). However, we did not observe any significant differ-
ences betweenWT, 1a/, and 1b/mice in the distribution of
GABAB1 immunoparticles at perisynaptic and extrasynaptic den-
dritic sites (Fig. 2B). Of note,20% of all immunoparticles were
found within 60 nm from the edge of the PSDs at perisynaptic
sites.
GABAB(1a,2) receptors are more efficient than GABAB(1b,2)
receptors in inhibiting glutamate release in response to
pharmacological activation
We used whole-cell patch-clamp recording in slice preparations
from WT, 1a/, and 1b/ mice to examine to what extent
GABAB(1a,2) and GABAB(1b,2) receptors can inhibit glutamate re-
lease in response to a maximally active concentration of the ago-
nist baclofen. Stimulation ofMFs in the stratum lucidum induces
EPSCs in CA3 pyramidal neurons that are reduced in amplitude
by activation of GABAB heteroreceptors. A high concentration of
baclofen (50M) reduced EPSC amplitudes in all three genotypes
(Fig. 3A,B). However, baclofen was significantly less effective in
inhibiting release in 1a/mice than inWT and 1b/mice. As
a control, activation of adenosine A1 receptors by adenosine in-
hibited glutamate release in all three genotypes to a similar extent
(Fig. 3A,B). We tested whether lower concentrations of baclofen
(0.1, 1 M) activate GABAB(1a,2) heteroreceptors without engag-
ingGABAB(1b,2) heteroreceptors (Fig. 3C). This was the case at 0.1
M, at which concentration baclofen reduced glutamate release
in WT and 1b/ mice but not in 1a/ mice (Fig. 3C). Alto-
gether, the electrophysiological data therefore parallel the ultra-
structural data described above (Figs. 1, 2). They support that the
number of GABAB(1a,2) heteroreceptors in 1b
/ mice is suffi-
cient to produce a maximal level of presynaptic inhibition (sim-
ilar toWT), while GABAB(1b,2) heteroreceptors in 1a
/mice are
limiting and consequently produce submaximal inhibition. At
low concentrations of baclofen, onlyGABAB(1a,2) heteroreceptors
appear to be present in sufficient numbers to inhibit glutamate
release.
Recent reports show that certain presynaptic GABAB recep-
tors can be tonically activated by ambient GABA (Jensen et al.,
2003; Lei andMcBain, 2003; Liu et al., 2006). Bath application of
the GABAB antagonist CGP54626A had no effect on the ampli-
tudes of evoked EPSCs in WT, 1a/, and 1b/ mice (Fig.
3D,E). This demonstrates that under our experimental condi-
tions ambient GABA does not tonically activate GABAB hetero-
receptors at MF boutons.
GABAB(1a,2) and GABAB(1b,2) receptors activate postsynaptic
K channels to a similar extent in response to
pharmacological activation
We next studied the relative contributions of GABAB1a and
GABAB1b isoforms to the formation of functional somatoden-
dritic GABAB receptors on CA3 pyramidal neurons, using so-
matic whole-cell patch-clamp recordings in slices. Somatoden-
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driticGABAB receptors induce a late IPSCby activatingKir3-type
K channels (Lu¨scher et al., 1997). At a holding potential of50
mV and at a physiological concentration of extracellular K,
pharmacological activation with a maximally active concentra-
tion of baclofen (100M) elicited smaller outwardK currents in
CA3 pyramidal cells of 1a/ and 1b/ mice compared with
WT mice (Fig. 4A,B). The maximal K currents induced by
baclofen were similar in 1a/ and 1b/ mice, thus showing
that GABAB(1b,2) and GABAB(1a,2) receptors activate K
 channels
to a similar extent. Pharmacological activation of adenosine A1
receptors, which converge on the same Kir3-type K channels
(Lu¨scher et al., 1997), induced similar outward currents in all
genotypes (Fig. 4A,B). This indicates that the expression levels of
4
the edge of the presynaptic membrane specialization and at perisynaptic and extrasynaptic
dendritic sites. D–F, In 1a/ mice, immunogold particles were almost exclusively found in
postsynaptic elements, predominantly at perisynaptic and extrasynaptic sites. In rare cases,
immunogoldparticleswerealsoobserved inMFboutons (E).G–I, In 1b/mice, immunogold
particles were observed in presynaptic and postsynaptic elements. Immunogold particles were
frequently found at the presynaptic membrane specialization of MF boutons. J, Quantitative
analysis of presynaptic versus postsynaptic immunogold particles in WT, 1a/, and 1b/
mice (percentage presynaptic particles: WT, 19.3 10.7%; 1a/, 7.3 2.1%; 1b/,
55.3 4.6%; n 3 mice per genotype). Immunogold particles were less frequent in 1b/
compared with 1a/ and WT mice, which is reflected by the total number of particles that
were analyzed (WT: n 1570; 1a/: n 1419; 1b/: n 1120). b, MF bouton; s,
dendritic spine; d, dendritic shaft; asterisk, degenerated unmyelinated axon. Scale bars: 200
nm. Values are means SD.
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Figure1. Electronmicrographs showing thedistributionofGABAB1 immunogoldparticles at
MF-CA3 pyramidal neuron synapses in the stratum lucidum. A–C, In WT mice, immunogold
particles were predominantly detected on dendritic spines and shafts of pyramidal cells (ar-
rows) as well as in MF boutons (arrowheads). Immunogold particles were frequently found at
Figure 2. Distribution of GABAB1 immunogold particles in presynaptic and postsynaptic
elements of MF-CA3 pyramidal neuron synapses. A, Percentage of GABAB1 immunogold parti-
cles at presynaptic membrane specializations of MF boutons opposite to PSDs (WT: 22.5
3.9%; 1a/: 11.1 2.8%; 1b/: 22.2 0.8%, n 3, *p 0.05, ANOVA/Dunnett’s
multiple comparison post hoc test). B, Histogram showing the spatial distribution of dendritic
GABAB1 immunogold particles relative to the postsynaptic density. No significant differences
between genotypes were detected. GABAB1 immunogold particles were generally enriched in
the perisynaptic region within 60 nm from the edge of the PSD. Values are means SEM.
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Kir3-type K channels are not altered as a
consequence of the lack of GABAB1 iso-
form proteins. We tested whether lower
concentrations of baclofen possibly gener-
ate distinct K outward currents in 1a/
and 1b/ mice, which was not the case
(Fig. 4C). A reduction of K current am-
plitudes in 1a/ and 1b/ mice was
only observed at high concentrations of
baclofen (100 M), while at lower concen-
trations ( 10 M) the K current ampli-
tudes were similar in all genotypes (Fig.
4C). Since at all concentrations of baclofen
the GABAB-induced K
 currents in 1a/
and 1b/mice were similar, this suggests
that GABAB(1b,2) and GABAB(1a,2) recep-
tors are able to activate K channels to a
similar extent.
GABAB(1a,2) but not GABAB(1b,2)
receptors inhibit glutamate release in
response to physiological activation
To address to what extent the two GABAB
receptor subtypes contribute to physiolog-
ical inhibition of glutamate release at MF
terminals we examined heterosynaptic de-
pression in WT, 1a/, and 1b/ mice.
GABAB receptor-mediated heterosynaptic
depression of MF transmission has been
studied using fEPSP recordings and relies
on the activation of GABAB heterorecep-
tors by GABA released from neighboring
interneurons (Vogt and Nicoll, 1999;
Chandler et al., 2003). We first verified
that the stimulating electrode in the den-
tate gyrus evokes fEPSPs with properties
consistent with MF transmission. MF syn-
aptic responseswere identified by the pres-
ence of paired-pulse facilitation,
frequency-dependent short-term facilita-
tion and sensitivity to the mGluR agonist
DCG-IV, which blocks glutamate release
from the MF but not from the
associational-commissural fibers (Kamiya
et al., 1996; Yeckel et al., 1999; Kirschstein
et al., 2004; Nicoll and Schmitz, 2005).
When fEPSPs were evoked with paired-
pulse stimulation (100 ms apart), fEPSPs
exhibited a pronounced facilitation of
197.4 14.6% (n 16 slices). In addition,
when the stimulation frequency was in-
creased from 0.05 to 1 Hz, fEPSPs exhib-
ited a marked frequency-dependent facili-
tation of 246.3 26.3% (n 8 slices) (Fig.
5). Finally, as described (Kamiya et al.,
1996; Yeckel et al., 1999), bath application
ofDCG-IV reduced the amplitudeof fEPSPs
measured at 0.05 Hz to 38.9  5.5% (n  9 slices) (Fig. 5). Bath
applicationofCGP54626A(2M)hadnosignificant effecton fEPSP
peak amplitudes (control: 100 19.5%, n 7 slices; CGP54626A:
98.9  18.3%, n  7 slices), in keeping with patch-clamp experi-
ments showing that ambient levels ofGABAdonot tonically activate
GABAB heteroreceptors (Fig. 3D,E).
To induce heterosynaptic depression at MF synapses we
placed a second stimulating electrode into the dentate gyrus. The
position of this electrode and the stimulus intensitywere adjusted
such that two independent MF pathways could be stimulated
(Fig. 6A). Pathway one was stimulated at a regular interval of 10 s
to evoke MF test fEPSPs (S1). Every tenth stimulus was preceded
Figure 3. GABAB heteroreceptor function at MF-CA3 pyramidal neuron synapses. A, B, EPSC peak amplitudes plotted versus
time, average current traces, and summary histogramofmonosynaptic EPSCs inhibition bybaclofen (bac) and adenosine (adeno).
Baclofen (50M) depressed the amplitude of EPSCs to the same extent inWT and 1b/mice, but was less effective in 1a/
mice (WT: 78.6 2.6% inhibition, n 7; 1b/: 75.6 3.7% inhibition, n 6; 1a/: 36.4 7.3% inhibition, n 10,
***p 0.001, 1a/ compared with WT and 1b/, ANOVA/Scheffe post hoc test). The inhibitory effect of baclofen was
blocked by the GABAB receptor antagonist CGP54626A (CGP, 1M). As a control, adenosine (100M) efficiently reduced the peak
amplitudes of EPSCs in all genotypes (WT: 87.7 1.6% inhibition, n 6; 1a/: 80.4% 4.4% inhibition, n 8; 1b/:
85.72.2% inhibition,n4). Current traces inA showaverages of 10 successive EPSCs (calibration: 20ms/100pA).C, Inhibition
of glutamate release by different concentrations of baclofen. In 1a/ mice, baclofen was ineffective in inhibiting glutamate
release at 0.1M (n 5). At higher concentrations, baclofenwas always less effective in inhibiting glutamate release in 1a/
mice comparedwithWTor 1b/mice (1M, 1a/: 248.3% inhibition,n5, *p0.05, 1a/ comparedwithWTand
1b/; 50M, 1a/: 38.46.6% inhibition,n5, ***p0.001, 1a/ comparedwithWTand1b/, ANOVA/Scheffe
post hoc test). InWT and 1b/mice, baclofen reduced the peak amplitude of EPSCs to the same extent at 0.1M (WT: 26.5
3.4% inhibition, n 4; 1b/: 23.4 6.1% inhibition, n 4), 1M (WT: 57.2 5.6% inhibition, n 4; 1b/: 50.1
8.9% inhibition, n 4), and 50M (WT: 94.8 2.6% inhibition, n 4; 1b/: 94.2 2.2% inhibition, n 4). D, E, Lack of
evidence for a tonic activity of GABAB heteroreceptors at MF boutons.D, Evoked EPSCs of aWT CA3 pyramidal neuron recorded in
the absence and presence of CGP54626A (1M). E, Summary histogram showing that in all genotypes the peak amplitudes of
evoked EPSCs are not significantly altered in the presence of CGP54626A (WT: 98.2 4.5%, n 6; 1a/: 100.9 9.0%, n
6; 1b/: 102.8 6.1%, n 5). Values are means SEM.
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by a conditioning train of 20 stimuli at 100 Hz on pathway two
(S2). The two pathwayswere stimulated 200ms apart. To prevent
interference from presynaptic opioid and A1 adenosine recep-
tors, heterosynaptic depression was measured in the presence of
the antagonists naloxone and DPCPX. Under these conditions a
marked GABAB receptor-mediated heterosynaptic depression is
observed; only at strongerMF activation levels a direct activation
of presynaptic mGluRs through spillover of glutamate will occur
(Vogt and Nicoll, 1999). In WT mice, the amplitudes of test
fEPSPs evoked after a train on pathway two (conditioned fEPSPs,
closed circles) were significantly reduced by 25.7  3.3% ( p 
0.01,n 6 slices) comparedwith fEPSPsmeasured in the absence
of a conditioning train (unconditioned fEPSPs) (Fig. 6B,E, open
circles). CGP54626A largely or totally inhibited the reduction of
conditioned fEPSP amplitudes (Fig. 6B,E), confirming that het-
erosynaptic depression was mainly mediated by GABAB recep-
tors. NoGABAB-mediated heterosynaptic depressionwas detect-
able in 1a/mice (conditioned fEPSPs reduced by 2.5 1.4%,
p 0.20, n 6 slices) and accordingly, CGP54626A had no effect
on fEPSPs (Fig. 6C,E). In contrast, we observed a significant het-
erosynaptic depression in 1b/ mice (conditioned fEPSP am-
plitudes reduced by 26.2 2.8%, n 7 slices; p 0.001), which
was markedly reduced or abolished by CGP54626A (Fig. 6D,E).
Confirming that our recordings relate to MF transmission, fEP-
SPswere always inhibited by application ofDCG-IV (Fig. 6B–D).
Of note, the amplitudes of unconditioned fEPSPs in WT and
1b/ mice were increased in the presence of CGP54626A (Fig.
6B,D, open circles), suggesting that the GABA released by the
conditioning train lasts long enough to significantly inhibit un-
conditioned fEPSPs during the 90 s preceding the next condition-
ing train. In support of this, we found that CGP54626Awas with-
out effect on unconditioned fEPSP amplitudes in the absence of
the conditioning train (control: 100  18.6%, n  8 slices;
CGP54626A: 100.8  19.1%, n  8 slices). CGP54626A had no
Figure 4. GABAB-receptor-activated K
 currents in CA3 pyramidal neurons. A, B,
Changes in the holding current of CA3 pyramidal neurons following bath application of
baclofen (bac; 100 M) or adenosine (adeno; 100 M) and summary histogram of the
amplitude of baclofen- and adenosine-induced K currents. The baclofen-induced out-
ward K current was blocked by CGP54626A (CGP; 1 M) and significantly reduced in
1a/ and 1b/mice compared with WT mice (WT: 255.9 23.8 pA, n 6; 1a/:
112.8 17.5 pA, n 7; 1b/: 130.3 31.9 pA, n 7; *p 0.05, 1a/ and 1b/
compared with WT, ANOVA/Scheffe post hoc test). Control adenosine-induced K cur-
rents were similar in all genotypes (WT: 79.4 15.2 pA, n 6; 1a/: 57.1 12.7 pA,
n  7; 1b/: 64.0  16.5 pA, n  7), showing that effector K channels are not
altered in 1a/ and 1b/mice. C, Normalized K current amplitudes in response to
increasing concentrations of baclofen. The maximal K current amplitude for each con-
centration was normalized to the meanmaximal K current amplitude recorded fromWT
neurons at a saturating concentration of baclofen (100M). In 1a/ and 1b/mice,
the amplitude of baclofen-induced Kwas significantly reduced compared with WT mice
at 100 M (WT: 100 13.6%, n 5; 1a/: 63.7 7.7%, n 8; 1b/: 58.7
9.1%, n 5; *p 0.05, 1a/ and 1b/ compared with WT, ANOVA/Scheffe post hoc
test). Baclofen-induced K current amplitudes were not statistically different between
genotypes at concentrations of 0.3 M (WT: 3.6 0.9%, n 5; 1a/: 3.6 0.6%,
n 4; 1b/: 0.8 0.2%, n 4), 1M (WT: 7.4 2%, n 5; 1a/: 5.7 1.1%,
n  5; 1b/: 2.4  0.8%, n  4), and 10 M (WT: 21.7  3.5%, n  5; 1a/:
19.5 3.4%, n 6; 1b/: 15.5 2.9%, n 5). Values are means SEM.
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Figure 5. MF fEPSPs exhibit frequency-dependent short-term facilitation and sensitivity to
themGluR agonist DCG-IV. Average traces of fEPSPs recorded in the stratum lucidum at 0.05 Hz
and 1Hz and in the presence of DCG-IV (top) aswell as amplitudes of fEPSPs plotted versus time
(bottom) are shown. Increasing the stimulus frequency from 0.05 to 1 Hz induced pronounced
facilitation. Bath application of DCG-IV (2M) strongly inhibited fEPSP amplitudes elicited at
0.05 Hz.
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effect on unconditioned fEPSP amplitudes
in 1a/mice, in agreement with a lack of
functional GABAB heteroreceptors in
these mice (Fig. 6C). In summary, our ex-
periments show that exclusively
GABAB(1a,2) receptors mediate heterosyn-
aptic depression at MF-CA3 synapses.
Late IPSCs are detectable inWTmice
but not in 1a/ and 1b/mice
GABAB(1a,2) and GABAB(1b,2) receptors
produce K-currents of similar amplitude
in response to pharmacological activation
with baclofen (Fig. 4).However, it remains
possible that GABAB(1a,2) and GABAB(1b,2)
receptors produce distinct postsynaptic
responses following physiological activa-
tion, due to local differences in their soma-
todendritic abundance. In the hippocam-
pus, synaptically released GABA induces
Cl-dependent early IPSCs and K-
dependent late IPSCs that are mediated by
GABAA and GABAB receptors, respec-
tively (Misgeld et al., 1995; Lu¨scher et al.,
1997). We simultaneously recorded early
and late IPSCs in WT, 1a/, and 1b/
mice. The early IPSC allowed us to verify
that stimulation of the MF pathway pro-
voked GABA release in all of our record-
ings. The amplitude of the late IPSC was
used to quantify the extent of GABAB re-
ceptor activation in response to synapti-
cally released GABA. Three stimuli at 100
Hz reliably evoked early and late IPSCs in
WT mice. The occurrence of late IPSCs
was prevented in the presence of
CGP54626A, confirming that the late IP-
SCs are mediated by GABAB receptors
(Fig. 7A,D). No late IPSCs were detectable
in 1a/ and 1b/ mice, although early
IPSCs were always induced (Fig. 7B–D).
This suggests that the reduction of func-
tional postsynaptic GABAB receptors seen
in 1a/ and 1b/mice after pharmaco-
logical stimulation (Fig. 4) leads to sub-
threshold late IPSCs under physiological
conditions.
Figure 6. GABAB-mediated heterosynaptic depression at MF-CA3 pyramidal neuron synapses. A, Two electrodes (S1, S2)
positioned in the dentate gyrus were used to stimulate two independent pathways. A third electrode in the CA3 stratum lucidum
was used to record MF fEPSPs. Pathway 1 was stimulated at a regular interval of 10 s to evoke test fEPSPs (S1, unconditioned
response). Pathway 2was stimulated 200ms before every tenth test stimuluswith a train of 20 stimuli at 100 Hz (S2, conditioned
responses). B, GABAB-mediated heterosynaptic depression in slices of WT mice. The amplitudes of fEPSPs plotted over time
(bottom) and average traces (top) are shown. The amplitudes of fEPSPs preceded by a train (closed circles, red traces) were
reduced comparedwith those of fEPSPs not preceded by a train (open circles, black traces). Heterosynaptic depressionwas largely
inhibited or lost in the presence of CGP54626A (CGP; 2M). Average fEPSP traces are shown in the absence (1) and the presence
(2) of CGP54626A (stimulation artifacts were removed). C, GABAB-mediated heterosynaptic depression was absent in slices of
1a/ mice. The amplitudes of conditioned fEPSPs were similar to those of unconditioned fEPSPs. D, GABAB-mediated het-
erosynaptic depression in slices of 1b/micewas similar to that inWTmice and inhibited by CGP54626A. Note that CGP54626A
also increased the amplitude of unconditioned fEPSPs in WT and 1b/mice but not in 1a/mice (B–D). In all genotypes,
fEPSPs were inhibited by DCG-IV (2M). E, Summary histogram of GABAB-mediated heterosynaptic depression. The amplitudes
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of conditioned fEPSPs were normalized to amplitudes of un-
conditioned fEPSPs in the absence (baseline) and presence of
CGP54626A. Significant CGP54626A-sensitive heterosynaptic
depression was observed in WT mice (baseline: 74.3 4%,
n 6 slices; CGP54626A: 100.8 2.7%, n 6 slices; **p
0.01, two-tailed paired Student’s t test) and 1b/ mice
(baseline: 73.8  2.8%, n  7 slices; CGP54626A: 95 
3.7%, n  7 slices; **p  0.01) but not in 1a/ mice
(baseline: 97.5 1.4%, n 6 slices; CGP54626A: 99.4
1.3%, n 6 slices; p 0.32). The ANOVA/Scheffe post hoc
test was used for the comparison of genotypes (***p 
0.001, normalized conditioned fEPSPs in 1a/ compared
with WT and 1b/mice). Values are means SEM.
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Discussion
GABAB(1a,2) andGABAB(1b,2) receptor subtypes exhibit compara-
ble pharmacological and functional properties when studied in
heterologous expression systems (Calver et al., 2002; Bettler et al.,
2004; Ulrich and Bettler, 2007). However, the two receptor sub-
types produce distinct responses at axonal and dendritic effectors
when pharmacologically activated by a saturating concentration
of baclofen (Pe´rez-Garci et al., 2006; Shaban et al., 2006; Vigot et
al., 2006; Ulrich and Bettler, 2007; Ulrich et al., 2007). Moreover,
the contributions of the two receptor subtypes to axonal or den-
dritic effector responses can vary in between neuronal popula-
tions. Two reasons probably account for neuron-specific differ-
ences in the responses of GABAB receptor subtypes. On the one
hand, GABAB1a and GABAB1b subunits are differentially distrib-
uted to axonal and dendritic compart-
ments (Vigot et al., 2006). On the other
hand, the expression of GABAB1a and
GABAB1b subunits is under separate tran-
scriptional control, which will influence
the ratio of receptor subtypes in individual
neurons (Steiger et al., 2004). It seems rea-
sonable to propose that separate control of
both transcription and distribution of
GABAB receptor subtypes has evolved to
provide neurons with ameans to indepen-
dently adjust signaling at select effector
systems. To support this concept, it is im-
portant to directly demonstrate that endo-
genously released GABA can differentially
activate GABAB receptor subtypes
(Huang, 2006). This is the case for inhibi-
tory synapses at cortical layer 5 pyramidal
neurons, where under physiological con-
ditions selectively GABAB(1a,2) and
GABAB(1b,2) receptors act as autoreceptors
and postsynaptic receptors, respectively
(Pe´rez-Garci et al., 2006). Here, we ad-
dressed whether this is also the case for
GABAB heteroreceptors at glutamatergic
synapses. A physiological phenomenon
that is reported to depend on the endoge-
nous activation of GABAB heteroreceptors
is heterosynaptic depression (Isaacson et
al., 1993; Vogt and Nicoll, 1999; Chandler
et al., 2003). We therefore determined the
individual contributions of the two
GABAB receptor subtypes to heterosynap-
tic depression at MF-CA3 pyramidal neu-
ron synapses, where this phenomenon can
be easily studied (Vogt and Nicoll, 1999;
Chandler et al., 2003). Our data show that
exclusively GABAB(1a,2) heteroreceptors
mediate heterosynaptic depression of MF
transmission. Yet the presence of func-
tional GABAB(1b,2) heteroreceptors at MF
boutons can be demonstrated in pharma-
cological experiments, in which concen-
trations of baclofen 1 M produce a
component of presynaptic inhibition me-
diated by GABAB(1b,2) receptors. In phar-
macological experiments, a selective pre-
synaptic inhibition via GABAB(1a,2)
heteroreceptors was only observed at a
lower concentration of baclofen (0.1 M). The most parsimoni-
ous explanation for these data is that the number of GABAB(1b,2)
receptors at presynaptic sites in 1a/mice is sufficient to mea-
surably inhibit glutamate release in response to pharmacological
activation with moderate to high concentrations of baclofen, but
not to inhibit release in response to low concentrations of spill-
over GABA from neighboring interneurons. This may be accen-
tuated by the fact that presynaptic GABAB receptors at MF bou-
tons display non-desensitizing properties (Tosetti et al., 2004),
which will render sustained pharmacological inhibition particu-
larly effective. Baclofen likely also activates somatic GABAB(1b,2)
receptors in the dentate granule cells. The ensuing hyperpolariz-
ing potentials may passively propagate to the MF boutons and
contribute to presynaptic inhibition (Alle and Geiger, 2006). The
Figure 7. GABAA-mediated early IPSCs and GABAB-mediated late IPSCs recorded from CA3 pyramidal neurons in acute hip-
pocampal slices. A–C, Average traces of early and late IPSCs recorded from WT, 1a/, and 1b/ brain slices (black traces).
IPSCs were recorded at a holding potential of60mV and an internal Cl concentration of 20mM, which yields inward currents
for early IPSCs and outward currents for late IPSCs. Application of CGP54626A (2M) abolished late IPSCs without affecting early
IPSCs (red traces).D, Mean peak amplitudes of the first early IPSC (GABAA, left) and the late IPSC (GABAB, right). Early IPSCs were
of similar amplitudes in all three genotypes (WT: 104.5 18.5 pA, n 9; 1a/: 128.6 23.4 pA, n 9; 1b/: 140.3
38.4 pA, n 5; p	 0.05). Late IPSCs were only detectable inWTmice (6.9 0.8 pA, n 9) but not in 1a/mice (n 9) or
1b/mice (n 5). Currents were recorded in the presence of kynurenic acid (2 mM), DNQX (10M), naloxone (10M), and
DPCPX (1M). Values are means SEM.
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exact reason for presynaptic inhibition following pharmacologi-
cal activation with baclofen is unknown. However, our results
support that the spatial segregation of GABAB1 isoforms at MF
terminals is sufficient to produce a strictly subtype-specific het-
eroreceptor response under physiological conditions. At other
glutamatergic synapses baclofen also produces a significant level
of presynaptic inhibition through GABAB(1b,2) heteroreceptors
(Shaban et al., 2006; Vigot et al., 2006; Ulrich et al., 2007). We
expect that under physiological conditions exclusively
GABAB(1a,2) receptors mediate heteroreceptor function at those
synapses as well.
Heterosynaptic depression at MF-CA3 pyramidal neuron
synapses is thought to play an important role in regulating mne-
monic processes (Jin and Chavkin, 1999; Vogt and Nicoll, 1999;
Vida and Frotscher, 2000; Chandler et al., 2003). Heterosynaptic
depression increases the sparseness of input signals to CA3 pyra-
midal cells, thereby enhancing the storage capacity of the CA3
network. Overt memory deficits in hippocampus-dependent
memory tasks in 1a/ mice (Vigot et al., 2006; Jacobson et al.,
2007) may therefore relate, at least in part, to the disinhibition of
MF inputs and the ensuing failure to store or recall memory
traces. In addition, the control of GABAB1a-mediated inhibition
at MF boutons may be important for regulating synaptic plastic-
ity and limbic seizure prevention, since these processes were also
shown to be controlled by GABAB heteroreceptors (Vogt and
Nicoll, 1999; Chandler et al., 2003).
We found that baclofen induces similar maximal K currents
in CA3 neurons of 1a/ and 1b/ mice. Given the surplus of
GABAB1b protein at dendritic sites opposite to MF terminals, it
may appear surprising that the maximal K currents induced by
GABAB(1b,2) receptors are not larger than those induced by
GABAB(1a,2) receptors. However, caution should be exerted when
comparing the ultrastructural data with the electrophysiological
data. On the one hand, the GABAB receptors included in the
ultrastructural analysis may not necessarily be coupled to K
channels. For example, it is conceivable that a larger fraction of
GABAB(1a,2) receptors is colocalized with Kir3-type K
 channels,
rendering their coupling to effector channelsmore efficient (Kar-
schin, 1999). Future studies, for example using high-resolution
immunocytochemical techniques (Kulik et al., 2006), will have to
address whether GABAB1 isoforms exhibit differences in the co-
localization with Kir3-type K channel subunits. On the other
hand, baclofen probably mostly activates K currents via soma-
todendritic GABAB receptors remote from MF synapses, and
these receptors were excluded from the ultrastructural analysis. It
is possible that the relative abundance of GABAB(1a,2) and
GABAB(1b,2) receptors differs between dendritic spines and shafts,
similar as observed in CA1 pyramidal neurons where GABAB1a
protein does not efficiently enter the spines (Vigot et al., 2006). It
further could be argued that the downregulation of GABAB1a
protein levels during early postnatal development (Malitschek et
al., 1998; Fritschy et al., 1999) accounts for the difference between
the morphological and electrophysiological data. However, rul-
ing out this possibility, all our experiments were performed with
mice 3 weeks of age or older, when GABAB1a and GABAB1b pro-
tein levels remain stable (Malitschek et al., 1998). While many
factors can contribute to the difference between the ultrastruc-
tural data of spines and the electrophysiological responses re-
corded for the soma of CA3 pyramidal neurons, our data further
consolidate that the relative contributions of GABAB1a and
GABAB1b subunits to the pool of GABAB receptors coupled to
effector K channels varies in between neurons (Ulrich and Bet-
tler, 2007). Importantly, a physiological activation of somatoden-
dritic GABAB receptors by synaptically released GABA does not
produce a segregation of GABAB(1a,2) and GABAB(1b,2) responses
in CA3 pyramidal neurons, in contrast to the findings with cor-
tical neurons (Huang, 2006; Pe´rez-Garci et al., 2006).
In conclusion, our results are consistentwith the proposal that
independent regulation of expression and distribution of GABAB
receptor subtypes enables neurons to dynamically adjust GABAB
signaling at axonal and dendritic effectors. The observation that
GABAB1a and GABAB1b cannot compensate for each other in
response to synaptically releasedGABA is important fromaphar-
maceutical perspective. The existence of two functionally distinct
GABAB receptor subtypes enables a more selective interference
with the GABAB receptor system, which may be of therapeutic
benefit for the treatment of neurological and psychiatric disor-
ders (Tiao et al., 2008).
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6.3. A mouse model for visualization of GABAB receptors 
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In the following work, a transgenic mouse model for the visualization of GABAB receptors 
was generated by using a modified bacterial artificial chromosome (BAC) containing the 
GABAB1 gene. The coding sequence for the enhanced green fluorescent protein (eGFP) 
was inserted into the BAC in frame at the C-terminus of GABAB1. The BAC contained 110 
kb of upstream and 50 kb of downstream sequences and was therefore likely to harbor 
most, if not all, regulatory elements that drive expression of the GABAB1a and GABAB1b 
subunit isoforms. GABAB1-eGFP BAC transgenic mice were backcrossed into the GABAB1
-/- 
background in order to assess whether the eGFP-tagged GABAB1 subunits were able to 
form functional receptors. 
Expression of eGFP was detected in brains of both young and adult mice. Moreover, 
immunohistochemistry demonstrated that the GABAB receptor expression pattern was 
similar in WT and GABAB1
-/-, GABAB1-eGFP BAC
+/+ (GB1-/-, BAC+/+) mice. Immunoblot 
analysis of GB1-/-, BAC+/+ mice revealed that GABAB1a and GABAB1b are expressed as eGFP-
fusion proteins and that protein levels are similar to endogenous GABAB1a and GABAB1b in 
WT mice. In addition, co-immunoprecipitation demonstrated successful 
heterodimerization of the GABAB1-eGFP fusion proteins with GABAB2. Functional analysis 
of GB1-/-, BAC+/+ mice revealed complete rescue of GABAB functions, indicating that 
GABAB1-eGFP fusion proteins are forming functional pre- and postsynaptic receptors with 
GABAB2. Next the temporal expression of GABAB1-eGFP fusion proteins was assessed in 
cultured hippocampal neurons of GB1-/-, BAC+/+ mice. GABAB1-eGFP expression was 
observed as early as day in vitro (DIV) 2, predominantly in the soma and the axon. From 
DIV4, GABAB1-eGFP expression was observed in the soma, dendrites and axon. 
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Furthermore, we demonstrated by examining the ileum and colon that this mouse model 
can be used as a new tool to localize GABAB receptor expressing cells in peripheral 
tissues. In conclusion, the mouse model presented in the following publication provides a 
validated tool for direct visualization of endogenous GABAB receptors and therefore 
allows the study of receptor dynamics under physiological and experimental conditions.  
 
Statement of personal contribution: 
- Characterization of the GB1-/-, BAC+/+ mouse model including western blot and 
immunohistochemical analysis of the brain 
- Experiments with primary hippocampal neuronal cultures 
- Breeding and genotyping of the mice 
- Contribution to the preparation of the manuscript 
- Design of all figures 
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Summary: GABAB receptors are the G-protein-coupled
receptors for the neurotransmitter c-aminobutyric acid
(GABA). Receptor subtypes are based on the subunit
isoforms GABAB1a and GABAB1b, which combine with
GABAB2 subunits to form heteromeric receptors. Here,
we used a modified bacterial artificial chromosome (BAC)
containing the GABAB1 gene to generate transgenic mice
expressing GABAB1a and GABAB1b subunits fused to the
enhanced green fluorescence protein (eGFP). We demon-
strate that the GABAB1-eGFP fusion proteins reproduce
the cellular expression patterns of endogenous GABAB1
proteins in the brain and in peripheral tissue. Crossing
the GABAB1-eGFP BAC transgene into the GABAB1
2/2
background restores pre and postsynaptic GABAB func-
tions, showing that the GABAB1-eGFP fusion proteins
substitute for the lack of endogenous GABAB1 proteins.
Finally, we demonstrate that the GABAB1-eGFP fusion
proteins replicate the temporal expression patterns of
native GABAB receptors in cultured neurons. These trans-
genic mice therefore provide a validated tool for direct
visualization of native GABAB receptors. genesis 47:595–
602, 2009. VC 2009 Wiley-Liss, Inc.
Key words: enhanced GFP; enteric; GABA-B; GABA(B);
GABAB1; GPCR; transgenic
GABAB receptors are the G-protein-coupled receptors
(GPCRs) for g-aminobutyric acid (GABA), the main inhib-
itory neurotransmitter in the brain. They are considered
as promising drug targets for the treatment of neurologi-
cal and psychiatric disorders (Bettler et al., 2004; Bow-
ery et al., 2002). Depending on their subcellular localiza-
tion, GABAB receptors exert distinct regulatory effects
on synaptic transmission (Couve et al., 2000; Ulrich and
Bettler, 2007). Presynaptic GABAB receptors inhibit the
release of GABA (autoreceptors) and other neurotrans-
mitters (heteroreceptors). Postsynaptic GABAB recep-
tors inhibit neuronal excitability by activating K1 chan-
nels that shunt excitatory currents and induce mem-
brane hyperpolarization. Functional GABAB receptors
are obligate heteromers composed of GABAB1 and
GABAB2 subunits (Gassmann et al., 2004; Marshall et al.,
1999; Prosser et al., 2001; Schuler et al., 2001). Molecu-
lar diversity in the GABAB system is based on the subunit
isoforms GABAB1a and GABAB1b, which are encoded by
the same gene but independently regulated at the tran-
scriptional level (Steiger et al., 2004). GABAB1a and
GABAB1b constitute two distinct receptor subtypes,
GABAB(1a,2) and GABAB(1b,2), which contribute differen-
tially to synaptic and nonsynaptic functions (Ulrich and
Bettler, 2007). At hippocampal mossy fiber-to-CA3 and
CA3-to-CA1 synapses, mainly GABAB1a assembles hetero-
receptors inhibiting glutamate release, while GABAB1b is
more abundant at postsynaptic sites (Guetg et al., 2009;
Vigot et al., 2006). A large body of work has addressed
the regulation of GABAB receptor assembly and surface
trafficking (Bettler and Tiao, 2006). However, the mecha-
nisms regulating the distribution of GABAB receptors to
axons and dendrites are less well understood. Likewise,
it remains unclear whether GABAB receptor localization
and surface expression is altered in disease and in
response to pharmacological treatment. Mice that allow
direct visualization of endogenous GABAB receptors
would therefore be useful to study receptor dynamics
under physiological and experimental conditions
(Scherrer et al., 2006).
Tagging proteins with GFP from the jellyfish Aequorea
victoria has been widely used to study the spatial and
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temporal expression patterns of proteins in various
model organisms. To faithfully recapitulate the endoge-
nous expression patterns, the tagged proteins are ideally
expressed under control of promoter elements of their
own gene. However, using traditional transgenic
approaches that usually rely on promoter elements in
the vicinity of the transcriptional start site, the tagged
proteins often failed to reproduce the endogenous
expression patterns. In particular, this has been a prob-
lem when expressing proteins in the mammalian central
nervous system (Heintz, 2001). The use of bacterial arti-
ficial chromosomes (BACs) for transgenic expression
potentially circumvents this problem as BACs are more
likely to contain all the cis regulatory elements that are
required for accurate expression of the transgene (Yang
et al., 1997; Zhang et al., 1998). However, because of
the random integration of the BAC into the genome, the
expression of the transgene may still be influenced by
sequences at the integration site. Moreover, overexpres-
sion of genes contained in the BAC in addition to the
gene of interest may produce unwanted effects. With
these potential drawbacks in mind, BAC transgenic mice
have been a very useful tool for analyzing protein distri-
bution and function in the brain. To generate transgenic
mice expressing eGFP-tagged GABAB1 subunits under
control of GABAB1 promoter elements, we therefore
resorted to BAC technology.
Specifically, we used homologous recombination in
Escherichia coli (ET-recombination) to modify a 200 kb
BAC encompassing the GABAB1 gene. The BAC con-
tained 110 kb of upstream and 50 kb of downstream
sequences and was therefore likely to harbor most, if
not all, regulatory elements that drive expression of the
GABAB1a and GABAB1b subunit isoforms. An eGFP cDNA
was inserted in frame at the C-terminus of the GABAB1
coding sequence (Fig. 1a). Transgenic mice were gener-
ated by pronuclear injection of the modified BAC. One
founder mouse was identified by Southern blot analysis
of genomic tail DNA (Fig. 1a). Breeding of the founder
mouse revealed that the BAC transgene was integrated
in the X chromosome. BAC transgenic mice were viable
and did not express any overt phenotypes. We next ana-
lyzed BAC transgenic mice for expression of GABAB1-
eGFP fusion proteins. Immunoblot analysis of brain
membranes showed that, as expected, the subunit iso-
forms GABAB1a and GABAB1b are both expressed as
FIG. 1. Generation of a GABAB1-eGFP BAC transgenic mouse line. (a) Schematic representation of the modified BAC containing the
GABAB1 gene. The eGFP cDNA was inserted in frame 5’ of the stop codon (TGA) of exon 23 (E23) in the GABAB1 gene. The junction
sequence between the GABAB1 C-terminus and the eGFP coding region contains an ACC insertion encoding a threonine (T). The 3’ untrans-
lated region (30 UTR) is indicated. Southern blot analysis with the indicated probe detects BglII restriction fragments of 4.1 and 4.8 kb for the
endogenous GABAB1 gene and the BAC transgene, respectively. (b) Immunoblot analysis of total brain lysates prepared from adult mice of
different genotypes. In GB11/1, BAC1/2 mice, an antibody recognizing the common C-terminus of GABAB1 (anti-GB1) detects the endoge-
nous GABAB1 subunit isoforms GB1a and GB1b as well as the C-terminal eGFP fusion proteins GB1a-eGFP and GB1b-eGFP. Of note,
GB1b-eGFP and GB1a migrate at a similar molecular weight and are not resolved on the blot. Immunoblot analysis with an anti-eGFP
antibody confirms that both GB1a and GB1b are expressed as eGFP fusion proteins from the modified BAC. Anti-syntaxin antibodies con-
trol for sample loading. (c) Anti-eGFP antibodies co-immunoprecipitate endogenous GABAB2 protein from total brain lysates of GB1
1/1,
BAC1/2 but not of WTcontrol mice. This demonstrates that the GABAB1-eGFP fusion proteins associate with GABAB2 protein in vivo.
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eGFP fusion proteins (Fig 1b). Crossing of the GABAB1-
eGFP BAC into the GABAB1
2/2 (from here on referred
to as GB12/2) background (Schuler et al., 2001)
showed a progressive increment in the levels of expres-
sion of the GABAB1-eGFP fusion proteins, reaching a
maximum when endogenous GABAB1 proteins are com-
pletely lacking (Fig. 1b, left panels). Because the BAC
integrated in the X chromosome, we also compared the
expression levels of the GABAB1-eGFP fusion proteins
in GB12/2, BAC1/1 females and GB12/2, BAC1/1
males. The expression levels of the GABAB1-eGFP fusion
proteins were similar in both sexes and comparable to
the expression level of endogenous GABAB1 protein in
wild-type (WT; GB11/1, BAC2/2) mice (Fig. 1b, right
panels). It is known that GABAB2 protein stabilizes the
GABAB1 proteins (Gassmann et al., 2004). It is therefore
likely that the maximal expression levels of the trans-
genic GABAB1-eGFP fusion proteins cannot exceed the
levels of the endogenous GABAB1 proteins because of
the limited availability of GABAB2 protein. Co-immuno-
precipitation experiments with anti-eGFP antibodies
confirmed that the GABAB1-eGFP fusion proteins hetero-
merize with endogenous GABAB2 protein (Fig. 1c). Im-
munoblot analysis using antibodies against the common
C-terminus of GABAB1a and GABAB1b or against eGFP did
not reveal any detectable protein degradation of the
fusion proteins (Fig. 1b).
We next examined expression of the GABAB1-eGFP
fusion proteins in GB12/2, BAC1/1 mice by fluores-
cence imaging and immunohistochemistry (see Fig. 2).
Strong eGFP fluorescence was observed in whole brain
as well as in brain sections (Fig. 2a). Immunohistochem-
istry using anti-GABAB1 and anti-eGFP antibodies con-
firmed that the GABAB1-eGFP fusion proteins are
expressed across the entire brain (Fig. 2b), consistent
with the known expression pattern of the endogenous
GABAB1 proteins in WT mice (Fritschy et al., 2004). We
also assessed whether the GB12/2, BAC1/1 mice can be
used to identify cell types expressing GABAB receptors
in peripheral tissues. Given the extensive distribution of
GABAB receptors previously reported in rat intestine
(Nakajima et al., 1996), we examined GABAB1-eGFP
expression in the mouse ileum and colon (see Fig. 3).
GABAB1-eGFP immunoreactivity was observed in both
the myenteric and submucosal plexus of longitudinal
sections of ileum (Fig. 3a) and colon (Fig. 3b), consistent
with the immunostaining for the endogenous GABAB1
proteins in WT mice (Fig. 3i,j). Predominantly cytoplas-
mic GABAB1-eGFP immunoreactivity was detected in
whole mount preparations of both the ileum and colon
(Fig. 3c,d; submucosal plexus). As a control, no eGFP im-
munoreactivity was detectable in WT tissues (Fig. 3e–h).
No epithelial GABAB1-eGFP was detected in either colo-
nic or ileal preparations, nor did we observe any enter-
oendocrine-like GABAB1-eGFP, suggesting that GABAB re-
ceptor localization in mouse ileum and colon is almost
exclusively neuronal in nature. This is consistent with a
prejunctional inhibitory role for GABAB receptors in
modulating ileal contraction, via actions within the
enteric nervous system (Sanger et al., 2002). The
GB12/2, BAC1/1 mice recently also allowed us to local-
ize GABAB receptors in cochlear neurons (Maison et al.,
2009). This shows that these mice represent a useful
tool to identify GABAB receptors in cells that are not yet
linked to GABAB receptor physiology. Importantly, the
eGFP fluorescence allows studying the roles of GABAB
receptors in identified cells, using for example electro-
physiological techniques.
GB12/2 mice heterozygous or homozygous for the
GABAB1-eGFP BAC were fertile and did not show any of
the overt behavioral abnormalities described for GB12/2
mice, such as sporadic episodes of intensive running
and epileptiform activity (Schuler et al., 2001). We next
investigated whether the GABAB1-eGFP BAC rescues pre
and postsynaptic GABAB receptor functions, which are
completely absent in GB12/2 mice (Schuler et al.,
2001). Using whole-cell patch-clamp recordings in acute
hippocampal slices, we first checked for the presence of
GABAB heteroreceptors on excitatory terminals. Stimula-
tion of the Schaffer collateral-commissural fibers induces
FIG. 2. GABAB1-eGFP fusion proteins reproduce the expression
pattern of endogenous GABAB1 proteins in the brain. (a) GABAB1-
eGFP fluorescence in whole brain of P8 and adult GB12/2, BAC1/1
mice. In coronal sections of adult GB12/2, BAC1/1mice strong fluo-
rescence was detected in the hippocampus and the striatum.
(b) Immunohistochemistry using anti-GB1 and anti-eGFP antibodies
revealed that the GABAB1-eGFP fusion proteins are expressed in
the entire brain of adult GB12/2, BAC1/1 mice, similar to the
expression pattern of endogenous GABAB1 proteins in WT mice
(top). No specific eGFP-immunoreactivity was detected in WT mice
(bottom).
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excitatory postsynaptic currents (EPSCs) in CA1 pyrami-
dal neurons, which are reduced by blocking the release
of glutamate through activation of GABAB heterorecep-
tors. Baclofen (50 lM), a GABAB agonist, was similarly
effective in reducing the EPSC amplitude in WT and
GB12/2, BAC1/1 mice (Fig. 4a). Next, we examined
autoreceptor-mediated responses to baclofen on
GABAergic terminals. We recorded inhibitory postsynap-
tic currents (IPSCs) in CA1 pyramidal neurons in the
presence of the ionotropic glutamate receptor antago-
nist kynurenate (2 mM). Baclofen reduced the amplitude
of IPSCs in both genotypes (Fig. 4b). Finally, we assessed
postsynaptic GABAB receptors, which induce a late IPSC
by activating Kir3-type K1 channels (Luscher et al.,
1997). At a holding potential of 250 mV and in physio-
logical extracellular K1 concentration, baclofen at 1, 10,
or 100 lM elicited similar outward currents in CA1 py-
ramidal neurons in WT and GB12/2, BAC1/1 mice (Fig.
4c,d). Normalization of the current amplitudes to cell ca-
pacitance showed that there were no significant differ-
ences in the baclofen-induced current densities between
WT and GB12/2, BAC1/1 mice (WT: 2.2 6 0.3 pA/pF, n
5 10; GB12/2, BAC1/1: 2.3 6 0.2 pA/pF, n 5 22; P 5
0.78). In conclusion, the GABAB1-eGFP BAC restores
normal GABAB functions in mice lacking endogenous
GABAB1 subunits, thus demonstrating that the GABAB1-
eGFP fusion proteins fully substitute for the lack of
endogenous GABAB1a and GABAB1b proteins.
We finally assessed expression of the GABAB1-eGFP
fusion proteins in cultured primary hippocampal neu-
rons, which are widely used to study the dynamics of
receptor trafficking. The subcellular distribution of
GABAB1-eGFP protein was studied by fluorescence imag-
ing of neurons established from embryos obtained from
GB12/2, BAC1/1 females mated with GB12/2, BAC1/y
males (Fig. 5a). GABAB1-eGFP fluorescence was detected
as early as 2 days in vitro (DIV). At this stage, the
GABAB1-eGFP fusion proteins were mainly present in
the soma as well as in axon-like processes expressing
the marker protein Tau1 (Kosik and Finch, 1987). From
DIV4 on, the GABAB1-eGFP fusion proteins were also
observed in dendritic processes expressing the marker
protein microtubule-associated protein 2 (MAP2)
(Caceres et al., 1986). Interestingly, a strong green fluo-
rescence signal was often observed in the distensions at
the termini of growing axons, most likely representing
axonal growth cones. At DIV14, the GABAB1-eGFP fusion
proteins displayed a punctuate distribution in the
FIG. 3. GABAB1-eGFP expression in the ileum and colon of GB1
2/2, BAC1/1 mice. Fluorescence immunohistochemistry using anti-eGFP
antibodies revealed GABAB1-eGFP localization in the submucosal (arrowheads) and myenteric plexus (arrows) of GB1
2/2, BAC1/1 ileum
(a) and colon (b), comparable to the localization of endogenous GABAB1 protein in WT sections, as detected with anti-GB1 antibodies
(i,j). GABAB1-eGFP was not detected in either the epithelial layer or enteroendocrine cells of GB1
2/2, BAC1/1 ileum and colon (a,b).
Whole mount preparations of ileum (c) and colon (d) revealed a cytoplasmic, nonnuclear, distribution of GABAB1-eGFP in enteric neurons of
GB12/2, BAC1/1mice. No GABAB1-eGFP activity was detected in WT tissues (e–h). Scale bars5 100 lm. LM, longitudinal muscle; CM, cir-
cular muscle; Mu, mucosa.
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somatodendritic compartment, as previously described
for the endogenous GABAB1 proteins (Correa et al.,
2004). In addition, the dense plexus of fine-caliber axo-
nal processes extending throughout the cultures also
expressed GABAB1-eGFP fusion proteins. At all develop-
mental stages, the GABAB1-eGFP fusion proteins dis-
played a subcellular distribution similar to that of the
endogenous GABAB1 proteins (Fig. 5b).
In conclusion, we have generated a BAC transgenic
mouse line that faithfully expresses GABAB1a-eGFP and
GABAB1b-eGFP fusion proteins under control of trans-
genic GABAB1 promoter elements. We show that the
FIG. 4. GABAB1-eGFP fusion proteins assemble with endogenous GABAB2 protein into functional pre and postsynaptic GABAB receptors.
(a) Rescue of GABAB heteroreceptor function in CA1 pyramidal neurons of GB1
2/2, BAC1/1 mice. Peak amplitudes and representative
traces plotted over time and summary bar graph of monosynaptic EPSC inhibition by baclofen (bac, 50 lM) and adenosine (adeno, 100
lM). Baclofen similarly depressed the amplitude of EPSCs in WT (76.5% 6 3.1% inhibition, n 5 6) and GB12/2, BAC1/1 (86.3% 6 3.2% in-
hibition, n 5 3), but not in GB12/2 (4.0% 6 3.0% inhibition, n 5 5) mice. As a control, adenosine-induced depression of EPSC amplitudes
did not differ between genotypes (WT: 89.1% 6 1.6% inhibition, n 5 6; GB12/2, BAC1/1: 87.2% 6 3.1% inhibition, n 5 3; GB12/2: 89.5%
6 2.8% inhibition, n 5 5). (b) Rescue of GABAB autoreceptor function in GB1
2/2, BAC1/1 mice. Peak amplitudes and representative traces
plotted versus time and summary bar graph of IPSC inhibition by baclofen (50 lM). Baclofen depressed the amplitude of IPSCs to the same
extent in WT (82.7% 6 4.8% inhibition, n 5 6) and GB12/2, BAC1/1 (90.1%6 2.3% inhibition, n 5 4) but not in GB12/2 (23.4% 6 4.2% in-
hibition, n 5 5) mice. (c) Rescue of postsynaptic GABAB receptor function in GB1
2/2, BAC1/1mice. Changes in the holding currents of CA1
pyramidal neurons and summary bar graph of the amplitudes of baclofen- and adenosine-induced K1 currents. The baclofen-induced K1
outward current is similar in WT (46.56 3.2 pA, n 5 10) and GB12/2, BAC1/1 (46.96 4.1 pA, n 5 22) and absent in GB12/2 (20.8 6 0.7 pA,
n 5 5) mice. Control adenosine-induced currents did not differ between genotypes (WT: 23.5 6 3.1 pA, n 5 9; GB12/2, BAC1/1: 22.5 6 2.1
pA, n 5 19; GB12/2: 25.3 6 5.0 pA, n 5 5). (d) Normalized K1 current amplitudes in response to increasing concentrations of baclofen. No
significant differences were observed between WT and GB12/2, BAC1/1 neurons at 1, 10, and 100 lM. All baclofen-induced responses
were fully blocked by the GABAB antagonist CGP54626A (CGP, 1 lM). Values are represented as means6 SEM.
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eGFP-tagged GABAB1 subunits combine with endoge-
nous GABAB2 subunits to form fully functional pre and
postsynaptic GABAB receptors. These mice therefore
provide a useful tool to visualize the spatio-temporal
distribution of GABAB receptors in vivo and in vitro.
METHODS
Generation of GABAB1-eGFP BAC Transgenic Mice
The BAC clone RP23-98F21 (Children Hospital Oak-
land Research Institute, CA) containing the GABAB1
gene was modified by homologous recombination in E.
coli (ET-recombination) using standard techniques (Casa-
nova et al., 2001; Zhang et al., 1998). In the targeting
construct the eGFP cDNA was inserted in front of the
stop codon of the GABAB1 gene generating a C-terminal
fusion protein. The 200 bp 5’ homology arm upstream
of the stop codon was amplified from the GABAB1 BAC
using primers P1 (5’-CCCACACTCCCAATTGTGTTT-3’)
and P2 (5’-CCATGGTCTTGTAAAGCAAATGTACTCG-3’).
The 200 bp 3’ homology arm within the 3’ untranslated
region was amplified with primers P3 (5’-TTAATTAAA
TCGAGAAGGATGAGGCCAGC-3’) and P4 (5’-GCTAGC
GAATAGCTCCAAGCAGGGTTC-3’). Downstream of the
eGFP the targeting construct contained an ampicillin
cassette flanked by two FRT sites. Correct homologous
recombination of the targeting construct with the
GABAB1 BAC was confirmed by Southern blot analysis
and direct sequencing of the recombined BAC. The
ampicillin cassette was removed from the modified BAC
by expressing the FLP recombinase in BAC-containing
bacteria (Buchholz et al., 1996).The isolated BAC DNA
was linearized with the homing endonuclease PI-SceI
(New England Biolabs), purified by pulse-field electro-
phoresis and injected into the pronucleus of B6D2/F1
oocytes at 1 ng/ll. GABAB1-eGFP BAC transgenic mice
were backcrossed three times to BALB/c mice and geno-
typed by PCR using primers P6 (5’-CACATGGTCCTGC
TGGAGTTCGTG-3’) and P7 (5’-CAAACGAGATGCCCC
FIG. 5. GABAB1-eGFP fusion proteins replicate the temporal expression pattern of endogenous GABAB1 subunits in cultured hippocampal
neurons. Fluorescence detection of GABAB1-eGFP expression in cultured primary hippocampal neurons derived from GB1
2/2, BAC1/1 or
GB12/2, BAC1/y embryos (a) compared to endogenous GABAB1 immunostaining in WT neurons (b). Somatodendritic and axonal compart-
ments were identified using antibodies directed against MAP2 (blue) and Tau1 (red), respectively. (a) At DIV2, GABAB1-eGFP is predomi-
nantly observed in the soma and in the axon (arrowhead) but not in dendrites (arrow). From day DIV4, eGFP fluorescence is evident through-
out the soma, axon, and dendrites. Strong eGFP fluorescence was observed in the distensions at the termini of growing axons, indicated by
an asterisk (DIV4, lower panels). At DIV14, eGFP fluorescence displayed a punctuate distribution in the somatodendritic compartment
(MAP2-positive) as well as in axonal processes extending throughout the cultures (MAP2-negative). The merged image of the green and
blue channel is shown on the right. At all developmental stages the distribution of GABAB1-eGFP fluorescence was similar to the distribution
of the endogenous GABAB1 proteins in WT neurons (b). Scale bars5 10 lm.
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TCTGGAGTC-3’) yielding a band of 390 bp for the BAC
transgene.
Whole Brain eGFP Imaging and
Immunohistochemistry
For eGFP imaging, brains were removed and washed
in phosphate buffered saline (PBS; pH 7.4) at 48C. Whole
brains and 1 mm coronal sections were imaged with a
Zeiss Axiovert 25 binocular equipped for GFP detection.
For immunohistochemistry, adult mice were perfused
with 4% paraformaldehyde (PFA; Sigma-Aldrich) in PBS;
pH 7.4. Brains were removed and postfixed overnight in
4% PFA at 48C. Fifty micrometer parasagital vibratome
sections were blocked in PBS with 0.3% Triton X-100
(Sigma-Aldrich) and 10% normal goat serum (NGS) and
probed with rabbit polyclonal anti-eGFP antibody
(1:200; Molecular Probes, Invitrogen) or anti-GABAB1
antibody Ab174.1 (1:200) (Malitschek et al., 1998). Im-
munostaining was visualized with an ABC kit (Vector
Labs). For immunohistochemistry of the enteric nervous
system, animals were killed by cervical dislocation, and
ileum and colon removed. Submucosal plexus prepara-
tions were prepared as described (Nasser et al., 2006).
For longitudinal sections, segments of colon and ileum
were flushed with PBS, fixed overnight at 48C in 4% PFA,
transferred to 30% sucrose, and cryosectioned at 10 lm.
Tissues were permeabilized in PBS, 0.1% Triton X-100,
blocked in 5% donkey serum, and probed with rabbit
polyclonal anti-eGFP antibody (1:500) or anti-GABAB1
antibody Ab25 (1:1,000) (Engle et al., 2006). Immuno-
staining was visualized using FITC-conjugated secondary
antibody (1:400; Jackson Immunoresearch).
Immunoblot and Immunoprecipitation
Mouse brain membranes were prepared as described
(Gassmann et al., 2004). For Western blot analysis 50 lg
protein were separated by 8% SDS-PAGE, blotted and
probed with rabbit polyclonal anti-GABAB1 antibody
Ab174.1 (1:3,000) recognizing the common C-terminus
of GABAB1a and GABAB1b, rabbit polyclonal anti-eGFP
antibody (1:2,000; Molecular Probes), or mouse mono-
clonal anti-syntaxin antibody (1:10,000; Sigma-Aldrich)
and peroxidase-conjugated secondary antibodies
(1:3,000; Amersham Biosciences). For immunoprecipita-
tion, brain membranes were resuspended in RIPA buffer
without SDS (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1%
NP-40, 0.5% DOC) and centrifuged at 10,000g for 30 min
to remove insoluble material. Supernatants (1 mg pro-
tein) were precleared for 3 h with 50 ll of Protein G-aga-
rose beads (Roche), incubated with 2.5 lg mouse mono-
clonal anti-eGFP antibody (Molecular probes) for 1 h
followed by an overnight incubation with 50 ll protein
G-agarose beads. Immunoprecipitated complexes were
washed tree times with RIPA buffer, separated by 8%
SDS-PAGE, blotted and probed with polyclonal guinea
pig anti-GABAB2 antibody (1:5000; Chemicon).
Electrophysiology
Standard procedures were used to prepare 300 lm
thick parasagital hippocampal slices from P18 to P28
mice. Pre and postsynaptic GABAB responses were
assessed by visualized whole-cell patch-clamp recording
techniques from CA1 pyramidal neurons as described
previously (Vigot et al., 2006). For dose–response
experiments, baclofen at different concentrations was
bath applied at 10 min intervals. Recordings were ampli-
fied with an Axopatch 200B (Axon Instruments), filtered
at 2 kHz, digitized at 10 kHz and analyzed with pClamp9
(Axon Instruments). Data are expressed as means 6
SEM.
Neuronal Cultures and Immunocytochemistry
Hippocampal neurons were prepared from 16.5-day
mouse embryos and cultured at a density of  750 cells/
mm2 on poly-L-lysine coated glass cover slips (Brewer,
1993; Goslin et al., 1998). Neurons were fixed with 4%
PFA in PBS containing 120 mM sucrose for 20 min at
room temperature (RT), permeabilized with 0.25% Tri-
ton-X-100 in PBS for 10 min, and blocked for 2 h in 10%
NGS. Antibodies were diluted in 10% NGS and incubated
at RT for 2 h. Primary antibodies: rabbit anti-GABAB1
Ab174.1 (1:500), chicken anti-MAP2 (1:100; Abcam),
and mouse anti-Tau1 (1:700; Chemicon). Secondary anti-
bodies: Alexa goat anti-chicken 647 and goat anti-mouse
568 (1:500; Molecular Probes). Images were acquired on
a Leica TCS SPE confocal microscope and identically
processed with ImageJ software (NIH).
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Abstract 
GABAB receptors are the G-protein coupled receptors for γ-aminobutyric acid (GABA), the main 
inhibitory neurotransmitter in the brain. GABAB receptors are abundant on dendritic spines, where 
they dampen postsynaptic excitability and inhibit Ca2+ influx through N-methyl-D-aspartic acid 
(NMDA) receptors when activated by spillover of GABA from neighboring GABAergic terminals. 
Here, we show that an excitatory signaling cascade enables spines to counteract this GABAB-
mediated inhibition. We found that NMDA application to cultured hippocampal neurons promotes 
dynamin-dependent endocytosis of GABAB receptors. NMDA-dependent internalization of GABAB 
receptors requires activation of Ca2+/Calmodulin-dependent protein kinase II (CaMKII), which 
associates with GABAB receptors in vivo and phosphorylates serine 867 (S867) in the intracellular C-
terminus of the GABAB1 subunit. Blockade of either CaMKII or phosphorylation of S867 renders 
GABAB receptors refractory to NMDA-mediated internalization. Time-lapse two-photon imaging of 
organotypic hippocampal slices reveals that activation of NMDA receptors removes GABAB 
receptors within minutes from the surface of dendritic spines and shafts. NMDA-dependent 
phosphorylation of S867 is detectable at the GABAB1b subunit isoform, which is the isoform that 
clusters with inhibitory effector K+ channels in the spines. Consistent with this, NMDA receptor 
activation in neurons impairs the ability of GABAB receptors to activate K
+ channels. Thus, our data 
support that NMDA receptor activity endocytoses postsynaptic GABAB receptors through CaMKII-
mediated phosphorylation of S867. This provides a means to spare NMDA receptors at individual 
glutamatergic synapses from reciprocal inhibition through GABAB receptors.  
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Introduction 
GABAB receptors modulate the excitability of neurons throughout the brain. They are therapeutic 
targets for a variety of disorders, including cognitive impairments, addiction, anxiety, depression 
and epilepsy (1). Depending on their subcellular localization GABAB receptors exert distinct 
regulatory effects on synaptic transmission (2-4). Presynaptic GABAB receptors inhibit 
neurotransmitter release (5,6). Postsynaptic GABAB receptors dampen neuronal excitability by 
gating Kir3-type K+ channels, which generates slow inhibitory postsynaptic potentials (IPSPs) and 
local shunting (7). Molecular diversity in the GABAB system arises from the GABAB1a and GABAB1b 
subunit isoforms, both of which combine with GABAB2 subunits to form the heteromeric receptor 
subtypes GABAB(1a,2) and GABAB(1b,2) (8). Genetically modified mice revealed that the two receptor 
subtypes convey non-redundant synaptic functions at glutamatergic synapses, owing to their 
differing distribution to axonal and dendritic compartments (3,9). Selectively GABAB(1a,2) receptors 
control the release of glutamate while predominantly GABAB(1b,2) receptors activate postsynaptic 
Kir3 channels in dendritic spines (10-12). Activation of GABAB receptors on spines inhibits NMDA 
receptors through hyperpolarization and the PKA pathway, which enhances Mg2+ block (13,14) and 
reduces Ca2+ permeability (15) of NMDA receptors. Reciprocally, there is evidence that glutamate 
receptors decrease surface expression of GABAB receptors (16-18). This supports that glutamate 
receptors and GABAB receptors crosstalk with each other in dendrites and spines.  
 Neither the glutamate receptors nor the signaling pathways controlling surface availability of 
GABAB receptors have been identified yet. Here we show that NMDA receptor-dependent 
phosphorylation via CaMKII targets GABAB receptors for internalization. This postsynaptic regulation 
of GABAB receptors has implications for the control of local excitability and Ca
2+-dependent 
neuronal functions. 
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Results 
NMDA receptors mediate GABAB receptor internalization. We used transfected cultured 
hippocampal neurons to identify the glutamate receptors regulating cell surface expression of 
GABAB receptors. Robust cell surface expression of tagged GABAB1b subunits (HA-GB1b-eGFP) was 
observed upon co-transfection with GABAB2 subunits (Fig. 1A), which are mandatory for GABAB1 
surface expression (8,19,20). GABAB1b surface expression was monitored by immunolabeling of the 
extracellular HA-tag prior to permeabilization of cells (red fluorescence). Total GABAB1b expression 
was monitored by immunolabeling of the intracellular eGFP-tag after permeabilization of cells 
(green fluorescence). To quantify the level of surface GABAB1b protein, we calculated the ratio of red 
to green fluorescence intensity (Fig. 1B and C). Upon glutamate treatment (50 µM glutamate/5 µM 
glycine for 30 min), surface GABAB1b protein was significantly reduced (41.4 ± 5.3% of control, n = 
10, P < 0.001), consistent with published data (18). The NMDA receptor antagonist APV (100 µM for 
2 h) prevented the glutamate-induced decrease in surface GABAB1b protein (98.4 ± 12.6% of control, 
n = 9, P > 0.05). We tested whether a selective activation of NMDA receptors is sufficient to 
decrease surface GABAB1b protein. Following NMDA treatment (75 µM NMDA/5 µM glycine for 3 
min) and recovery in conditioned medium for 27 min, surface GABAB1b protein was significantly 
reduced (54.8 ± 3.2% of control, n = 10, P < 0.01). Heteromerization with GABAB2 is mandatory for 
exit of GABAB1 from the endoplasmic reticulum and for receptor function (19,20). As expected from 
the assembly with GABAB1, surface GABAB2 protein was also significantly decreased following 
glutamate or NMDA application and this decrease was prevented by APV (Fig. S1A). We also 
observed a trend towards decreased surface GABAB1a protein in response to glutamate or NMDA 
but this did not reach statistical significance (Fig. S1B). Likewise, surface biotinylation of the 
endogenous GABAB subunits in NMDA-treated cultured cortical neurons showed that GABAB1b was 
more efficiently removed from the cell surface than GABAB1a (Fig. 2B). Endogenous surface GABAB2 
protein was also significantly down-regulated following NMDA treatment (Fig. 2B). This supports 
that preferentially the GABAB(1b,2) receptor subtype is removed from the cell surface in response to 
NMDA application, possibly as a consequence of its selective localization in the somatodendritic 
compartment (10). 
We examined whether the decrease in surface GABAB1b protein following glutamate or 
NMDA treatment is due to endocytosis. We observed basal endocytosis of surface GABAB1b protein 
under control conditions (Fig. S2A), as reported (21). Glutamate or NMDA treatment visibly 
increased endocytosis of GABAB1b protein, which was inhibited in the presence of APV (Fig. S2A). 
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Constitutively internalized GABAB1b protein co-localized with Rab11-eGFP (22,23), a marker for 
recycling endosomes (Fig. S2B). Following glutamate or NMDA treatment a fraction of internalized 
GABAB1b protein segregated into structures devoid of Rab11-eGFP, possibly indicating GABAB1b 
protein targeted for degradation (24,25). Preincubation of neurons with dynasore (80 µM for 15 
min), a cell-permeable inhibitor of dynamin-dependent endocytosis (26), interfered with the 
NMDA-mediated removal of surface GABAB1b protein (NMDA: 58.8 ± 5.4% of control, n = 8, P < 0.05; 
NMDA + dynasore: 105 ± 10% of control, n = 10, P > 0.05; dynasore: 98.4 ± 9.0% of control, n = 9, P 
> 0.05; Fig. 1C). Agonists accelerate basal endocytosis of GABAB receptors (25). Antagonizing GABAB 
receptor activity with CGP54626A (2 µM for 10 min) did not attenuate NMDA-mediated removal of 
surface GABAB1b protein (NMDA + CGP54626A: 60.2 ± 9.6% of control, n = 10, P < 0.05; Fig. 1C). Thus 
NMDA receptor activation triggers dynamin-dependent endocytosis of GABAB receptors, 
irrespective of whether GABAB receptors are active or not. 
 
Removal of surface GABAB receptors requires CaMKII activity. NMDA failed to reduce surface 
GABAB1b protein in transfected hippocampal neurons in the presence of the membrane-permeable 
Ca2+-chelator EGTA-AM (100 µM for 10 min; NMDA: 51.7 ± 6.7% of control, n = 10, P < 0.01; NMDA 
+ EGTA-AM: 83.4 ± 9.0% of control, n = 9, P > 0.05; Fig. 2A). NMDA also failed to reduce surface 
GABAB1b protein in the presence of the CaMKII inhibitor KN-93 (10 µM for 10 min; NMDA + KN-93: 
85.6 ± 11.1% of control, n = 10, P > 0.05), implicating activation of CaMKII by NMDA receptors (27) 
in the removal of surface GABAB1b. Likewise, KN-93 also prevented the NMDA-induced decrease of 
exogenous (Fig. S1A) and endogenous surface GABAB2 protein (Fig. 2B). In contrast, the NMDA-
mediated decrease in surface GABAB1b protein was not inhibited in the presence of KN-92 (28), an 
inactive structural analogue of KN-93 (10 µM for 10 min; NMDA + KN-92: 48.9 ± 7.9% of control, n = 
9, P < 0.01; Fig. 2A).  
 
S867 in GABAB1 is phosphorylated by CaMKII. Both anti-GABAB1 and anti-GABAB2 antibodies 
efficiently co-immunoprecipitated CaMKII from purified mouse brain membranes while control sera 
did not (Fig. 2C). This indicates that CaMKII associates with the GABAB1 and/or GABAB2 subunits of 
heteromeric GABAB receptors (29). We corroborated this finding by performing pull-down assays 
with GST fusion proteins encoding the GABAB1 and GABAB2 C-termini (GST-GB1, GST-GB2). CaMKII in 
whole-brain lysate associated to a larger extent with GST-GB1 than with GST-GB2, supporting that 
CaMKII preferentially associates with GABAB1 (Fig. 2D). For in vitro phosphorylation, the GST-fusion 
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proteins were incubated for 30 min at 30°C with [γ-32P]-ATP and recombinant CaMKII. CaMKII-
dependent phosphorylation was detectable on GST-GB1 but not on GST-GB2 or GST alone (Fig. 2E). 
Thus CaMKII associates with native GABAB receptors and phosphorylates site(s) in the C-terminus of 
GABAB1.  
 To identify the CaMKII phosphorylation site(s) in GABAB1, we digested phosphorylated GST-
GB1 protein with LysC and trypsin, separated the resulting peptides by reverse-phase high-
performance liquid chromatography (RP-HPLC) and collected fractions at 1 min intervals (Fig. 3A). 
The majority of radiolabel eluted in a single peak in fraction 54, which we further analyzed using 
mass spectrometry (ESI-MS/MS). Database searches of the ESI-MS/MS scans revealed the presence 
of the phosphopeptide GEWQSETQDTMK (whose methionine was oxidized). The fragmentation 
spectrum indicated phosphorylation of the serine residue corresponding to S867 in the full-length 
GABAB1a protein (Fig. 3B). S867 is localized in the juxtamembrane domain, a regulatory region for 
many transmembrane proteins, including G-protein coupled receptors (30). S867 does not conform 
to the consensus sequence for phosphorylation by CaMKII (31) or other kinases (Table S1). 
Nonetheless, alanine substitution of putative phosphorylation sites within the GEWQSETQDTMK 
motif (GST-GB1S867A, GST-GB1T869A, GST-GB1T872A, GST-GB1T869A/T872A) confirmed that 
recombinant CaMKII only phosphorylates S867 in this sequence (Fig. 3C). In addition, we found that 
CaMKII in brain extracts also specifically phosphorylates S867 in GST-GB1 (Fig. S3).  
 
NMDA increases phosphorylation at S867 in native GABAB receptors. To analyze S867 
phosphorylation in native tissue we generated a S867 phosphorylation-state specific antibody, anti-
GB1pS867. After phosphorylation of GST fusion proteins with recombinant CaMKII this antibody 
labeled GST-GB1 but not GST-GB1S867A (Fig. S4A). No S867 phosphorylation was seen when using 
recombinant PKC instead of CaMKII for phosphorylation (Fig. S4B). Importantly, the anti-GB1pS867 
antibody revealed weak basal S867 phosphorylation (i) in mouse brain membranes after 
enrichment of GABAB receptors by immunoprecipitation and (ii) in synaptic plasma membranes 
after subcellular fractionation (Fig. 4A and B). Application of NMDA to cultured cortical neurons 
significantly increased phosphorylation of S867 (Fig. 4C). Phosphorylation of S867 in brain 
membranes or cortical neurons was only detectable in the GABAB1b subunit isoform. However, we 
cannot exclude that NMDA treatment also weakly phosphorylates the GABAB1a subunit and that this 
phosphorylation is below our detection limit. Of note, GABAB(1b,2) but not GABAB(1a,2) receptors reside 
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in spines (10) where NMDA and GABAB receptors are particularly abundant (15). This may explain 
why NMDA receptor activation preferentially targets GABAB1b for phosphorylation.  
 
Removal of surface GABAB receptors requires S867 phosphorylation. Cultured hippocampal 
neurons expressing HA-GB1b-eGFP or HA-GB1bS867A-eGFP in combination with exogenous GABAB2 
were analyzed for surface expression of transfected GABAB1b protein (Fig. 4D and S5). HA-
GB1bS867A-eGFP exhibited a similar surface expression level as HA-GB1b-eGFP, showing that lack 
of S867 phosphorylation does not prevent surface expression. However, HA-GB1bS867A-eGFP was 
refractory to removal from the surface upon NMDA treatment, as determined by the ratio of 
surface to total fluorescence intensity (GB1b NMDA: 52.6 ± 4.8%, n = 10, P < 0.01; GB1bS867A 
control: 82.4 ± 6.3%, n = 9, P > 0.05; GB1bS867A NMDA: 98.1 ± 16.0, n = 8, P > 0.05; data normalized 
to GB1b control; Fig. 4D). This implicates S867 phosphorylation in GABAB receptor removal from the 
cell surface. 
 
NMDA-mediated CaMKII activation reduces GABAB-induced K
+ currents. Well-known effectors of 
dendritic GABAB receptors are the Kir3-type K
+ channels, which cluster with GABAB receptors in 
spines (12). We used whole-cell patch-clamp recording to address whether NMDA-treatment 
reduces baclofen-induced K+ currents due to GABAB receptor internalization. Baclofen-evoked K
+ 
currents were recorded from cultured hippocampal neurons clamped at -50 mV after 
pharmacological blockade of Na+ channels, GABAA, glycine, AMPA and kainate receptors (Fig. 5A). 
Baclofen-induced K+ currents were recorded before and 30 min after NMDA treatment (30 μM 
NMDA/5 μM glycine in Mg2+-free solution for 1 min). During NMDA applications neurons were held 
at -70 mV to minimize Ca2+ entry through voltage-gated Ca2+ channels. Following NMDA treatment 
the maximal amplitudes of the baclofen-induced K+ currents were reduced (19.1 ± 6.5%, n = 5; Fig. 
5C). Likewise, baclofen-induced K+ currents was decreased following glutamate treatment (5 μM 
glutamate/5 μM glycine in Mg2+-free solution for 1 min; 35.2 ± 5.1%, n = 3) and this decrease was 
prevented by the NMDA-receptor antagonist dCPP (20 µM; 93.5 ± 0.5%, n = 3, P < 0.001 compared 
to NMDA alone; Fig. 5A and C). Intracellular dialysis with the CaMKII inhibitor KN-93 (5 μM) 
significantly attenuated the NMDA-mediated reduction of K+ currents (65.5 ± 9.0%, n = 5, P < 0.001 
compared to NMDA alone). Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) 
promotes phosphorylation of the GABAB2 subunit by 5’AMP-dependent protein kinase (32). 
Intracellular dialysis with the CaMKK inhibitor STO-609 (5 μM) resulted in a modest attenuation of 
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NMDA-mediated reduction of K+-currents that, however, did not reach significance (41.3 ± 2.9%, n = 
5, P > 0.05 compared to NMDA alone; Fig. 5A and C). We next addressed whether phosphorylation 
at S867 is critical for the NMDA-mediated decrease in K+-current amplitude. We transfected 
cultured hippocampal neurons from GABAB1
-/- (GB1-/-) mice (33) with expression constructs for 
GABAB1b (GB1b), GABAB1a (GB1a) or GB1bS867A. All exogenous GABAB1 subunits, including 
GB1bS867A, fully rescued GABAB receptor function, demonstrating that they heteromerize with 
endogenous GABAB2 subunits (Fig. 5B and D). In GB1
-/- neurons reconstituted with GB1b, NMDA 
application decreased the baclofen-induced K+ currents to a similar extent as in wild-type neurons. 
In contrast, in GB1-/- neurons reconstituted with GB1a or GB1bS867A NMDA application decreased 
the K+ currents significantly less (GB1b: 28.3 ± 3.0%, n = 5; GB1a: 54.2 ± 7.2%, n = 6, P < 0.05; 
GB1bS867A: 64.1 ± 7.0%, n = 5, P < 0.01). Thus predominantly phosphorylation of GABAB1b at S867 is 
implicated in the NMDA-mediated decrease of the K+-current amplitude. 
 
NMDA-mediated endocytosis of GABAB receptors in dendritic shafts and spines. The GABAB(1b,2) 
receptor subtype, which appears to be the main substrate for S867 phosphorylation, resides in 
dendritic spines and shafts (10). We therefore addressed whether GABAB receptors at these 
locations internalize in response to NMDA. We transfected GABAB1b fused to a pH-sensitive eGFP 
(Super Ecliptic pHluorin, SEP-GB1b) together with GABAB2 into organotypic hippocampal slice 
cultures. SEP-GB1b selectively visualizes GABAB1b protein at the cell surface (34). In addition, we 
expressed the freely diffusible red fluorescent protein (RFP) t-dimer2 to visualize the morphology of 
transfected cells (10). Time-lapse two-photon images of transfected CA1 pyramidal cells were 
collected at days-in-vitro (DIV) 14-21 (Fig. 6A). Dendrites were imaged at 5 min intervals before and 
after bath-application of NMDA (30 µM for 1 min). NMDA application resulted in a long-lasting 
decrease in green fluorescence in dendritic spines and shafts, indicating GABAB receptor 
internalization (Fig. 6B and C, green traces; SEP-GB1b fluorescence ratio after/before NMDA: spine, 
0.82 ± 0.05, n = 22, P < 0.001; shaft, 0.73 ± 0.04, n = 8, P < 0.001; 5 cells analyzed). NMDA 
application did not significantly affect RFP fluorescence in dendritic spines and shafts (Fig. 6B and C, 
red traces; RFP fluorescence ratio after/before NMDA: spine, 1.04 ± 0.05, n = 22, P > 0.05; shaft, 
0.88 ± 0.03, n = 8, P > 0.05). The decrease in green fluorescence was inhibited in the presence of the 
NMDA receptor antagonist dCPP (20 µM; Fig. 6B and C, green traces; SEP-GB1b fluorescence ratio 
after/before NMDA: spine, 1.00 ± 0.05, n = 15, P > 0.05; shaft, 0.99 ± 0.04, n = 3, P > 0.05; 2 cells 
analyzed). No significant change in the red fluorescence under NMDA receptor blockade was 
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observed (Fig. 6B and C, red traces; RFP fluorescence ratio after/before NMDA: spine, 1.06 ± 0.07, n 
= 15, P > 0.05; shaft, 1.02 ± 0.03, n = 3, P > 0.05). Thus NMDA receptor stimulation leads to GABAB 
receptor internalization in dendritic spines and shafts. In agreement with experiments described 
above (Figs. 4D, 5 D and S5B) the SEP-GB1bS867A protein is refractory to NMDA-induced 
internalization in dendritic spines and shafts (Fig. S6).  
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Discussion 
Activity-dependent phosphorylation and internalization of dendritic GABAB receptors. A previous 
report showed that glutamate application to cortical neurons decreases the number of GABAB 
receptors at the cell surface (18). Another report showed that glutamate application increases the 
steady-state level of GABAB receptor endocytosis while at the same time reducing the rate of 
endocytosis (35). Here, we show that glutamate acts via NMDA receptors to activate CaMKII (36), 
which directly phosphorylates S867 in the C-terminus of GABAB1 to trigger endocytosis. Intriguingly, 
NMDA-dependent phosphorylation of S867 is only detectable in the GABAB1b subunit, which mostly 
resides in the dendrites and, in contrast to the GABAB1a subunit, efficiently penetrates spines (10). 
Consistent with this we found that GABAB receptors undergo endocytosis in dendritic spines and 
shafts within minutes of NMDA receptor activation. Notably, endocytosis of GABAB receptors 
prevents them from activating effector K+ channels that cluster with GABAB receptors in spines (12).  
 
Physiological implications. GABA from interneurons firing in synchrony can spill over to pre- and 
postsynaptic GABAB receptors on excitatory synapses (11,37). This will reduce glutamate release 
and produce hyperpolarizing inhibitory postsynaptic potentials (IPSP) that enhance Mg2+ block of 
NMDA receptors and thus reduce their Ca2+ signals (13,14). In addition to modulating the electrical 
properties of neurons, GABAB receptors can also reduce the Ca
2+ permeability of NMDA receptors in 
dendritic spines via activation of the PKA signaling pathway (15). Here, we demonstrate that NMDA 
receptors can counter this suppression of Ca2+ signals and rapidly endocytose GABAB receptors from 
the surface of dendritic shafts and spines. Hence, there appears to be a reciprocal regulation where 
both NMDA and GABAB receptors can cancel each other out. The temporal interplay of NMDA and 
GABAB receptors may be particularly relevant to phenomena controlling synaptic strength, where 
NMDA receptor activity is of importance. Of note, the same NMDA receptor/CaMKII signaling 
cascade regulating synaptic strength also internalizes GABAB receptors. This provides a means to 
keep individual glutamatergic synapses modifiable (38,39) and to spare them from volume 
inhibition through spillover of GABA. A previous study reported that NMDA receptor activation 
promotes surface expression of Kir3 channels in hippocampal neurons (40), which was paralleled 
with an increase in basal Kir3 currents and adenosine A1-mediated Kir3 currents (41). However, 
GABAB mediated Kir3 currents were not altered, in apparent conflict with an earlier report (42) and 
our own findings. The reasons for these discrepancies are unclear but may relate to differences in 
the signaling pathways activated under the different experimental conditions used. Reciprocal 
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regulation of NMDA and GABAB receptors is reminiscent of the recently reported interplay of NMDA 
and muscarinic receptors (43). In this crosstalk, NMDA receptors phosphorylate and inactivate 
muscarinic receptors in a CaMKII-dependent manner, much in the same way as now observed with 
GABAB receptors.  
  
Materials and Methods 
Neuronal cultures. Dissociated hippocampal and cortical neurons were prepared from embryonic 
day 18.5 Wistar rats or from embryonic day 16.5 wild-type and GABAB1
-/- mice (33,44) and cultured 
in Neurobasal medium (GIBCO) supplemented with B27 (GIBCO). Neurons were transfected at DIV7 
using Lipofectamin 2000 (Invitrogen). Pharmacological treatments were performed in conditioned 
medium at 37°C/5% CO2.  
Biochemistry. Surface biotinylation, immunoprecipitation, in vitro phosphorylation, HPLC analysis 
and mass spectrometry were essentially performed as described (24,45,46). To generate GST-GB1 
and GST-GB2, the full-length C-termini of GABAB1 (amino acids 857–960) and GABAB2 (amino acid 
745-940) were amplified by PCR from the rat cDNAs and inserted in-frame into the pGEX-4T-1 fusion 
vector (GE Healthcare). GST-fusion proteins were expressed in E. coli BL21(DE3). 
Electrophysiology. Recordings in cultured hippocampal neurons were performed with an Axopatch 
200B patch-clamp amplifier. GABAB responses were evoked by fast application of 100 µM baclofen 
(47). Normalized K+ current amplitudes were calculated as the maximal baclofen-induced K+ current 
amplitudes recorded 30 min after pharmacological treatment relative to the maximal baclofen-
induced K+ current amplitudes recorded before pharmacological treatment of the same neuron.  
Two-photon imaging. Organotypic hippocampal slice cultures for two-photon time-lapse imaging 
(48) were prepared from Wistar rats at postnatal day 5 (49). For time-lapse imaging, we used a 
custom-built two-photon laser scanning microscope based on a BX51WI microscope (Olympus) and 
a pulsed Ti:Sapphire laser (Chameleon XR, Coherent) tuned to λ = 930 nm, controlled by the open 
source software ScanImage. Fluorescence was detected in epi- and transfluorescence mode using 
four photomultiplier tubes (R2896, Hamamatsu). The slice was placed into a perfusion chamber and 
superfused with ACSF containing (in mM): 127 NaCl, 25 NaHCO3, 25 D-glucose, 2.5 KCl, 4 CaCl2, 1.25 
NaH2PO4, 0.03 serine and 0.001 TTX (320 mosm, pH 7.4). In a subset of experiments 0.02 mM dCPP 
was added to the ACSF. Experiments were performed at 28°C. Stacks of images (256 × 256 pixels) 
from secondary dendritic branches were obtained from transfected CA1 pyramidal neurons (Z step: 
0.5 µm). Green fluorescence (SEP-GB1b or SEP-GB1bS867A) and red fluorescence (RFP) was imaged 
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at 5 min intervals before and after bath-application of NMDA and quantified in regions of interest 
(ROIs) containing either a dendritic shaft or spines. Control ROIs in the image background were 
always included and did not show changes in fluorescence during the course of the experiment. To 
quantify NMDA-mediated changes the green and red fluorescence intensities after NMDA 
application (7 values) were normalized to the intensities before NMDA application (2 values). For 
the ratio images, we used a hue/saturation/brightness model, where hue was determined by the 
G/R ratio (using a rainbow color table), and the intensity in the red channel was used to set the 
brightness. 
Data analysis. Data are given as mean ± SEM and statistical significance was assessed using ANOVA 
with the Dunnett's multiple comparison test or non-parametric Mann-Whitney test using GraphPad 
Prism 5.0. 
Additional experimental procedures are described in SI Materials and Methods published on the 
PNAS Web site.  
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Figure Legends 
Fig. 1. NMDA-dependent removal of surface GABAB receptors. (A) Rat hippocampal neurons 
coexpressing exogenous HA-GB1b-eGFP and GABAB2 were treated at DIV14 as indicated. Surface 
GABAB1b (GB1b) protein was fluorescence-labeled with anti-HA antibodies prior to permeabilization. 
Total GB1b protein was fluorescence-labeled with anti-eGFP antibodies after permeabilization. 
Single optical planes captured with a confocal microscope are shown. Scale bar = 15 µm. Insets 
show representative spines at higher magnification. (B) Surface GABAB1b protein was quantified by 
the ratio of surface to total fluorescence intensity. Values were normalized to control values in the 
absence of any pharmacological treatment. Surface GABAB1b protein was significantly decreased 
following glutamate or NMDA treatment. No significant reduction was observed with glutamate 
treatment after preincubation with APV. n = 9-10, **P < 0.01, ***P < 0.001. (C) Dynasore but not 
CGP54626A prevented the NMDA-induced reduction of surface GABAB1b protein. n = 8-10, *P < 
0.05. Quantification was from non-saturated images, data are presented as mean ± SEM. 
 
Fig. 2. NMDA-induced removal of surface GABAB receptors requires CaMKII. (A) Rat hippocampal 
neurons coexpressing exogenous HA-GB1b-eGFP and GABAB2 were analyzed at DIV14. Surface 
GABAB1b protein was quantified by the ratio of surface to total fluorescence intensity. Preincubation 
of neurons with the Ca2+-chelator EGTA-AM or the CaMKII inhibitor KN-93 prevented the NMDA-
induced reduction in surface GABAB1b protein. KN-92 was ineffective. Data are means ± SEM, n = 9-
10, **P < 0.01. (B) NMDA-mediated removal of endogenous surface GABAB receptors. Live cortical 
neurons were treated at DIV14 as indicated and then biotinylated. Cell homogenates (total) and 
avidin-purified cell surface proteins (surf) were probed on Western blots with anti-GABAB1 (anti-
GB1) and anti-GABAB2 (anti-GB2) antibodies. While all GABAB subunits were removed from the cell 
surface in response to NMDA, GABAB1b was more efficiently removed than GABAB1a. NMDA-
mediated removal of surface protein was inhibited by KN-93. Anti-tubulin antibodies were used as a 
control. (C) CaMKII interacts with GABAB receptors in the brain. Anti-GB1 and anti-GB2 antibodies 
co-immunoprecipitated CaMKII from purified mouse brain membranes, while control rabbit (serum 
rb) or guinea-pig serum (serum gp) did not. (D) Pull-down assays with GST-fusion proteins 
containing the entire C-terminal domain of GABAB1 (GST-GB1) or GABAB2 (GST-GB2) and whole brain 
lysates. CaMKII bound to a larger extent to GST-GB1 than to GST-GB2. Control assays were with 
glutathione beads alone or with beads together with GST protein. (E) In vitro phosphorylation of 
GST-fusion proteins with [γ-32P]-ATP in the presence or absence of recombinant CaMKII. 
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Phosphorylated proteins were separated by SDS-PAGE and exposed to autoradiography. CaMKII 
specifically phosphorylated GST-GB1 but not GST-GB2 or GST alone. Coomassie blue staining 
controlled for loading. The GST-GB2 fusion protein tended to degrade (50).  
 
Fig. 3. CaMKII phosphorylates S867 in the GABAB1 subunit. (A) RP-HPLC analysis of proteolytically 
digested GST-GB1 after phosphorylation with recombinant CaMKII and [γ-32P]-ATP. Peptide elution 
was monitored at 214 nm and radioactivity (red) determined by liquid scintillation counting. The 
asterisk marks elution of the 32P-labeled peptide in fraction 54. (B) Fragmentation spectrum of the 
doubly charged 768.29 Da precursor from the phosphorylated peptide of fraction 54. The 
fragmentation pattern agrees with the predicted ESI-MS/MS spectrum for the phosphopeptide 
GEWQpS867ETQDTMK. The y- and b-ions matching the GEWQpS867ETQDTMK sequence are labeled. 
Phosphorylated ions are marked by asterisks. (C) In vitro phosphorylation of GST fusion proteins 
with recombinant CaMKII and [γ-32P]-ATP. Phosphorylated proteins were separated by SDS-PAGE 
and exposed to autoradiography. Substitution of S867 with alanine in GST-GB1S867A prevented 
phosphorylation by CaMKII, while alanine substitutions of other putative phosphorylation sites in 
proximity of S867 (GST-GB1T869A, GST-GB1T872A and GST-GB1T869A/T872A) did not. Coomassie 
blue staining controlled for loading. 
 
Fig. 4. S867 phosphorylation in brain tissue and cultured neurons. (A) S867 phosphorylation was 
detectable after immunoprecipitation of GABAB receptors with anti-GABAB1 antibodies (IP:GB1) 
from WT but not GB1-/- brain membranes. S867 phosphorylation was detected on Western blots 
with a phosphorylation-state specific antibody (anti-GB1pS867). The same blot was reprobed with 
anti-GB1 antibodies. Immunoprecipitation with rabbit IgG (IP:IgG) was used as a control. Note the 
specific phosphorylation of the GABAB1b subunit. (B) S867 phosphorylation of GABAB1b was clearly 
detectable in synaptic plasma membranes (SPM) and barely detectable in the P2 membrane 
fraction purified from total mouse brain homogenates. (C) NMDA application to cultured cortical 
neurons increased S867 phosphorylation in the GABAB1b subunit. Neurons were treated with NMDA 
for 3 min and harvested at the times indicated. Whole cell lysates (input) were subjected to 
immunoprecipitation with anti-GB1 antibodies (IP:GB1). S867 phosphorylation was detected on 
Western blot with anti-GB1pS867; anti-tubulin antibodies were used as control. (D) Alanine 
mutation of S867 in GABAB1b prevents NMDA-induced internalization. Cultured hippocampal 
neurons expressing exogenous HA-GB1b-eGFP (GB1b) or HA-GB1bS867A-eGFP (GB1bS867A) 
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together with GABAB2 were analyzed at DIV14. Surface GABAB1b protein was quantified by the ratio 
of surface to total fluorescence intensity. Values were normalized to GB1b control in the absence of 
NMDA. Data are means ± SEM, n = 8-10, **P < 0.01. 
 
Fig. 5. CaMKII reduces GABAB-mediated K
+ currents in cultured hippocampal neurons. (A) 
Representative baclofen-induced K+ currents recorded at -50 mV before and after application of 
NMDA or glutamate. Baclofen-induced K+ currents were strongly reduced 30 min after NMDA or 
glutamate application. KN-93 and dCPP but not STO-609 attenuated the NMDA-mediated K+ current 
reduction. (B) Representative baclofen-induced K+ currents recorded from neurons of GABAB1
-/- 
(GB1-/-) mice transfected with GABAB1a (GB1a) GABAB1b (GB1b) or GB1bS867A expression vectors. 
NMDA was less effective in decreasing the K+ current in neurons transfected with GB1bS867A or 
GABAB1a. (C) Bar graph illustrating that dCPP and KN-93 attenuated the NMDA-mediated reduction 
of baclofen-induced K+ currents. (D) NMDA was significantly less effective in decreasing the K+ 
current in GB1-/- neurons transfected with GB1a or GB1bS867A than with GB1b. Maximal K+-current 
amplitudes after NMDA application were normalized to the maximal K+-current amplitudes before 
NMDA application. Data are means ± SEM, n = 3-6, *P < 0.05, **P < 0.01, ***P < 0.001. 
 
Fig. 6. NMDA-mediated endocytosis of GABAB receptors in dendritic spines and shafts. (A) Red 
fluorescence (R), green fluorescence (G) and G/R ratio images of dendrites expressing freely 
diffusible RFP and SEP-GB1b before and after NMDA application. NMDA application leads to a 
decrease in green fluorescence in dendritic spines and shafts. The G/R ratio is coded in rainbow 
colors and is scaled to encompass 2 standard deviations (2σ) of the average dendritic ratio before 
NMDA application. Scale bar = 5 µm. (B and C) Time course of red and green fluorescence in 
dendritic spines (B) and shafts (C) before and after NMDA application. NMDA leads to a long-lasting 
decrease in SEP-fluorescence within minutes, which is prevented by prior application of dCPP. Data 
are means ± SEM.  
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Supporting Information 
 
SI Materials and Methods 
Transfection of neuronal cultures. High-density primary hippocampal neuronal cultures were 
prepared from 18.5-day embryonic rats or 16.5-day embryonic mice and cultured in Neurobasal 
medium (GIBCO) supplemented with B27 (GIBCO) at a density of ~750 cells/mm2 on poly-L-lysine 
coated coverslips as described previously (1). At day-in-vitro (DIV) 7, neurons were co-transfected 
with (i) GABAB1b (HA-GB1b-eGFP or HA-GB1bS867A-eGFP) and GABAB2 (GB2) expression vectors, (ii) 
GABAB1b (Myc-GB1b) and GABAB2 (HA-GB2), (iii) GABAB1a (HA-GB1a-eGFP) and GB2 or (iv) Myc-GB1b, 
GB2 and Rab11-eGFP using Lipofectamin 2000 (Invitrogen) according to the manufacturer’s 
instruction. The HA- and Myc-tags are located at the extracellular N-terminus and the eGFP-tag at the 
intracellular C-terminus. Gene expression was under control of the neuron specific synapsin-1 
promoter (gift from K. Svoboda). 
 
Treatment protocols for neuronal cultures. All treatments were performed in conditioned medium 
at 37°C / 5% CO2. Control neurons were incubated for 30 min with 5 µM glycine. Glutamate-treated 
neurons were incubated for 30 min with 50 µM glutamate and 5 µM glycine. NMDA-treated neurons 
were incubated for 3 min with 75 µM NMDA (Tocris) / 5 µM glycine (adapted from (2)). The following 
inhibitors were dissolved in DMSO and applied to the cultures prior to glutamate or NMDA 
treatment: D-(-)-2-Amino-5-phosphonopentanoic acid (APV, 100 µM for 2 h, Tocris), dynasore (80 µM 
for 15 min, Sigma), ethylene glycol-bis-(2-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA-AM, 100 µM 
for 10 min (adapted from (3)), Molecular Probes), KN-93 (10 µM for 10 min, Tocris) and KN-92 (10 
µM for 10 min, Calbiochem). Inhibitors were kept in the medium during the glutamate or NMDA 
treatment. After glutamate or NMDA treatment neurons were returned to conditioned medium for 
27 min before analysis. The final DMSO concentration never exceeded 1% (v/v). Preincubation of 
neurons with DMSO 1% (v/v) for 2 h did not significantly affect the NMDA-mediated reduction in 
surface GABAB1b levels (control: 100% ± 13%; NMDA: 49.7 ± 7.4%, P < 0.001 compared to control; 
NMDA + DMSO: 58.6 ± 3.7%, P < 0.01 compared to control; mean ± SEM, n = 10. No significant 
difference was observed between NMDA and NMDA + DMSO treatment.) 
 
Immunocytochemistry and quantification of surface receptors. Neurons were fixed after treatment 
with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) containing 120 mM sucrose for 
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20 min and blocked for 2 h in 10% normal goat serum (GIBCO) in PBS (NGS/PBS). Neurons were 
incubated with primary mouse anti-HA antibodies (1:500 in 10% NGS/PBS; Covance) for 2 h to 
visualize surface GABAB1b receptors. Subsequently neurons were permeabilized with 0.25% Triton-X-
100 in PBS for 10 min. The total amount of GABAB1b receptors was detected by staining with rabbit 
anti-GFP antibodies (1:500 in 10% NGS/PBS; Molecular Probes). Secondary antibodies Alexa Fluor 568 
goat anti-mouse and Alexa Fluor 488 goat anti-rabbit (1:500; Molecular Probes) were incubated for 1 
h in 10% NGS/PBS. Stained neuronal cultures were mounted in FluorSave Reagent (Calbiochem) and 
viewed on a Leica TCS SPE confocal microscope. Digital pictures were captured with Leica Software 
(LAS AF) and identically processed with ImageJ software (4). The fluorescence intensity of labeled 
surface HA-GB1b-eGFP proteins was measured on the soma of transfected neurons and visualized in 
single optical planes using ImageJ software. For quantification of surface HA-GB1b-eGFP protein 
levels, the fluorescence intensity of surface HA-GB1b-eGFP (red) was normalized to the total HA-
GB1b-eGFP (green) fluorescence intensity. Statistical analysis was performed with GraphPad Prism 
5.0. For each statistical analysis independent sample groups were analyzed. All steps were performed 
at room temperature. For visualization of surface Myc-GB1a-eGFP and HA-GB2 proteins mouse anti-
Myc (1:500, Roche) and mouse anti-HA antibodies were used. Total protein levels were determined 
by using rabbit anti-GFP and rabbit anti-GB2 (1:500, Abcam) antibodies.  
 
Immunocytochemistry of internalized receptors. Anti-HA antibodies (1:50, Immunology Consultants 
Laboratory) were used to label the N-terminal HA-tag of GABAB1b protein at the cell surface. Live 
neurons were then incubated at 37ºC/5% CO2 for 30 min to allow internalization in the presence or 
absence of glutamatergic agonists and antagonists. After removal of residual anti-HA antibodies from 
the cell surface by acid wash (2 min wash in Neurobasal medium pH 2.0 on ice, followed by intensive 
washing with Neurobasal medium pH 7.4 on ice), internalized anti-HA antibodies were visualized 
with fluorescence-labeled secondary antibodies. Following fixation and permeabilization of neurons, 
the total amount of HA-GB1b-eGFP protein was dtermined by staining with mouse anti-GFP 
antibodies (1:500 in 10% NGS/PBS, Molecular Probes). Secondary antibodies (Alexa Fluor 568 goat 
anti-rabbit and Alexa Fluor 488 goat anti-mouse, 1:500, Molecular Probes) were incubated for 1 h in 
10% NGS/PBS. To control for complete removal of anti-HA antibodies from the cell surface upon acid 
wash, some non-permeabilization cultures were stained with Alexa Fluor 568 goat anti-rabbit 
antibodies. For colocalization experiments, neurons were co-transfected with Myc-GABAB1b, GABAB2 
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and Rab11-eGFP (5). Internalization experiments were performed as described above by surface 
labeling of live neurons with mouse anti-Myc antibodies (1:50, Roche). 
 
Surface biotinylation of neuronal cultures. After treatment with pharmacological agents, rat cortical 
neurons were rinsed twice with PBS on ice. Neurons were then incubated with 1 mg/ml EZ-Link Sulfo-
NHS-SS-Biotin (Pierce Chemicals) in PBS for 30 min. The biotinylation solution was removed by 
washing with PBS followed by 5 min quenching with 50 mM glycine in PBS. Neurons were rinsed with 
Tris-buffered saline (TBS) and PBS, collected in 2 ml PBS and transferred into tubes. Neurons were 
washed twice by resuspension in PBS followed by centrifugation at 2000 x g. Finally, neurons were 
lysed in RIPA buffer and incubated for 30 min on a rotor wheel. Lysates were cleared by 
centrifugation for 20 min at 16000 x g and incubated with immobilized NeutrAvidin gel (Pierce 
Chemicals) overnight on a rotor wheel. Beads were washed five times with RIPA buffer and the 
adsorbed proteins eluted with SDS sample buffer for 60 min at room temperature. All steps were 
performed on ice or at 4°C unless indicated differently. 
 
Whole-brain lysate and brain membrane preparation. Whole brains from BALB/c mice were 
polytron-homogenized in HEPES buffer (4 mM HEPES pH 7.4, 320 mM sucrose, 1 mM EDTA, 1 mM 
EGTA) containing Complete Protease Inhibitor Cocktail (Roche) and centrifuged for 10 min at 1000 x g 
to remove debris and the crude nuclear fraction. Samples were kept at 4°C throughout the 
procedure. The supernatant (S2) containing the cytosolic fraction of whole brain lysates was 
removed and stored at -80°C until used for in vitro phosphorylation assays. The remaining pellets 
(P2) containing the membrane fraction were solubilized in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 
mM NaCl, 1% NP-40, 0.5% deoxycholate) and were centrifuged for 30 min at 10000 x g to remove 
insoluble material. Solubilized brain membranes were stored at -80°C until used for 
immunoprecipitation and/or Western blot analysis. Synaptic plasma membranes were purified from 
total mouse brain by combined flotation-sedimentation density gradient centrifugation as described 
previously (6). 
 
Co-immunoprecipitation. Solubilized brain membranes were precleared for 3 h by incubation with 
protein G-agarose beads (Roche). Rabbit anti-GABAB1 antibody 174.1 (7) or guinea pig anti-GABAB2 
antibody (Chemicon) were added to the precleared lysates and incubated for 1 h followed by 
overnight incubation with protein G-agarose beads. Rabbit and guinea preimmune pig serum were 
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used as a control. Immunoprecipitated complexes were repeatedly washed with RIPA buffer, 
separated by SDS-PAGE and probed with an anti-CaMKIIα antibody (1:1000, Santa Cruz). 
 
GST-fusion proteins. To generate GST-GB1, the full-length C-terminus of GABAB1 (amino acids 857–
960) was amplified by PCR from rat GABAB1 cDNA (8), digested with BamHI and XhoI, and subcloned 
in-frame into pGEX-4T-1 fusion vector (GE Healthcare). GST-fusion protein expression vectors 
containing alanine substitutions of serine or threonine residues in the GABAB1 C-terminus (GST-
GB1S867A, GST-GB1T869A, GST-GB1T872A and GST-GB1T869A/T872A) were generated by 
overlapping PCR from GST-GB1. To generate GST-GB2, the full-length C-terminus of GABAB2 (amino 
acid 745-940) was amplified by PCR from rat GABAB2 cDNA (9), digested with BamHI and EcoRI and 
subcloned in-frame into pGEX-4T-1. GST-fusion proteins were expressed in E. coli BL21(DE3). 
Expression of the fusion-proteins was induced by 1 mM isopropyl 1-thio-β-D-galactopyranoside 
(IPTG) for 4 h. Cells were lysed by sonication and GST-fusion proteins were purified by incubation 
with Glutathione Sepharose 4B (Amersham Biosciences) overnight at 4°C and washed with PBS. 
 
Pull-down assay. Whole-brain lysates from BALB/c mice were prepared by polytron-homogenization 
in modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% Triton X-
100) containing Complete Protease Inhibitor Cocktail. Lysates were cleared by centrifugation at 
15700 x g for 30 min at 4°C and incubated for 4 h with GST-fusion proteins immobilized on sepharose 
beads. Following extensive washing in RIPA buffer, isolated proteins were eluted by boiling in 
Laemmli buffer, separated by SDS-PAGE and probed with anti-CaMKII antibody (1:5000, BD 
Biosciences). 
 
In vitro phosphorylation assay. GST-fusion proteins immobilized on sepharose beads were 
phosphorylated with recombinant CaMKII (New England Biolabs) or the cytosolic P2 fraction of 
whole-brain lysates prepared from BALB/c mice by polytron-homogenization in HEPES buffer. 
Recombinant CaMKII was activated in phosphorylation buffer for 10 min at 30°C, according to the 
manufacturer’s instructions. For whole-brain lysates the following phosphorylation buffer was used 
(in mM): 20 HEPES pH7.4, 1.7 CaCl2, 100 dithiothreitol, 10 MgCl2, 1.6 unlabeled ATP. For each 
phosphorylation reaction, 20 µg GST fusion-protein was incubated with recombinant CaMKII (500 
units) or whole-brain lysates (50 µg) in the appropriate phosphorylation buffer in the presence of 1 µl 
[γ-32P]-ATP (3000 Ci/mmol) for 30 min at 30°C. Free [γ-32P]-ATP was removed by extensive washing 
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with ice-cold phosphorylation buffer. To inhibit CaMKII activity, whole-brain extracts were 
preincubated with 10 µM KN-93 for 20 min at 4°C. Phosphorylated GST-fusion proteins were either 
separated by SDS-PAGE and subjected to autoradiography or subsequently used for RP-HPLC and ESI-
MS/MS analysis. 
 
Reverse-phase high-pressure liquid chromatography (RP-HPLC). For HPLC analysis, 20 µg of 
phosphorylated GST-fusion protein was digested with the endoproteinase Lys C (Wako Chemicals) 
followed by a second digestion with trypsin (Promega). Digestion was stopped by adding TFA 
(Applied Biosystems) to a final concentration of 0.1% (v/v). Insoluble material was removed by 
centrifugation (12000 rpm, 5 min) and the supernatant was subjected to RP-HPLC on Vydac C18 
reverse-phase columns (218TP52, 2.1 x 250 mm; Grace Vydac) connected to a Hewlett Packard 1090 
HPLC system. Bound peptides were eluted during 60 min at 150 μl/min with a linear gradient of 0.1% 
TFA/2% acetonitrile to 0.09% TFA/75% acetonitrile. The effluent was monitored at 214 nm. Fractions 
were collected at 1 min intervals. Phosphopeptides in the fractions were located by liquid 
scintillation counting. 
 
Electrospray ionization mass spectrometry (ESI-MS/MS). The radioactively labeled peptides were 
analyzed by capillary liquid chromatography tandem MS (LC/MS/MS) using a set up of a trapping 
300SB C-18 column (0.3x50 mm) (Agilent Technologies) and a separating column (0.1x100 mm) 
packed with Magic 300 Å C18 reverse-phase material (5 μm particle size, Michrom Bioresources Inc.). 
The columns were connected on line to an Orbitrap FT hybrid instrument (Thermo Finnigan). A linear 
gradient from 2 to 80% solvent B (0.1% acetic acid and 80% acetonitrile in water) in solvent A (0.1% 
acetic acid and 2% acetonitrile in water) in 85 min was delivered with a Rheos 2200 pump (Flux 
Instruments) at a flow rate of 100 μl/min. A pre-column split was used to reduce the flow to 100 
μl/min. The eluting peptides were ionized at 1.7 kV. The mass spectrometer was operated in a data-
dependent fashion. The precursor scan was done in the Orbitrap set to 60000 resolution, while the 
fragment ions were mass analyzed in the LTQ instrument. The five most intense precursors were 
selected for fragmentation. The MS/MS spectra were searched against the NCBI non-redundant 
database using TurboSequest or Mascot software (10, 11). 
 
Electrophysiology in cultured hippocampal neurons. Recordings were performed 1-2 weeks after 
transfection at DIV14-21 at room temperature (23-24ºC). Neurons were continuously superfused 
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with an extracellular solution (ECS) composed of (in mM): 145 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2, 10 
HEPES, 25 Glucose; pH 7.3, 323 mosm supplemented with 5 μM DNQX, 0.5 μM TTX, 0.3 μM 
strychnine, 100 μM picrotoxin. Patch pipettes had resistances between 3-4 MΩ when filled with 
intracellular solution composed of (in mM): 107.5 potassium gluconate, 32.5 KCl, 10 HEPES, 0.1 
EGTA, 4 MgATP, 0.6 NaGTP, 10 Tris phosphocreatine; pH 7.2, 297 mosm. Series resistance (< 5 MΩ) 
was compensated by 80%. GABAB responses were evoked by fast application of baclofen and 
recorded with an Axopatch 200B patch-clamp amplifier; filtering and sampling frequencies were set 
to 1 kHz and 5 kHz, respectively. Normalized K+ current amplitudes were calculated as the maximal 
baclofen-induced K+ current amplitudes recorded 30 min after pharmacological treatment relative to 
the maximal baclofen-induced K+ current amplitudes recorded before pharmacological treatment of 
the same neuron. 
 
Transfection of organotypic slice cultures and two-photon time-lapse imaging. Organotypic 
hippocampal slices were prepared from Wistar rats at postnatal day 5 as described (12). After 3 days 
in vitro, cultures were biolistically co-transfected with a Helios Gene Gun (Bio-Rad) with the following 
plasmids: GABAB1b or GABAB1bS867A N-terminally tagged with a pH-sensitive eGFP (Super Ecliptic 
pHluorin, SEP-GB1b or SEP-GB1bS867A, 2.2 µg DNA per mg gold), GABAB2 (2 µg/mg) and a freely 
diffusible red fluorescent protein (RFP) tdimer2 (1 µg/mg). Gene expression was under control of the 
neuron specific synapsin-1 promoter. For time-lapse imaging, we used a custom-built two-photon 
laser scanning microscope based on a BX51WI microscope (Olympus) and a pulsed Ti:Sapphire laser 
(Chameleon XR, Coherent) tuned to λ = 930 nm, controlled by the open source software ScanImage 
written in Matlab (13). Fluorescence was detected in epi- and transfluorescence mode using four 
photomultiplier tubes (R2896, Hamamatsu). The slice was placed into a perfusion chamber and 
superfused with ACSF containing (in mM): 127 NaCl, 25 NaHCO3, 25 D-glucose, 2.5 KCl, 4 CaCl2, 1.25 
NaH2PO4, 0.03 serine and 0.001 TTX (320 mosm, pH 7.4). In a subset of experiments 0.02 mM dCPP 
was added to the ACSF. Experiments were performed at 28°C. Stacks of images (256 × 256 pixels) 
from secondary dendritic branches were obtained from transfected CA1 pyramidal neurons (Z step: 
0.5 µm) Green fluorescence (SEP-GB1b or SEP-GB1bS867A) and red fluorescence (RFP) was imaged at 
5 min intervals before and after bath-application of NMDA and quantified in regions of interest 
(ROIs) containing either a dendritic shaft or spines. Control ROIs in the image background were 
always included and did not show changes in fluorescence during the course of the experiment. To 
quantify NMDA-mediated changes the green and red fluorescence intensities after NMDA application 
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(7 values) were normalized to the intensities before NMDA application (2 values). For the ratio 
images, we used a hue/saturation/brightness model, where hue was determined by the G/R ratio 
(using a rainbow color table), and the intensity in the red channel was used to set the brightness. To 
allow the comparison of ratio images the rainbow color table is scaled to encompass 2 standard 
deviations (2σ) of the average dendritic G/R pixel ratios before NMDA application. 
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Figure Legends 
Fig. S1. NMDA-dependent internalization of GABAB receptors. (A) Rat hippocampal neurons 
coexpressing exogenous HA-GB2 and GABAB1b were treated at DIV14 as indicated. Surface GABAB2 
(GB2) protein was fluorescence-labeled with anti-HA antibodies prior to permeabilization. Total GB2 
protein was fluorescence-labeled with anti-GB2 antibodies after permeabilization. Single optical 
planes captured with a confocal microscope are shown (scale bar = 15 µm). Insets show 
representative spines at higher magnification. Surface GB2 protein was quantified by the ratio of 
surface to total fluorescence intensity. Values were normalized to control values in the absence of 
any pharmacological treatment. Surface GB2 protein was significantly decreased following glutamate 
or NMDA treatment. No significant reduction was observed with glutamate treatment after 
preincubation with APV and with NMDA treatment after preincubation with KN-93 (glutamate: 54.4 ± 
13.2% of control, n = 10, **P < 0.01; glutamate + APV: 111 ± 8.7%, n = 8; NMDA: 55.9 ± 6.2%, n = 10, 
**P < 0.01; NMDA + KN-93: 105 ± 13.2, n = 10). (B) Rat hippocampal neurons coexpressing 
exogenous Myc-GB1a-eGFP and GABAB2 were treated at DIV14 as indicated. Surface GABAB1a (GB1a) 
protein was fluorescence-labelled with anti-Myc antibodies prior to permeabilization. Total GB1a 
protein was fluorescence-labeled with anti-eGFP antibodies after permeabilization. Single optical 
planes captured with a confocal microscope are shown (scale bar = 15 µm). Insets show 
representative spines at higher magnification. Note that GB1a does not efficiently penetrate the 
spines. Surface GB1a protein was quantified by the ratio of surface to total fluorescence intensity. 
Values were normalized to control values in the absence of any pharmacological treatment. Surface 
GB1a protein was decreased following glutamate or NMDA treatment, but this decrease did not 
reach statistical significance. No reduction in surface GB1a protein was observed with glutamate 
treatment after preincubation with APV and with NMDA treatment after preincubation with KN-93 
(glutamate: 62.5 ± 7.5% of control, n = 10; glutamate + APV: 108 ± 10.7%, n = 9; NMDA: 67.4 ± 9.6%, 
n = 8; NMDA + KN-93: 108 ± 15.5, n = 9). Quantification was from non-saturated images, data are 
presented as mean ± SEM; ns, not significant. 
 
Fig. S2. NMDA receptor-dependent internalization of GABAB receptors in neurons. (A) Rat 
hippocampal neuronal cultures were co-transfected with HA-GB1b-eGFP and GABAB2 expression 
vectors and analyzed at DIV14. Constitutive internalization was observed under control conditions. 
After glutamate treatment the rate of HA-GB1b-eGFP internalization was visibly increased. 
Preincubation with APV prevented glutamate-induced internalization of HA-GB1b-eGFP above 
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constitutive levels. NMDA treatment was sufficient to increase internalization of HA-GB1b-eGFP. 
Maximum projections of representative neurons visualized by confocal microscopy are shown. Scale 
bar = 15µm. (B) Rat hippocampal neurons were co-transfected with Myc-GB1b, GABAB2 and Rab11-
eGFP, which labels recycling endosomes. Under control conditions constitutively internalized GB1b 
appears to mostly co-localize with Rab11-eGFP. Following glutamate or NMDA treatment a fraction 
of internalized Myc-GB1b is observed in structures that are not labelled by Rab11-eGFP 
(arrowheads). Single optical planes of representative neurons visualized with confocal microscopy 
are shown. Scale bar = 15 µm. 
 
Fig. S3. Endogenous CaMKII phosphorylates S867 in GABAB1. (A-C) GST-fusion proteins were 
incubated with the cytosolic fraction of whole mouse brain extracts in the presence of [γ-32P]-ATP. 
Proteolytic peptides were separated by RP-HPLC (top panels) and the radioactivity in the eluted 
fractions determined (lower panels). (A) The C-terminal GABAB1 peptide GEWQSETQDTMK was 
identified by ESI-MS/MS as a major constituent of a highly radiolabeled fraction (asterisk) of the GST-
GB1 effluent. Because the phosphorylation stoichiometry with brain extracts was low, a direct 
demonstration of phosphorylation at S867 was impossible. (B) Following phosphorylation of GST-
GB1S867A with brain extracts no radiolabel was detected in the RP-HPLC fraction containing the 
peptide GEWQA867ETQDTMK (arrow head), supporting that brain extracts normally phosphorylate 
S867. (C) No radiolabel was detected in the fraction containing GEWQSETQDTMK (arrow head) after 
phosphorylation of GST-GB1 in the presence of KN-93, implicating native CaMKII in phosphorylation 
of S867. 
 
Fig. S4. Validation of the phosphorylation-state specific anti-GB1pS867 antibody. (A) The anti-
GB1pS867 antibody was generated against the phosphorylated peptide ITRGEWQpS867EAQDT and 
recognized GST-GB1 but not GST-GB1S867A after phosphorylation with recombinant CaMKII. 
Moreover, unphosphorylated GST-GB1 was not recognized by the anti-GB1p867 antibody 
demonstrating its specificity for phosphorylated S867 (top panel). The same blot was probed with an 
anti-GABAB1 antibody (anti-GB1) to demonstrate expression of the GST-fusion proteins (bottom 
panel). (B) In vitro phosphorylation of GST-GB1 with recombinant CaMKII and PKC in the presence of 
[γ-32P]-ATP. Phosphorylated proteins were separated by SDS-PAGE and exposed to autoradiography 
(top panel) or probed with anti-GB1pS867 (middle panel) or anti-GB1 (bottom panel). Anti-GB1pS867 
recognized GST-GB1 phosphorylated by CaMKII but not by PKC. 
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Fig. S5. Surface localization of transfected GABAB1b protein. Cultured hippocampal neurons 
expressing exogenous (A) HA-GB1b-eGFP (GB1b) or (B) HA-GB1bS867A-eGFP (GB1bS867A) together 
with GABAB2 were treated at DIV14 as indicated. Surface GB1b or GB1bS867A protein was 
fluorescence-labeled with anti-HA antibodies prior to permeabilization. Total GB1b or GB1bS867A 
protein was fluorescence-labeled with anti-eGFP antibodies after permeabilization. Alanine mutation 
of S867 prevented the NMDA-induced reduction of surface GB1b protein (quantification of data 
presented in Fig. 4D). Single optical planes captured with a confocal microscope are shown. Scale bar 
= 15 µm. Insets show representative spines at higher magnification. 
 
Fig. S6. Reduced NMDA-mediated internalization of SEP-GB1bS867A protein in dendritic spines and 
shafts. (A) Red fluorescence (R), green fluorescence (G) and G/R ratio images of dendrites expressing 
freely diffusible RFP and SEP-GB1bS867A before and after NMDA application. NMDA application does 
not lead to a decrease in green fluorescence in spines and only evokes minor internalization in shafts. 
The G/R ratio is coded in rainbow colors and is scaled to encompass 2 standard deviations (2σ) of the 
average dendritic ratio before NMDA application to allow direct comparison with Fig. 6A. Similar to 
GB1b (14), GB1bS867A is effectively excluded from axons (arrowheads). Scale bar = 5 µm. (B) Time 
course of red and green fluorescence in dendritic spines and shafts before and after NMDA 
application. 7 cells were analyzed; data are means ± SEM, spines: n = 34, dendrites: n = 7. 
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Table S1. Putative phosphorylation sites in the C-terminal domain of GABAB1. 
Residue Position 
Consensus 
Sequence 
Experimental 
Evidence 
Kinase 
Serine 867  this paper CaMKII 
 877    
 878 CK1   
 887    
 909    
 917  (1) AMPK 
 923 PKC   
 934    
 942 CaMKII   
 949    
 953    
Threonine 861 CaMKII/CK2   
 869 GRK   
 872 CK1/GRK/PKC   
 875 CK1   
 879 CK1   
 929 CK2/MAPK (2-5) not specified 
Tyrosine 959    
 
 
Prediction of phosphorylation sites in the C-terminal domain of GABAB1 with PredPhospho available 
at http://www.nih.go.kr/phosphovariant/html/predphospho.htm. Kinase(s) for each predicted 
phosphorylation site were allocated by consensus sequence. Where available experimental evidence 
is indicated and the kinase specified. 
 
1. Kuramoto N, et al. (2007) Phospho-dependent functional modulation of GABAB receptors by 
the metabolic sensor AMP-dependent protein kinase. Neuron 53:233-247. 
2. Trinidad JC, et al. (2006) Comprehensive identification of phosphorylation sites in 
postsynaptic density preparations. Mol Cell Proteomics 5:914-922. 
3. Munton RP, et al. (2007) Qualitative and quantitative analyses of protein phosphorylation in 
naive and stimulated mouse synaptosomal preparations. Mol Cell Proteomics 5:283-293. 
4. Trinidad JC, et al. (2008) Quantitative analysis of synaptic phosphorylation and protein 
expression. Mol Cell Proteomics 7:684-696. 
5. Schwenk J, et al. (2010) Native GABAB receptors are heteromultimers with a family of 
auxiliary subunits. Nature in press. 
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